
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Nanoparticle-based delivery systems for targeted therapy in brain tumors: Progress, challenges and perspectives (Review) - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E481DE8AEECAE30581DE005951A430.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="intjoncol">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370360/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="International Journal of Oncology">
<meta name="citation_title" content="Nanoparticle-based delivery systems for targeted therapy in brain tumors: Progress, challenges and perspectives (Review)">
<meta name="citation_author" content="Jing-Xing Si">
<meta name="citation_author_institution" content="Department of Neurosurgery, Cancer Center, Zhejiang Provincial People&#x27;s Hospital (Affiliated People&#x27;s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China">
<meta name="citation_author_institution" content="Clinical Research Institute, Zhejiang Provincial People&#x27;s Hospital (Affiliated People&#x27;s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China">
<meta name="citation_author" content="Zheng-Chuang Liu">
<meta name="citation_author_institution" content="Department of Neurosurgery, Cancer Center, Zhejiang Provincial People&#x27;s Hospital (Affiliated People&#x27;s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China">
<meta name="citation_author_institution" content="Clinical Research Institute, Zhejiang Provincial People&#x27;s Hospital (Affiliated People&#x27;s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China">
<meta name="citation_author" content="Fang Gu">
<meta name="citation_author_institution" content="Department of Paediatrics, Center for Reproductive Medicine, Zhejiang Provincial People&#x27;s Hospital (Affiliated People&#x27;s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China">
<meta name="citation_author" content="Xiaoli Jin">
<meta name="citation_author_institution" content="Department of Paediatrics, Center for Reproductive Medicine, Zhejiang Provincial People&#x27;s Hospital (Affiliated People&#x27;s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China">
<meta name="citation_author" content="Ying-Yu Ma">
<meta name="citation_author_institution" content="Department of Neurosurgery, Cancer Center, Zhejiang Provincial People&#x27;s Hospital (Affiliated People&#x27;s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China">
<meta name="citation_author_institution" content="Clinical Research Institute, Zhejiang Provincial People&#x27;s Hospital (Affiliated People&#x27;s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China">
<meta name="citation_publication_date" content="2025 Aug 19">
<meta name="citation_volume" content="67">
<meta name="citation_issue" content="4">
<meta name="citation_firstpage" content="83">
<meta name="citation_doi" content="10.3892/ijo.2025.5789">
<meta name="citation_pmid" content="40849813">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370360/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370360/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370360/pdf/ijo-67-04-05789.pdf">
<meta name="description" content="Brain tumors, particularly gliomas, are among the most lethal malignancies, with high mortality driven by a delayed diagnosis and limited therapeutic efficacy. A central challenge lies in the presence of the blood-brain barrier (BBB), which severely ...">
<meta name="og:title" content="Nanoparticle-based delivery systems for targeted therapy in brain tumors: Progress, challenges and perspectives (Review)">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Brain tumors, particularly gliomas, are among the most lethal malignancies, with high mortality driven by a delayed diagnosis and limited therapeutic efficacy. A central challenge lies in the presence of the blood-brain barrier (BBB), which severely ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370360/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12370360">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3892/ijo.2025.5789"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/ijo-67-04-05789.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12370360%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12370360/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12370360/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370360/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-intjoncol.gif" alt="International Journal of Oncology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to International Journal of Oncology" title="Link to International Journal of Oncology" shape="default" href="http://www.spandidos-publications.com/ijo" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Int J Oncol</button></div>. 2025 Aug 19;67(4):83. doi: <a href="https://doi.org/10.3892/ijo.2025.5789" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3892/ijo.2025.5789</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Int%20J%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Int%20J%20Oncol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Int%20J%20Oncol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Int%20J%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Nanoparticle-based delivery systems for targeted therapy in brain tumors: Progress, challenges and perspectives (Review)</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Si%20JX%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Jing-Xing Si</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Jing-Xing Si</span></h3>
<div class="p">
<sup>1</sup>Department of Neurosurgery, Cancer Center, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China</div>
<div class="p">
<sup>2</sup>Clinical Research Institute, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Si%20JX%22%5BAuthor%5D" class="usa-link"><span class="name western">Jing-Xing Si</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20ZC%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Zheng-Chuang Liu</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Zheng-Chuang Liu</span></h3>
<div class="p">
<sup>1</sup>Department of Neurosurgery, Cancer Center, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China</div>
<div class="p">
<sup>2</sup>Clinical Research Institute, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20ZC%22%5BAuthor%5D" class="usa-link"><span class="name western">Zheng-Chuang Liu</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gu%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Fang Gu</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Fang Gu</span></h3>
<div class="p">
<sup>3</sup>Department of Paediatrics, Center for Reproductive Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gu%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Fang Gu</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jin%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Xiaoli Jin</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Xiaoli Jin</span></h3>
<div class="p">
<sup>3</sup>Department of Paediatrics, Center for Reproductive Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jin%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiaoli Jin</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ma%20YY%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Ying-Yu Ma</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Ying-Yu Ma</span></h3>
<div class="p">
<sup>1</sup>Department of Neurosurgery, Cancer Center, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China</div>
<div class="p">
<sup>2</sup>Clinical Research Institute, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ma%20YY%22%5BAuthor%5D" class="usa-link"><span class="name western">Ying-Yu Ma</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="af1-ijo-67-04-05789">
<sup>1</sup>Department of Neurosurgery, Cancer Center, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China</div>
<div id="af2-ijo-67-04-05789">
<sup>2</sup>Clinical Research Institute, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China</div>
<div id="af3-ijo-67-04-05789">
<sup>3</sup>Department of Paediatrics, Center for Reproductive Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China</div>
<div class="author-notes p"><div class="fn" id="c1-ijo-67-04-05789">
<sup>✉</sup><p class="display-inline">Correspondence to: Dr Ying-Yu Ma, Clinical Research Institute, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, 158 Shangtang Road, Hangzhou, Zhejiang 310014, P.R. China, E-mail: <span>myy011525@163.com</span></p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Apr 29; Accepted 2025 Aug 1; Collection date 2025 Oct.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright: © 2025 Si et al.</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution-NonCommercial-NoDerivs License</a>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12370360  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40849813/" class="usa-link">40849813</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Brain tumors, particularly gliomas, are among the most lethal malignancies, with high mortality driven by a delayed diagnosis and limited therapeutic efficacy. A central challenge lies in the presence of the blood-brain barrier (BBB), which severely impedes the delivery of systemically administered therapeutics to tumor sites. Addressing this clinical urgency, nanoparticle (NP)-based delivery systems have emerged as a transformative strategy to enhance brain-specific drug accumulation, minimize off-target toxicity and improve treatment outcomes. The present review systematically examined the recent advances in nanocarrier technologies for targeted brain tumor therapy, including liposomes, solid lipid NPs, dendrimers, polymeric nanoplatforms and inorganic nanomaterials. The design principles, mechanisms for BBB traversal, therapeutic payload compatibility and tumor-targeting capabilities of NP technologies demonstrated in preclinical models have also been highlighted. In addition to drug delivery, emerging applications of nanocarriers in gene therapy were explored and the impact of protein corona formation on NP behavior <em>in vivo</em> was discussed. Finally, current translational bottlenecks were identified and future design considerations to achieve clinically viable, precision-targeted nanomedicines for brain tumors were outlined.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Key words:</strong> nanoparticle, delivery systems, targeted therapy, brain tumors</p></section></section><section id="sec1"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Brain tumors, especially those originating in the central nervous system (CNS) such as gliomas, rank among the most aggressive and lethal forms of cancer. Gliomas are typically derived from neural stem cells, progenitor cells or dedifferentiated mature neural cells, and are characterized by a poor 5-year survival rate of &lt;30% (<a href="#b1-ijo-67-04-05789" class="usa-link" aria-describedby="b1-ijo-67-04-05789">1</a>,<a href="#b2-ijo-67-04-05789" class="usa-link" aria-describedby="b2-ijo-67-04-05789">2</a>). The poor survival rate associated with brain tumors can be ascribed to the difficulty of an early diagnosis (<a href="#b3-ijo-67-04-05789" class="usa-link" aria-describedby="b3-ijo-67-04-05789">3</a>) and the lack of standard treatment regimens (<a href="#b4-ijo-67-04-05789" class="usa-link" aria-describedby="b4-ijo-67-04-05789">4</a>).</p>
<p>A major obstacle in brain tumor therapy is the presence of physiological barriers, most notably, the blood-brain barrier (BBB) and the blood-brain tumor barrier, that severely limit the delivery of therapeutic agents to intracranial tumors (<a href="#b5-ijo-67-04-05789" class="usa-link" aria-describedby="b5-ijo-67-04-05789">5</a>,<a href="#b6-ijo-67-04-05789" class="usa-link" aria-describedby="b6-ijo-67-04-05789">6</a>). These barriers restrict the permeability of most chemotherapeutic agents and are compounded by active efflux mechanisms and insufficient tumor specificity (<a href="#b7-ijo-67-04-05789" class="usa-link" aria-describedby="b7-ijo-67-04-05789">7</a>,<a href="#b8-ijo-67-04-05789" class="usa-link" aria-describedby="b8-ijo-67-04-05789">8</a>). As a result, conventional treatment strategies often fail to deliver adequate drug concentrations to the tumor site, diminishing therapeutic efficacy and increasing the risk of systemic toxicity (<a href="#b8-ijo-67-04-05789" class="usa-link" aria-describedby="b8-ijo-67-04-05789">8</a>). To address these challenges, increasing attention has been directed toward the development of drug delivery systems capable of traversing the BBB and achieving site-specific accumulation within tumor tissues. In this context, nanomedicine has emerged as a particularly promising approach. Among its various applications, nanoparticle (NP)-based delivery systems stand out for their ability to enhance the pharmacokinetic and pharmacodynamic profiles of therapeutic agents (<a href="#b9-ijo-67-04-05789" class="usa-link" aria-describedby="b9-ijo-67-04-05789">9</a>,<a href="#b10-ijo-67-04-05789" class="usa-link" aria-describedby="b10-ijo-67-04-05789">10</a>). Rapid progress in nanotechnology has led to the design and optimization of various nanocarriers, such as liposomes, solid lipid NPs (SLNs), dendrimers, polymeric micelles and inorganic NPs, that are engineered with specific physicochemical properties, including particle size, surface charge and ligand functionalization, to enhance biological compatibility and targeting efficiency (<a href="#b9-ijo-67-04-05789" class="usa-link" aria-describedby="b9-ijo-67-04-05789">9</a>). These tailored systems have demonstrated the ability to across the BBB, accumulate selectively in tumor tissues and facilitate efficient cellular uptake; thereby, enabling localized and sustained therapeutic effects. In neuro-oncology, NP-based platforms have shown strong potential for selective tumor accumulation and localized drug release, reducing off-target effects and enhancing treatment efficacy (<a href="#b10-ijo-67-04-05789" class="usa-link" aria-describedby="b10-ijo-67-04-05789">10</a>).</p>
<p>Unlike a number of existing reviews that separately discuss drug (<a href="#b8-ijo-67-04-05789" class="usa-link" aria-describedby="b8-ijo-67-04-05789">8</a>,<a href="#b9-ijo-67-04-05789" class="usa-link" aria-describedby="b9-ijo-67-04-05789">9</a>,<a href="#b11-ijo-67-04-05789" class="usa-link" aria-describedby="b11-ijo-67-04-05789">11</a>) or gene (<a href="#b12-ijo-67-04-05789" class="usa-link" aria-describedby="b12-ijo-67-04-05789">12</a>,<a href="#b13-ijo-67-04-05789" class="usa-link" aria-describedby="b13-ijo-67-04-05789">13</a>) delivery systems, the present review systematically integrates both therapeutic modalities. This comprehensive synthesis provides a holistic view of how different nanocarriers, ranging from liposomes to dendrimers and inorganic systems, are being engineered to deliver not only chemotherapeutics but also genetic payloads [such as small interfering RNA (siRNA), short hairpin RNA (shRNA) and micro RNA (miRNA)] across the BBB. Furthermore, the present review also adopts a material-based classification (lipid-based, dendritic, polymeric and inorganic nanocarriers) rather than a payload-based or mechanism-based classification. This structure allows readers to directly compare and contrast the physicochemical properties, targeting strategies and translational potential of each nanocarrier platform. To address the gap between bench and bedside, a new section titled 'Clinical challenges in translating NP-based therapies for brain tumors' is also introduced, where the limitations in immunogenicity, scalability, model relevance and human BBB heterogeneity (critical considerations that are often overlooked in reviews focused solely on laboratory advancements) are discussed (<a href="#b14-ijo-67-04-05789" class="usa-link" aria-describedby="b14-ijo-67-04-05789">14</a>-<a href="#b18-ijo-67-04-05789" class="usa-link" aria-describedby="b18-ijo-67-04-05789">18</a>). To support conceptual understanding, new schematic diagrams illustrating the BBB structure, transport mechanisms and NP-cell interactions are presented, which distinguish the present review from more text-heavy reviews. We consider that these additions and the integrative approach significantly enhance the value of the present review and differentiate it from prior literature in the field.</p></section><section id="sec2"><h2 class="pmc_sec_title">2. Structural features and transport mechanisms of the BBB</h2>
<p>The BBB is a dynamic and highly selective interface that separates the systemic circulation from the CNS. The BBB plays a pivotal role in maintaining neural homeostasis by strictly regulating the entry of ions, nutrients and xenobiotics into the brain parenchyma (<a href="#b5-ijo-67-04-05789" class="usa-link" aria-describedby="b5-ijo-67-04-05789">5</a>). However, this protective function also presents a challenge for the delivery of therapeutics to brain tumors, including glioblastoma multiforme (GBM), which requires sustained and targeted drug accumulation in the tumor microenvironment (<a href="#b6-ijo-67-04-05789" class="usa-link" aria-describedby="b6-ijo-67-04-05789">6</a>).</p>
<section id="sec3"><h3 class="pmc_sec_title">Structural and functional composition of the BBB</h3>
<p>The BBB is composed primarily of a monolayer of non-fenestrated endothelial cells that are tightly sealed by continuous tight junctions (TJs). These endothelial cells function within the context of the neurovascular unit, which includes pericytes embedded within the basement membrane, astrocyte end-foot processes that ensheath &gt;90% of the vascular surface and the surrounding extracellular matrix components, such as collagen and laminin (<a href="#f1-ijo-67-04-05789" class="usa-link">Fig. 1A</a>) (<a href="#b19-ijo-67-04-05789" class="usa-link" aria-describedby="b19-ijo-67-04-05789">19</a>). Together, these elements ensure integrity, selectivity and homeostatic regulation of the brain microenvironment.</p>
<figure class="fig xbox font-sm" id="f1-ijo-67-04-05789"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370360_ijo-67-04-05789-g00.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/408e/12370360/97102afe46e1/ijo-67-04-05789-g00.jpg" loading="lazy" height="605" width="677" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/f1-ijo-67-04-05789/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Structural and transport features of the BBB. (A) Overview of the brain capillaries and the neurovascular unit, including endothelial cells, pericytes and astrocyte end-feet. (B) Tight junctions formed by claudins, occludin and ZO-1 limit paracellular diffusion. (C) The main BBB transport pathways include transcellular diffusion, paracellular transport, receptor-mediated and adsorptive transcytosis, efflux by ABC transporters and influx via solute carrier proteins. This figure was created in BioRender (paid version; <a href="https://www.biorender.com/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.biorender.com/</a>). BBB, blood-brain barrier; ZO-1, zonula occludens-1; Ang-2, angiopoietin-2.</p></figcaption></figure><p>BBB endothelial cells possess a unique set of functional characteristics that distinguish them from cells in the peripheral vasculature. A key feature of BBB endothelial cells is their exceptionally high transendothelial electrical resistance, often exceeding 1,000-2,000 Ω cm<sup>2</sup>
<em>in vivo</em>, which effectively limits paracellular diffusion of water-soluble and charged molecules (<a href="#b20-ijo-67-04-05789" class="usa-link" aria-describedby="b20-ijo-67-04-05789">20</a>,<a href="#b21-ijo-67-04-05789" class="usa-link" aria-describedby="b21-ijo-67-04-05789">21</a>). Moreover, these cells exhibit markedly low rates of pinocytosis and transcytosis; thereby, restricting non-specific vesicular transport and preserving the selectivity of the barrier (<a href="#b22-ijo-67-04-05789" class="usa-link" aria-describedby="b22-ijo-67-04-05789">22</a>). Notably, the BBB possesses an active drug efflux system, predominantly mediated by adenosine triphosphate-binding cassette transporters, which effectively transport a wide variety of endogenous metabolites and exogenous compounds, such as a number of chemotherapeutic agents, back into the bloodstream (<a href="#b23-ijo-67-04-05789" class="usa-link" aria-describedby="b23-ijo-67-04-05789">23</a>).</p>
<p>At the molecular level, the restrictive nature of the BBB is governed by the TJ complexes located at the apical lateral membrane between adjacent endothelial cells. These complexes are composed of integral membrane proteins, such as claudins (particularly claudin-5), occludin and junctional adhesion molecules. These proteins are anchored intracellularly by cytoplasmic scaffold proteins that include zonula occludens-1 (ZO-1), ZO-2 and cingulin (<a href="#f1-ijo-67-04-05789" class="usa-link">Fig. 1B</a>) (<a href="#b24-ijo-67-04-05789" class="usa-link" aria-describedby="b24-ijo-67-04-05789">24</a>). These structures not only maintain the structural cohesion of the endothelial monolayer but also dynamically regulate paracellular permeability in response to physiological or pathological stimuli.</p>
<p>Collectively, these structural and functional features make the BBB an extraordinarily effective yet formidable obstacle to therapeutic delivery, especially in the treatment of brain tumors. Therefore, any strategy that enhances drug penetration into the brain must be designed with a comprehensive understanding of this intricate barrier system.</p></section><section id="sec4"><h3 class="pmc_sec_title">Main transport pathways across the BBB</h3>
<p>Despite its restrictive nature, the BBB allows specific translocation of molecules through several tightly regulated pathways (<a href="#f1-ijo-67-04-05789" class="usa-link">Fig. 1C</a>) (<a href="#b19-ijo-67-04-05789" class="usa-link" aria-describedby="b19-ijo-67-04-05789">19</a>). Among the various mechanisms, the paracellular route refers to the movement of hydrophilic molecules between adjacent endothelial cells. However, this pathway is effectively sealed in the BBB due to the presence of TJs, which consist of transmembrane proteins (such as claudins, occludin and junctional adhesion molecules) connected to the cytoskeleton via adaptor proteins, such as ZO-1 and ZO-2 (<a href="#b25-ijo-67-04-05789" class="usa-link" aria-describedby="b25-ijo-67-04-05789">25</a>). Unless TJ modulators or novel nanotechnologies are used, most drugs fail to achieve effective brain exposure via paracellular diffusion (<a href="#b26-ijo-67-04-05789" class="usa-link" aria-describedby="b26-ijo-67-04-05789">26</a>). However, even when TJs are transiently loosened through pharmacological or physical means to enhance permeability, the risks of drug-induced toxicity and barrier disruption persist and limit the clinical applicability of the paracellular pathway (<a href="#b27-ijo-67-04-05789" class="usa-link" aria-describedby="b27-ijo-67-04-05789">27</a>,<a href="#b28-ijo-67-04-05789" class="usa-link" aria-describedby="b28-ijo-67-04-05789">28</a>). Therefore, the paracellular aqueous pathway contributes minimally to drug penetration and remains a formidable hurdle in brain tumor therapy.</p>
<p>Unlike the paracellular pathway, the transcellular lipophilic route allows small, lipid-soluble compounds to diffuse directly through endothelial cell membranes. This route is exploited by endogenous molecules, such as oxygen, carbon dioxide and certain hormones, as well as small-molecule drugs, such as some anesthetics. However, successful diffusion requires favorable physicochemical characteristics; typically, low molecular weight, low hydrogen-bonding potential and a relatively high logP value for the lipid-water partition coefficient (<a href="#b29-ijo-67-04-05789" class="usa-link" aria-describedby="b29-ijo-67-04-05789">29</a>-<a href="#b31-ijo-67-04-05789" class="usa-link" aria-describedby="b31-ijo-67-04-05789">31</a>). Numerous anticancer drugs and alkylating agents, including doxorubicin (DOX) or temozolomide (<a href="#b32-ijo-67-04-05789" class="usa-link" aria-describedby="b32-ijo-67-04-05789">32</a>) and monoclonal antibodies (<a href="#b33-ijo-67-04-05789" class="usa-link" aria-describedby="b33-ijo-67-04-05789">33</a>), do not meet these criteria, rendering passive diffusion across the BBB inefficient. Moreover, even lipophilic drugs are often subject to rapid efflux via transporters, such as P-glycoprotein, further limiting their accumulation in the brain (<a href="#b34-ijo-67-04-05789" class="usa-link" aria-describedby="b34-ijo-67-04-05789">34</a>).</p>
<p>Receptor-mediated transcytosis (RMT) is one of the most promising routes for NP-based delivery across the BBB due to its high specificity, affinity and potential for receptor recycling. This mechanism involves ligand binding to specific receptors on the luminal surface of endothelial cells, followed by clathrin-mediated endocytosis and exocytosis into the brain parenchyma (<a href="#b11-ijo-67-04-05789" class="usa-link" aria-describedby="b11-ijo-67-04-05789">11</a>,<a href="#b35-ijo-67-04-05789" class="usa-link" aria-describedby="b35-ijo-67-04-05789">35</a>). Numerous preclinical studies have shown that NPs conjugated with ligands, such as transferrin, lactoferrin, angiopep-2 or monoclonal antibodies targeting the transferrin receptor or the insulin receptor, achieve significantly enhanced brain penetration (<a href="#b36-ijo-67-04-05789" class="usa-link" aria-describedby="b36-ijo-67-04-05789">36</a>-<a href="#b38-ijo-67-04-05789" class="usa-link" aria-describedby="b38-ijo-67-04-05789">38</a>). These ligands not only facilitate BBB transcytosis but also enable subsequent tumor targeting, making RMT an attractive platform for theranostic applications in glioblastoma and other CNS malignancies.</p>
<p>Adsorptive-mediated transcytosis (AMT) relies on electrostatic interactions between the negatively-charged luminal surface of endothelial cells and positively-charged ligands or carriers (<a href="#b39-ijo-67-04-05789" class="usa-link" aria-describedby="b39-ijo-67-04-05789">39</a>). This non-specific mechanism is particularly useful to enhance the transport of cationic proteins (<a href="#b40-ijo-67-04-05789" class="usa-link" aria-describedby="b40-ijo-67-04-05789">40</a>), peptides (<a href="#b41-ijo-67-04-05789" class="usa-link" aria-describedby="b41-ijo-67-04-05789">41</a>) and NPs (<a href="#b42-ijo-67-04-05789" class="usa-link" aria-describedby="b42-ijo-67-04-05789">42</a>) across the BBB. Cell-penetrating peptides, such as trans-activator of transcription (TAT), penetratin and rabies virus glycoprotein 29, have been widely used to facilitate AMT-mediated delivery of both small molecules and macromolecules (<a href="#b43-ijo-67-04-05789" class="usa-link" aria-describedby="b43-ijo-67-04-05789">43</a>-<a href="#b45-ijo-67-04-05789" class="usa-link" aria-describedby="b45-ijo-67-04-05789">45</a>). Although AMT is less selective than RMT, it has the advantage of delivering diverse payloads independent of specific receptor expression, which expands its applicability across different brain tumor subtypes. However, the use of strong cationic charges must be balanced against the risk of cytotoxicity and non-specific distribution.</p>
<p>Solute carrier transporters constitute a broad family of influx proteins at the BBB that enable the uptake of essential nutrients, metabolites and ions into the brain (<a href="#b46-ijo-67-04-05789" class="usa-link" aria-describedby="b46-ijo-67-04-05789">46</a>). These transporters include glucose transporter 1, which facilitates glucose entry (<a href="#b47-ijo-67-04-05789" class="usa-link" aria-describedby="b47-ijo-67-04-05789">47</a>), L-type amino acid transporter 1, which is responsible for transporting large neutral amino acids (<a href="#b48-ijo-67-04-05789" class="usa-link" aria-describedby="b48-ijo-67-04-05789">48</a>), and monocarboxylate transporters, which mediate the influx of lactate and other monocarboxylates (<a href="#b49-ijo-67-04-05789" class="usa-link" aria-describedby="b49-ijo-67-04-05789">49</a>). Notably, these transporters can be harnessed for brain-targeted drug delivery by chemically modifying drugs or nanocarriers to resemble endogenous substrates. For example, glucose-conjugated or amino acid-decorated NPs have shown promise in facilitating carrier-mediated transport across the BBB (<a href="#b50-ijo-67-04-05789" class="usa-link" aria-describedby="b50-ijo-67-04-05789">50</a>). Such approaches offer a non-invasive, receptor-independent route to enhance the delivery of small-molecule therapeutics or genetic materials into brain tumor tissues, making solute carrier-mediated influx an attractive mechanism for developing effective brain-targeted therapies.</p>
<p>An in-depth understanding of these transport routes is critical for designing effective nanocarrier platforms for brain tumor therapy. Functionalization with targeting ligands (such as angiopep-2 and transferrin) enables RMT-based entry, while surface charge modulation enhances AMT. Dual-targeting strategies that combine BBB penetration with tumor specificity are also emerging as effective approaches for glioma therapy.</p></section></section><section id="sec5"><h2 class="pmc_sec_title">3. NP-based drug delivery in brain tumors</h2>
<p>Advancements in nanotechnology have opened new avenues to overcome the notable challenges posed by the BBB and the complex microenvironment of brain tumors. In particular, NP-based delivery systems offer versatile platforms capable of transporting a wide array of therapeutic agents across the BBB, including small-molecule drugs, nucleic acids and gene-editing constructs, with enhanced precision, stability and efficacy. Over the past decade, a diverse spectrum of nanocarriers has been engineered to meet the distinct physicochemical and biological requirements of CNS drug delivery. These include lipid-based carriers, such as liposomes and SLNs (<a href="#b51-ijo-67-04-05789" class="usa-link" aria-describedby="b51-ijo-67-04-05789">51</a>,<a href="#b52-ijo-67-04-05789" class="usa-link" aria-describedby="b52-ijo-67-04-05789">52</a>), polymeric NPs (<a href="#b50-ijo-67-04-05789" class="usa-link" aria-describedby="b50-ijo-67-04-05789">50</a>) constructed from biodegradable materials, such as poly(lactic-co-glycolic acid) (PLGA) (<a href="#b53-ijo-67-04-05789" class="usa-link" aria-describedby="b53-ijo-67-04-05789">53</a>) or polyethylene glycol (PEG) (<a href="#b50-ijo-67-04-05789" class="usa-link" aria-describedby="b50-ijo-67-04-05789">50</a>), dendrimers with highly-branched architectures (<a href="#b54-ijo-67-04-05789" class="usa-link" aria-describedby="b54-ijo-67-04-05789">54</a>) and inorganic systems, such as gold NPs (AuNPs) (<a href="#b55-ijo-67-04-05789" class="usa-link" aria-describedby="b55-ijo-67-04-05789">55</a>), graphene oxide (GO) (<a href="#b56-ijo-67-04-05789" class="usa-link" aria-describedby="b56-ijo-67-04-05789">56</a>) and magnetic iron oxide NPs (IONPs) (<a href="#b57-ijo-67-04-05789" class="usa-link" aria-describedby="b57-ijo-67-04-05789">57</a>). These platforms possess unique advantages in drug loading capacity, targeting capabilities, biocompatibility and multifunctionality, making them suitable not only for conventional chemotherapy but also for gene silencing, messenger RNA replacement and immunomodulation. <a href="#tI-ijo-67-04-05789" class="usa-link">Table I</a> (<a href="#b50-ijo-67-04-05789" class="usa-link" aria-describedby="b50-ijo-67-04-05789">50</a>-<a href="#b69-ijo-67-04-05789" class="usa-link" aria-describedby="b69-ijo-67-04-05789">69</a>) summarizes representative NP-based delivery systems applied to brain tumor therapy, highlighting their physicochemical characteristics (such as particle size and zeta potential), payloads, targeting strategies and therapeutic outcomes. Furthermore, given the formidable barrier posed by the BBB, a variety of surface modification approaches have been developed to enhance nanocarrier penetration and targeting efficiency. These approaches, including ligand conjugation, cell-penetrating peptides and stimuli-responsive coatings, are summarized in <a href="#tII-ijo-67-04-05789" class="usa-link">Table II</a> (<a href="#b7-ijo-67-04-05789" class="usa-link" aria-describedby="b7-ijo-67-04-05789">7</a>,<a href="#b70-ijo-67-04-05789" class="usa-link" aria-describedby="b70-ijo-67-04-05789">70</a>-<a href="#b86-ijo-67-04-05789" class="usa-link" aria-describedby="b86-ijo-67-04-05789">86</a>).</p>
<section class="tw xbox font-sm" id="tI-ijo-67-04-05789"><h3 class="obj_head">Table I.</h3>
<div class="caption p"><p>Summary of nanoparticle-based delivery systems for brain tumor therapy.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr><th colspan="10" valign="top" align="left" rowspan="1">A, Lipid-based
<hr>
</th></tr>
<tr>
<th valign="top" align="left" rowspan="1" colspan="1">First author, year</th>
<th valign="top" align="center" rowspan="1" colspan="1">Nanocarrier type</th>
<th valign="top" align="center" rowspan="1" colspan="1">Particle size (nm)</th>
<th valign="top" align="center" rowspan="1" colspan="1">Surface charge (zeta potential)</th>
<th valign="top" align="center" rowspan="1" colspan="1">Drug loading efficiency (%)</th>
<th valign="top" align="center" rowspan="1" colspan="1">Encapsulation efficiency (%)</th>
<th valign="top" align="center" rowspan="1" colspan="1">Therapeutic payload</th>
<th valign="top" align="center" rowspan="1" colspan="1">Application mode</th>
<th valign="top" align="center" rowspan="1" colspan="1">Targeting strategy</th>
<th valign="top" align="center" rowspan="1" colspan="1">(Refs.)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Cen <em>et al</em>, 2023</td>
<td valign="top" align="left" rowspan="1" colspan="1">Liposomes</td>
<td valign="top" align="center" rowspan="1" colspan="1">120-170</td>
<td valign="top" align="left" rowspan="1" colspan="1">Negative</td>
<td valign="top" align="center" rowspan="1" colspan="1">5.5</td>
<td valign="top" align="center" rowspan="1" colspan="1">90</td>
<td valign="top" align="left" rowspan="1" colspan="1">DOX</td>
<td valign="top" align="center" rowspan="1" colspan="1">Drug</td>
<td valign="top" align="left" rowspan="1" colspan="1">Mitochondria-targeting</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b58-ijo-67-04-05789" class="usa-link" aria-describedby="b58-ijo-67-04-05789">58</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Zong <em>et al</em>, 2014</td>
<td valign="top" align="left" rowspan="1" colspan="1">Liposomes</td>
<td valign="top" align="center" rowspan="1" colspan="1">100-120</td>
<td valign="top" align="left" rowspan="1" colspan="1">Negative</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">90</td>
<td valign="top" align="left" rowspan="1" colspan="1">DOX</td>
<td valign="top" align="center" rowspan="1" colspan="1">Drug</td>
<td valign="top" align="left" rowspan="1" colspan="1">TAT/T7 dual-targeting</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b63-ijo-67-04-05789" class="usa-link" aria-describedby="b63-ijo-67-04-05789">63</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Estella-Hermoso de Mendoza <em>et al</em>, 2011</td>
<td valign="top" align="left" rowspan="1" colspan="1">SLNs</td>
<td valign="top" align="center" rowspan="1" colspan="1">105-140</td>
<td valign="top" align="left" rowspan="1" colspan="1">Negative</td>
<td valign="top" align="center" rowspan="1" colspan="1">15.31±3.29</td>
<td valign="top" align="center" rowspan="1" colspan="1">85</td>
<td valign="top" align="left" rowspan="1" colspan="1">Edelfosine</td>
<td valign="top" align="center" rowspan="1" colspan="1">Drug</td>
<td valign="top" align="left" rowspan="1" colspan="1">Passive accumulation</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b52-ijo-67-04-05789" class="usa-link" aria-describedby="b52-ijo-67-04-05789">52</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Pandian <em>et al</em>, 2021</td>
<td valign="top" align="left" rowspan="1" colspan="1">SLNs</td>
<td valign="top" align="center" rowspan="1" colspan="1">113</td>
<td valign="top" align="left" rowspan="1" colspan="1">Negative</td>
<td valign="top" align="center" rowspan="1" colspan="1">22.14±1.2</td>
<td valign="top" align="center" rowspan="1" colspan="1">88±2.05</td>
<td valign="top" align="left" rowspan="1" colspan="1">Rutin</td>
<td valign="top" align="center" rowspan="1" colspan="1">Drug</td>
<td valign="top" align="left" rowspan="1" colspan="1">EGFR targeting</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b54-ijo-67-04-05789" class="usa-link" aria-describedby="b54-ijo-67-04-05789">54</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Campani <em>et al</em>, 2020</td>
<td valign="top" align="left" rowspan="1" colspan="1">LPHNs</td>
<td valign="top" align="center" rowspan="1" colspan="1">120-160</td>
<td valign="top" align="left" rowspan="1" colspan="1">Positive</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">72-100</td>
<td valign="top" align="left" rowspan="1" colspan="1">miR 603</td>
<td valign="top" align="center" rowspan="1" colspan="1">Gene</td>
<td valign="top" align="left" rowspan="1" colspan="1">Passive accumulation</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b51-ijo-67-04-05789" class="usa-link" aria-describedby="b51-ijo-67-04-05789">51</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Saw <em>et al</em>, 2018</td>
<td valign="top" align="left" rowspan="1" colspan="1">Liposomes</td>
<td valign="top" align="center" rowspan="1" colspan="1">~112</td>
<td valign="top" align="left" rowspan="1" colspan="1">Neutral</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">90</td>
<td valign="top" align="left" rowspan="1" colspan="1">siRNA</td>
<td valign="top" align="center" rowspan="1" colspan="1">Gene</td>
<td valign="top" align="left" rowspan="1" colspan="1">EDB-targeting</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b62-ijo-67-04-05789" class="usa-link" aria-describedby="b62-ijo-67-04-05789">62</a>)</td>
</tr>
<tr><td colspan="10" align="left" valign="bottom" rowspan="1">
<hr>
</td></tr>
<tr><td colspan="10" valign="top" align="left" rowspan="1">B, Dendrimers</td></tr>
<tr><td colspan="10" align="left" valign="bottom" rowspan="1">
<hr>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">First author, year</td>
<td valign="top" align="center" rowspan="1" colspan="1">Nanocarrier type</td>
<td valign="top" align="center" rowspan="1" colspan="1">Particle size (nm)</td>
<td valign="top" align="center" rowspan="1" colspan="1">Surface charge (zeta potential)</td>
<td valign="top" align="center" rowspan="1" colspan="1">Drug loading efficiency (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">Encapsulation efficiency (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">Therapeutic payload</td>
<td valign="top" align="center" rowspan="1" colspan="1">Application mode</td>
<td valign="top" align="center" rowspan="1" colspan="1">Targeting strategy</td>
<td valign="top" align="center" rowspan="1" colspan="1">(Refs.)</td>
</tr>
<tr><td colspan="10" align="left" valign="bottom" rowspan="1">
<hr>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">He <em>et al</em>, 2011</td>
<td valign="top" align="left" rowspan="1" colspan="1">PAMAM</td>
<td valign="top" align="center" rowspan="1" colspan="1">~14</td>
<td valign="top" align="left" rowspan="1" colspan="1">Neutral</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">DOX</td>
<td valign="top" align="center" rowspan="1" colspan="1">Drug</td>
<td valign="top" align="left" rowspan="1" colspan="1">Tf/WGA dual-targeting</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b59-ijo-67-04-05789" class="usa-link" aria-describedby="b59-ijo-67-04-05789">59</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Liu <em>et al</em>, 2019</td>
<td valign="top" align="left" rowspan="1" colspan="1">PAMAM</td>
<td valign="top" align="center" rowspan="1" colspan="1">7-34</td>
<td valign="top" align="left" rowspan="1" colspan="1">Positive</td>
<td valign="top" align="center" rowspan="1" colspan="1">4.3</td>
<td valign="top" align="center" rowspan="1" colspan="1">58.9</td>
<td valign="top" align="left" rowspan="1" colspan="1">DOX</td>
<td valign="top" align="center" rowspan="1" colspan="1">Drug</td>
<td valign="top" align="left" rowspan="1" colspan="1">LRP1/EGFR-mediated</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b61-ijo-67-04-05789" class="usa-link" aria-describedby="b61-ijo-67-04-05789">61</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Khoury <em>et al</em>, 2020</td>
<td valign="top" align="left" rowspan="1" colspan="1">PAMAM</td>
<td valign="top" align="center" rowspan="1" colspan="1">4.8±0.9</td>
<td valign="top" align="left" rowspan="1" colspan="1">Neutral</td>
<td valign="top" align="center" rowspan="1" colspan="1">12</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">JHU29</td>
<td valign="top" align="center" rowspan="1" colspan="1">Drug</td>
<td valign="top" align="left" rowspan="1" colspan="1">TAMs targeting</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b60-ijo-67-04-05789" class="usa-link" aria-describedby="b60-ijo-67-04-05789">60</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Liaw <em>et al</em>, 2021</td>
<td valign="top" align="left" rowspan="1" colspan="1">PAMAM</td>
<td valign="top" align="center" rowspan="1" colspan="1">4.7±0.6</td>
<td valign="top" align="left" rowspan="1" colspan="1">Neutral</td>
<td valign="top" align="center" rowspan="1" colspan="1">18</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Triptolide</td>
<td valign="top" align="center" rowspan="1" colspan="1">Drug</td>
<td valign="top" align="left" rowspan="1" colspan="1">TAMs targeting</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b65-ijo-67-04-05789" class="usa-link" aria-describedby="b65-ijo-67-04-05789">65</a>)</td>
</tr>
<tr><td colspan="10" align="left" valign="bottom" rowspan="1">
<hr>
</td></tr>
<tr><td colspan="10" valign="top" align="left" rowspan="1">C, Polymeric</td></tr>
<tr><td colspan="10" align="left" valign="bottom" rowspan="1">
<hr>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">First author, year</td>
<td valign="top" align="center" rowspan="1" colspan="1">Nanocarrier type</td>
<td valign="top" align="center" rowspan="1" colspan="1">Particle size (nm)</td>
<td valign="top" align="center" rowspan="1" colspan="1">Surface charge (zeta potential)</td>
<td valign="top" align="center" rowspan="1" colspan="1">Drug loading efficiency (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">Encapsulation efficiency (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">Therapeutic payload</td>
<td valign="top" align="center" rowspan="1" colspan="1">Application mode</td>
<td valign="top" align="center" rowspan="1" colspan="1">Targeting strategy</td>
<td valign="top" align="center" rowspan="1" colspan="1">(Refs.)</td>
</tr>
<tr><td colspan="10" align="left" valign="bottom" rowspan="1">
<hr>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Wohlfart <em>et al</em>, 2011</td>
<td valign="top" align="left" rowspan="1" colspan="1">PLGA nanoparticles</td>
<td valign="top" align="center" rowspan="1" colspan="1">72.5±2.2</td>
<td valign="top" align="left" rowspan="1" colspan="1">Neutral</td>
<td valign="top" align="center" rowspan="1" colspan="1">8.2±0.6</td>
<td valign="top" align="center" rowspan="1" colspan="1">90.4±2.3</td>
<td valign="top" align="center" rowspan="1" colspan="1">PTX</td>
<td valign="top" align="center" rowspan="1" colspan="1">Drug</td>
<td valign="top" align="left" rowspan="1" colspan="1">Passive accumulation</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b56-ijo-67-04-05789" class="usa-link" aria-describedby="b56-ijo-67-04-05789">56</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Jiang <em>et al</em>, 2014</td>
<td valign="top" align="left" rowspan="1" colspan="1">PEG-PTMC</td>
<td valign="top" align="center" rowspan="1" colspan="1">71</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">6.52</td>
<td valign="top" align="center" rowspan="1" colspan="1">94.8</td>
<td valign="top" align="center" rowspan="1" colspan="1">PTX</td>
<td valign="top" align="center" rowspan="1" colspan="1">Drug</td>
<td valign="top" align="left" rowspan="1" colspan="1">GLUT targeting</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b50-ijo-67-04-05789" class="usa-link" aria-describedby="b50-ijo-67-04-05789">50</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Zhang <em>et al</em>, 2016</td>
<td valign="top" align="left" rowspan="1" colspan="1">PEG-PLA</td>
<td valign="top" align="center" rowspan="1" colspan="1">39.95</td>
<td valign="top" align="left" rowspan="1" colspan="1">Neutral</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">DOX, AR-825</td>
<td valign="top" align="center" rowspan="1" colspan="1">Drug</td>
<td valign="top" align="left" rowspan="1" colspan="1">α<sub>v</sub>β<sub>3</sub> integrin-targeting</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b69-ijo-67-04-05789" class="usa-link" aria-describedby="b69-ijo-67-04-05789">69</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Lu <em>et al</em>, 2006</td>
<td valign="top" align="left" rowspan="1" colspan="1">PEG-PLA</td>
<td valign="top" align="center" rowspan="1" colspan="1">70-130</td>
<td valign="top" align="left" rowspan="1" colspan="1">Negative</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.04</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">6-coumarin</td>
<td valign="top" align="center" rowspan="1" colspan="1">Drug</td>
<td valign="top" align="left" rowspan="1" colspan="1">Passive accumulation</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b66-ijo-67-04-05789" class="usa-link" aria-describedby="b66-ijo-67-04-05789">66</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Negron <em>et al</em>, 2019</td>
<td valign="top" align="left" rowspan="1" colspan="1">PEG-PEI</td>
<td valign="top" align="center" rowspan="1" colspan="1">50</td>
<td valign="top" align="left" rowspan="1" colspan="1">Positive</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">100</td>
<td valign="top" align="center" rowspan="1" colspan="1">DNA</td>
<td valign="top" align="center" rowspan="1" colspan="1">Gene</td>
<td valign="top" align="left" rowspan="1" colspan="1">Passive accumulation</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b67-ijo-67-04-05789" class="usa-link" aria-describedby="b67-ijo-67-04-05789">67</a>)</td>
</tr>
<tr><td colspan="10" align="left" valign="bottom" rowspan="1">
<hr>
</td></tr>
<tr><td colspan="10" valign="top" align="left" rowspan="1">D, Inorganic</td></tr>
<tr><td colspan="10" align="left" valign="bottom" rowspan="1">
<hr>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">First author, year</td>
<td valign="top" align="center" rowspan="1" colspan="1">Nanocarrier type</td>
<td valign="top" align="center" rowspan="1" colspan="1">Particle size (nm)</td>
<td valign="top" align="center" rowspan="1" colspan="1">Surface charge (zeta potential)</td>
<td valign="top" align="center" rowspan="1" colspan="1">Drug loading efficiency (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">Encapsulation efficiency (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">Therapeutic payload</td>
<td valign="top" align="center" rowspan="1" colspan="1">Application mode</td>
<td valign="top" align="center" rowspan="1" colspan="1">Targeting strategy</td>
<td valign="top" align="center" rowspan="1" colspan="1">(Refs.)</td>
</tr>
<tr><td colspan="10" align="left" valign="bottom" rowspan="1">
<hr>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Feng <em>et al</em>, 2017</td>
<td valign="top" align="left" rowspan="1" colspan="1">AuNPs</td>
<td valign="top" align="center" rowspan="1" colspan="1">80</td>
<td valign="top" align="left" rowspan="1" colspan="1">Negative</td>
<td valign="top" align="center" rowspan="1" colspan="1">16%</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">DOX</td>
<td valign="top" align="center" rowspan="1" colspan="1">Drug</td>
<td valign="top" align="left" rowspan="1" colspan="1">EGFR targeting</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b64-ijo-67-04-05789" class="usa-link" aria-describedby="b64-ijo-67-04-05789">64</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Grafals-Ruiz <em>et al</em>, 2020</td>
<td valign="top" align="left" rowspan="1" colspan="1">AuNPs</td>
<td valign="top" align="center" rowspan="1" colspan="1">20</td>
<td valign="top" align="left" rowspan="1" colspan="1">Negative</td>
<td valign="top" align="center" rowspan="1" colspan="1">AuNP:OMIs (mol/mol)=1:50</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">RNAi</td>
<td valign="top" align="center" rowspan="1" colspan="1">Gene</td>
<td valign="top" align="left" rowspan="1" colspan="1">ApoE/RVG dual-targeting</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b53-ijo-67-04-05789" class="usa-link" aria-describedby="b53-ijo-67-04-05789">53</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Zhao <em>et al</em>, 2020</td>
<td valign="top" align="left" rowspan="1" colspan="1">GO</td>
<td valign="top" align="center" rowspan="1" colspan="1">100-400</td>
<td valign="top" align="left" rowspan="1" colspan="1">Negative</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">DOX</td>
<td valign="top" align="center" rowspan="1" colspan="1">Drug</td>
<td valign="top" align="left" rowspan="1" colspan="1">LRP targeting</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b57-ijo-67-04-05789" class="usa-link" aria-describedby="b57-ijo-67-04-05789">57</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Wang <em>et al</em>, 2013</td>
<td valign="top" align="left" rowspan="1" colspan="1">Silica-Graphene</td>
<td valign="top" align="center" rowspan="1" colspan="1">50-250</td>
<td valign="top" align="left" rowspan="1" colspan="1">Negative</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.27±0.11 <em>μ</em>g<br>DOX/<em>μ</em>g GSP</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">DOX</td>
<td valign="top" align="center" rowspan="1" colspan="1">Drug</td>
<td valign="top" align="left" rowspan="1" colspan="1">Passive accumulation</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b68-ijo-67-04-05789" class="usa-link" aria-describedby="b68-ijo-67-04-05789">68</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Norouzi <em>et al</em>, 2020</td>
<td valign="top" align="left" rowspan="1" colspan="1">IONPs</td>
<td valign="top" align="center" rowspan="1" colspan="1">4.76±0.7</td>
<td valign="top" align="left" rowspan="1" colspan="1">Positive</td>
<td valign="top" align="center" rowspan="1" colspan="1">3.45±0.01%</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Salinomycin</td>
<td valign="top" align="center" rowspan="1" colspan="1">Drug</td>
<td valign="top" align="left" rowspan="1" colspan="1">External magnetic fields</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b55-ijo-67-04-05789" class="usa-link" aria-describedby="b55-ijo-67-04-05789">55</a>)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tI-ijo-67-04-05789/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="tfn1-ijo-67-04-05789"><p>DOX, doxorubicin; EGFR, epidermal growth factor receptor; EDB, extra domain B; LRP, lipoprotein receptor-related protein; TAM, tumor-associated macrophage; PTX, paclitaxel; GO, graphite oxide; IONP, iron oxide nanoparticles; PEG, polyethylene glycol; PEI, polyetherimide; GLUT, glucose transporter; SLN, solid lipid NPs; LPHN, lipid-polymer hybrid NPs; PAMAM, poly(amidoamine); PLGA, poly(lactic-co-glycolic acid); PTMC, Poly(trimethylene carbonate); PLA, polylactic acid ; GSPI, mesoporous silica-coated graphene nanosheet; OMI, oligonucleotide miRNA inhibitors; AuNP, gold nanoparticles.</p></div></div></section><section class="tw xbox font-sm" id="tII-ijo-67-04-05789"><h3 class="obj_head">Table II.</h3>
<div class="caption p"><p>Current modification strategies for nanocarriers to cross the BBB.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left" rowspan="1" colspan="1">Modification strategies</th>
<th valign="top" align="center" rowspan="1" colspan="1">Related protein</th>
<th valign="top" align="center" rowspan="1" colspan="1">Role in crossing the BBB</th>
<th valign="top" align="center" rowspan="1" colspan="1">(Refs.)</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="6" valign="top" align="left" colspan="1">Receptor-mediated transcytosis</td>
<td valign="top" align="left" rowspan="1" colspan="1">TfR</td>
<td valign="top" align="left" rowspan="1" colspan="1">Responsible for intracellular transport of transferrin and is the most used and validated receptor.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b72-ijo-67-04-05789" class="usa-link" aria-describedby="b72-ijo-67-04-05789">72</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">LDLR</td>
<td valign="top" align="left" rowspan="1" colspan="1">Responsible for the endocytosis of LDLs, such as apolipoprotein B and apolipoprotein E.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b70-ijo-67-04-05789" class="usa-link" aria-describedby="b70-ijo-67-04-05789">70</a>,<a href="#b73-ijo-67-04-05789" class="usa-link" aria-describedby="b73-ijo-67-04-05789">73</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Insulin receptor</td>
<td valign="top" align="left" rowspan="1" colspan="1">Widely expressed receptor in the brain microvessels.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b74-ijo-67-04-05789" class="usa-link" aria-describedby="b74-ijo-67-04-05789">74</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Insulin-like growth factor 1 receptor</td>
<td valign="top" align="left" rowspan="1" colspan="1">Expressed in the brain and the cerebral vessels</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b75-ijo-67-04-05789" class="usa-link" aria-describedby="b75-ijo-67-04-05789">75</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">LDLR-related protein 1</td>
<td valign="top" align="left" rowspan="1" colspan="1">Expressed on the surface of BBB cells. Angiopep 2 has been investigated for LRP1-mediated drug delivery into the brain.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b71-ijo-67-04-05789" class="usa-link" aria-describedby="b71-ijo-67-04-05789">71</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Nicotinic acetylcholine receptors</td>
<td valign="top" align="left" rowspan="1" colspan="1">Highly expressed on the capillary endothelium of the brain, susceptible to the inhibition by peptide neurotoxins.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b77-ijo-67-04-05789" class="usa-link" aria-describedby="b77-ijo-67-04-05789">77</a>)</td>
</tr>
<tr>
<td rowspan="7" valign="top" align="left" colspan="1">Peptides</td>
<td valign="top" align="left" rowspan="1" colspan="1">GYR</td>
<td valign="top" align="left" rowspan="1" colspan="1">Targets the TfR.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b76-ijo-67-04-05789" class="usa-link" aria-describedby="b76-ijo-67-04-05789">76</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Interleukin 13 peptide</td>
<td valign="top" align="left" rowspan="1" colspan="1">IL-13Rα2-mediated transcytosis.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b7-ijo-67-04-05789" class="usa-link" aria-describedby="b7-ijo-67-04-05789">7</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Transactivating-transduction</td>
<td valign="top" align="left" rowspan="1" colspan="1">Endocytosis micropinocytosis pore formation.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b81-ijo-67-04-05789" class="usa-link" aria-describedby="b81-ijo-67-04-05789">81</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Leptin30</td>
<td valign="top" align="left" rowspan="1" colspan="1">Endocytosis pathway</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b82-ijo-67-04-05789" class="usa-link" aria-describedby="b82-ijo-67-04-05789">82</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Angiopep-2 peptide</td>
<td valign="top" align="left" rowspan="1" colspan="1">Binds with LRP1 and promotes drug delivery by LRP1-mediated transcytosis.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b79-ijo-67-04-05789" class="usa-link" aria-describedby="b79-ijo-67-04-05789">79</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Penetratin</td>
<td valign="top" align="left" rowspan="1" colspan="1">Direct penetration endocytosis.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b86-ijo-67-04-05789" class="usa-link" aria-describedby="b86-ijo-67-04-05789">86</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">DK17</td>
<td valign="top" align="left" rowspan="1" colspan="1">Membrane potential.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b78-ijo-67-04-05789" class="usa-link" aria-describedby="b78-ijo-67-04-05789">78</a>)</td>
</tr>
<tr>
<td rowspan="3" valign="top" align="left" colspan="1">Carrier-mediated transcytosis</td>
<td valign="top" align="left" rowspan="1" colspan="1">Glucose receptors</td>
<td valign="top" align="left" rowspan="1" colspan="1">Utilizing GLUT transporter protein for transmembrane transport</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b80-ijo-67-04-05789" class="usa-link" aria-describedby="b80-ijo-67-04-05789">80</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Fatty acid</td>
<td valign="top" align="left" rowspan="1" colspan="1">Targeted lipid metabolism as a substrate for energy production.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b84-ijo-67-04-05789" class="usa-link" aria-describedby="b84-ijo-67-04-05789">84</a>,<a href="#b85-ijo-67-04-05789" class="usa-link" aria-describedby="b85-ijo-67-04-05789">85</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Nucleoside transporters</td>
<td valign="top" align="left" rowspan="1" colspan="1">Binds to receptors important for recycling pathways.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b83-ijo-67-04-05789" class="usa-link" aria-describedby="b83-ijo-67-04-05789">83</a>)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tII-ijo-67-04-05789/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="tfn2-ijo-67-04-05789"><p>TfR, transferrin receptor; LDL, low-density lipoprotein; LDLR, LDL receptor; GYR, GYRPVHNIRGHWAPG, herein as GYR peptide; DK17, DRQIKIWFQNRRMKWKK, herein as Dk17 peptide; GLUT, glucose transporter; LRP1, LDL receptor-related protein 1; BBB, blood brain barrier.</p></div></div></section><p>The present review also provides a holistic view of how different nanocarriers, ranging from liposomes to dendrimers and inorganic systems, are being engineered to deliver not only chemotherapeutics but also genetic payloads (such as siRNA, shRNA and miRNA) across the BBB. In the following sections, these nanocarrier classes and their applications in delivering both chemical and genetic therapeutics to brain tumors are reviewed, with an emphasis on structural design, delivery mechanisms and preclinical outcomes.</p>
<section id="sec6"><h3 class="pmc_sec_title">Lipid-based nanocarriers</h3>
<p>Lipid-based nanocarriers, including liposomes, SLNs and lipid-polymer hybrid NPs (LPHNs), represent some of the most well-established and clinically relevant platforms for brain-targeted drug and gene delivery. These carriers are biocompatible, structurally versatile and easily modifiable, making them ideal for encapsulating hydrophilic and lipophilic drugs, as well as genetic materials, such as siRNA, miRNA and plasmid DNA (<a href="#b51-ijo-67-04-05789" class="usa-link" aria-describedby="b51-ijo-67-04-05789">51</a>,<a href="#b62-ijo-67-04-05789" class="usa-link" aria-describedby="b62-ijo-67-04-05789">62</a>).</p></section><section id="sec7"><h3 class="pmc_sec_title">Liposomes</h3>
<p>Liposomes are spherical vesicles composed of lipid bilayers that can be modified with targeting ligands to enhance BBB penetration and tumor specificity. Human interleukin-13 (IL-13) is a cytokine released by activated T cells and can induce proinflammatory and anti-inflammatory immune responses (<a href="#b87-ijo-67-04-05789" class="usa-link" aria-describedby="b87-ijo-67-04-05789">87</a>). Reports have indicated that IL-13 receptor α2 (IL-13Rα2) is found at high levels in brain tumors, such as GBM and pilocytic astrocytomas, but not in normal tissues (<a href="#b88-ijo-67-04-05789" class="usa-link" aria-describedby="b88-ijo-67-04-05789">88</a>,<a href="#b89-ijo-67-04-05789" class="usa-link" aria-describedby="b89-ijo-67-04-05789">89</a>). Therefore, IL-13Rα2 is a promising target to deliver cytotoxic drugs to various aggressive brain tumors. Madhankumar <em>et al</em> (<a href="#b90-ijo-67-04-05789" class="usa-link" aria-describedby="b90-ijo-67-04-05789">90</a>) developed IL-13-conjugated liposomes to deliver DOX specifically to brain tumors, which led to less cytotoxicity and greater accumulation and retention of DOX in the glioma cells compared with therapy without these liposomes. Mice receiving intraperitoneal injections of IL-13-conjugated liposomes carrying DOX showed a significant decrease in U251 glioma growth (<a href="#b90-ijo-67-04-05789" class="usa-link" aria-describedby="b90-ijo-67-04-05789">90</a>). In addition to IL-13, numerous other ligands promote the brain tumor targeting ability of liposomes. Zong <em>et al</em> (<a href="#b63-ijo-67-04-05789" class="usa-link" aria-describedby="b63-ijo-67-04-05789">63</a>) designed a dual-targeting liposomal system modified with TAT (AYGRKKRRQRRR) and T7 (HAIYPRH) peptides. The specific ligand, T7, targets the BBB and brain tumors, while the non-specific ligand, TAT, enhances passage through the BBB and increases tumor penetration. Intravenous administration of dual-targeted DOX liposomes led to enhanced delivery of DOX to brain glioma tissue in a C6 glioma mouse model. Furthermore, Cen <em>et al</em> (<a href="#b58-ijo-67-04-05789" class="usa-link" aria-describedby="b58-ijo-67-04-05789">58</a>) developed a DOX-loaded liposomal system modified with the SS31 peptide, which exhibits dual-targeting capabilities by facilitating both BBB penetration and mitochondrial targeting within glioma cells. Liposomal system-DOX liposomes accumulated effectively in tumor tissues, significantly inhibiting tumor growth and extending survival rates without notable toxicity. This dual-targeting approach offers a promising strategy to enhance the therapeutic efficacy of liposomal DOX in glioma treatment.</p>
<p>In gene delivery, cationic liposomes have enabled the systemic administration of siRNAs and miRNAs to brain tumors. For instance, Wei <em>et al</em> (<a href="#b91-ijo-67-04-05789" class="usa-link" aria-describedby="b91-ijo-67-04-05789">91</a>) performed a layer-by-layer assembly of protamine/chondroitin sulfate/siRNA/cationic liposomes followed by T7 peptide modification to create a targeted siRNA-epidermal growth factor receptor (EGFR) delivery system. This modified NP specifically accumulated anti-EGFR siRNA in brain tumor tissues upon intravenous administration, leading to downregulation of EGFR expression and high survival rates in a U87 mouse glioma model.</p>
<p>Cyclophilin A (CypA) is a tumor marker that is elevated in various cancer types, including liver, brain and lung cancer (<a href="#b92-ijo-67-04-05789" class="usa-link" aria-describedby="b92-ijo-67-04-05789">92</a>-<a href="#b94-ijo-67-04-05789" class="usa-link" aria-describedby="b94-ijo-67-04-05789">94</a>). CypA plays a crucial role in epithelial to mesenchymal transition and cancer metastasis (<a href="#b94-ijo-67-04-05789" class="usa-link" aria-describedby="b94-ijo-67-04-05789">94</a>) and can be used as a target for tumor therapy. Saw <em>et al</em> (<a href="#b62-ijo-67-04-05789" class="usa-link" aria-describedby="b62-ijo-67-04-05789">62</a>) developed a liposome-based extra domain B targeting nanoplatform for CypA siRNA delivery and glioblastoma therapy. After systemic administration, these new siRNA delivery NPs targeted glioma cells and effectively inhibited glioblastoma tumor growth by silencing CypA, which plays a crucial role in the malignant transformation of brain cancer and the maintenance of glioma cell stemness (<a href="#b62-ijo-67-04-05789" class="usa-link" aria-describedby="b62-ijo-67-04-05789">62</a>). These findings indicate that this RNA interference NP platform is a potentially effective tool for targeted brain tumor therapy.</p>
<p>The biopharmaceutical challenges related to the therapeutic use of non-coding RNAs could potentially be addressed by lipid NPs (<a href="#b95-ijo-67-04-05789" class="usa-link" aria-describedby="b95-ijo-67-04-05789">95</a>). The therapeutic efficacy of non-coding RNAs delivered by lipid NPs has been confirmed in different forms of cancer (<a href="#b96-ijo-67-04-05789" class="usa-link" aria-describedby="b96-ijo-67-04-05789">96</a>).</p></section><section id="sec8"><h3 class="pmc_sec_title">SLNs</h3>
<p>SLNs are submicron colloidal carriers composed of biocompatible solid lipids stabilized by surfactants. Compared with conventional liposomes, SLNs offer superior physicochemical stability, lower burst release and improved control over drug release kinetics (<a href="#b97-ijo-67-04-05789" class="usa-link" aria-describedby="b97-ijo-67-04-05789">97</a>). SLNs are capable of encapsulating both hydrophilic and lipophilic agents and are amenable to various administration routes, including intravenous and oral delivery (<a href="#b52-ijo-67-04-05789" class="usa-link" aria-describedby="b52-ijo-67-04-05789">52</a>,<a href="#b54-ijo-67-04-05789" class="usa-link" aria-describedby="b54-ijo-67-04-05789">54</a>).</p>
<p>SLNs have shown notable success in enhancing brain delivery of chemotherapeutics. For example, edelfosine-loaded SLNs administered orally to glioma-bearing mice crossed the BBB efficiently and accumulated within tumor tissues, leading to a significant reduction in tumor volume and prolonged survival compared with non-SLN therapy (<a href="#b52-ijo-67-04-05789" class="usa-link" aria-describedby="b52-ijo-67-04-05789">52</a>). Beyond synthetic drugs, SLNs have been used to deliver poorly-soluble natural products with anticancer properties. Rutin, a flavonol glycoside with pro-apoptotic and anti-proliferative effects, has low water solubility and poor oral bioavailability (<a href="#b98-ijo-67-04-05789" class="usa-link" aria-describedby="b98-ijo-67-04-05789">98</a>). Encapsulation within SLNs improves the BBB permeability and bioavailability of rutin, resulting in enhanced brain accumulation and tumor suppression in preclinical models (<a href="#b54-ijo-67-04-05789" class="usa-link" aria-describedby="b54-ijo-67-04-05789">54</a>,<a href="#b99-ijo-67-04-05789" class="usa-link" aria-describedby="b99-ijo-67-04-05789">99</a>). Further innovations include surface-modified SLNs with targeting ligands, such as transferrin or apolipoprotein E (ApoE) mimetics, which exploit RMT pathways to improve brain specificity (<a href="#b100-ijo-67-04-05789" class="usa-link" aria-describedby="b100-ijo-67-04-05789">100</a>). Additionally, SLNs have been used for co-delivery systems, such as the simultaneous encapsulation of paclitaxel (PTX) and P-glycoprotein inhibitors, to overcome drug efflux mechanisms in glioma cells, with less cytotoxicity and enhanced therapeutic outcomes (<a href="#b101-ijo-67-04-05789" class="usa-link" aria-describedby="b101-ijo-67-04-05789">101</a>).</p></section><section id="sec9"><h3 class="pmc_sec_title">LPHNs</h3>
<p>LPHNs combine the structural stability of polymeric cores with the membrane fluidity and biocompatibility of lipid shells; thereby, bridging the functional advantages of both systems. These hybrid carriers are particularly well-suited for gene delivery due to their high encapsulation efficiency, low cytotoxicity and the ability to promote endosomal escape and intracellular release of nucleic acid cargos (<a href="#b102-ijo-67-04-05789" class="usa-link" aria-describedby="b102-ijo-67-04-05789">102</a>).</p>
<p>One of the most promising hybrid platforms is the self-assembled lipid-coated calcium phosphate NP (SANP). These carriers typically consist of a calcium phosphate core complexed with genetic material that is coated with PEGylated cationic lipids, such as N-[1-(2,3-dioleoyloxy) propyl]-N,N,N-trimethylammonium and modified lipids, such as ceramide-PEG2000. In glioma models, SANPs have demonstrated high miRNA and shRNA delivery efficiency, with significant accumulation in tumor tissue and potent gene silencing effects <em>in vivo</em> (<a href="#b51-ijo-67-04-05789" class="usa-link" aria-describedby="b51-ijo-67-04-05789">51</a>,<a href="#b103-ijo-67-04-05789" class="usa-link" aria-describedby="b103-ijo-67-04-05789">103</a>). As with miRNA therapy, SANPs have been used for co-delivery of nucleic acids and chemotherapeutics, such as bisphosphonates or DOX (<a href="#b104-ijo-67-04-05789" class="usa-link" aria-describedby="b104-ijo-67-04-05789">104</a>). The lipid shell allows prolonged systemic circulation and BBB traversal, while the calcium phosphate core promotes endosomal rupture via a 'proton sponge' effect, enhancing cytoplasmic release. For instance, a recent study incorporated miRNA-124 and PTX into SANPs to simultaneously silence oncogenic pathways and induce apoptosis, achieving synergistic antitumor efficacy with minimal systemic toxicity (<a href="#b105-ijo-67-04-05789" class="usa-link" aria-describedby="b105-ijo-67-04-05789">105</a>).</p>
<p>Further optimization strategies include the use of targeted peptides (such as arginyl-glycyl-aspartic peptides and T7) on the NP surface to increase glioma-specific uptake, as well as pH-responsive lipids that enable controlled gene release in the acidic tumor microenvironment (<a href="#b63-ijo-67-04-05789" class="usa-link" aria-describedby="b63-ijo-67-04-05789">63</a>).</p></section><section id="sec10"><h3 class="pmc_sec_title">Dendrimers</h3>
<p>Dendrimers are highly-branched, monodisperse and nanoscale macromolecules that offer exceptional versatility for drug and gene delivery in brain tumors. Their well-defined architecture, multivalent surface and internal cavities allow for the simultaneous loading of therapeutic agents and targeting ligands (<a href="#b106-ijo-67-04-05789" class="usa-link" aria-describedby="b106-ijo-67-04-05789">106</a>). Among dendrimers, poly(amidoamine) (PAMAM) dendrimers have been the most extensively studied due to their biocompatibility, tunable size and ease of functionalization. These features enable dendrimers to serve as flexible nanocarriers for drug molecules, genetic materials and multifunctional payloads (<a href="#b107-ijo-67-04-05789" class="usa-link" aria-describedby="b107-ijo-67-04-05789">107</a>).</p>
<p>In drug delivery, dendrimers function either as nanocapsules to encapsulate hydrophobic agents or as nanoconjugates bearing covalently attached drugs via cleavable linkers. PAMAM dendrimers have shown particular promise in brain tumor models when engineered with dual-targeting moieties. For instance, dendrimers co-modified with angiopep-2 and an EGFR-binding peptide exhibited enhanced BBB permeability and glioma-targeting ability via low-density lipoprotein receptor-related protein 1 (LRP1)- and EGFR-mediated transcytosis. This platform significantly improved the delivery of DOX, resulting in prolonged survival and reduced systemic toxicity in glioma-bearing mice compared with therapy without this platform (<a href="#b61-ijo-67-04-05789" class="usa-link" aria-describedby="b61-ijo-67-04-05789">61</a>). Similarly, dendrimers functionalized with transferrin and wheat germ agglutinin achieved dual-site targeting, facilitating enhanced uptake into glioma cells and accumulation within tumor tissues; thereby, improving therapeutic outcomes after systemic administration of DOX (<a href="#b59-ijo-67-04-05789" class="usa-link" aria-describedby="b59-ijo-67-04-05789">59</a>).</p>
<p>Dendrimers also provide a promising scaffold for gene delivery owing to their cationic surface, which facilitates complexation with nucleic acids. PAMAM dendrimers have been used to deliver a range of genetic payloads, including siRNA, shRNA and plasmid DNA, for gene silencing and transcriptional modulation in brain tumors (<a href="#b108-ijo-67-04-05789" class="usa-link" aria-describedby="b108-ijo-67-04-05789">108</a>). Surface modification with PEG or β-cyclodextrin improves stability and biocompatibility while reducing immunogenicity (<a href="#b109-ijo-67-04-05789" class="usa-link" aria-describedby="b109-ijo-67-04-05789">109</a>). By tuning the surface charge and size, these dendrimer complexes can traverse the BBB and achieve transgene expression within tumor cells. Notably, dendrimers support intracellular delivery via endosomal escape mechanisms and avoid rapid degradation of nucleic acids in circulation (<a href="#b110-ijo-67-04-05789" class="usa-link" aria-describedby="b110-ijo-67-04-05789">110</a>).</p>
<p>Beyond direct tumor cell killing, dendrimers have demonstrated potential in modulating the tumor immune microenvironment. Hydroxyl-terminated PAMAM dendrimers have been shown to selectively accumulate in tumor-associated macrophages and activated microglia, particularly in glioma tissues with compromised BBB integrity (<a href="#b60-ijo-67-04-05789" class="usa-link" aria-describedby="b60-ijo-67-04-05789">60</a>,<a href="#b111-ijo-67-04-05789" class="usa-link" aria-describedby="b111-ijo-67-04-05789">111</a>-<a href="#b113-ijo-67-04-05789" class="usa-link" aria-describedby="b113-ijo-67-04-05789">113</a>). A notable example is the targeted delivery of triptolide, a potent immunomodulatory agent, via dendrimer conjugation. This formulation not only enhanced tumor localization but also reprogrammed tumor-associated macrophages from an M2-like immunosuppressive phenotype to an M1-like pro-inflammatory state, resulting in both reduced tumor burden and minimized systemic toxicity in glioblastoma (<a href="#b65-ijo-67-04-05789" class="usa-link" aria-describedby="b65-ijo-67-04-05789">65</a>).</p>
<p>The multivalency of dendrimers allows them to be co-loaded with chemotherapeutic agents and nucleic acids, facilitating combination therapies in a single nanoplatform. For example, hybrid systems have been developed to simultaneously deliver DOX and siRNA, thereby achieving synergistic effects through cytotoxicity and gene silencing (<a href="#b114-ijo-67-04-05789" class="usa-link" aria-describedby="b114-ijo-67-04-05789">114</a>). Such designs enable coordinated regulation of tumor proliferation and resistance mechanisms, providing a rational strategy for multifaceted glioma therapy.</p></section><section id="sec11"><h3 class="pmc_sec_title">Polymeric NPs</h3>
<p>Polymeric NPs have garnered notable interest for both drug and gene delivery in brain tumor therapy due to their excellent biocompatibility, structural flexibility and tunable physicochemical properties (<a href="#b115-ijo-67-04-05789" class="usa-link" aria-describedby="b115-ijo-67-04-05789">115</a>). Typically synthesized from US Food and Drug Administration-approved polymers, such as PLGA, PEG, polycaprolactone and polyethylenimine (PEI), these systems allow for fine control of particle size, surface charge, release kinetics and functional modification (<a href="#b50-ijo-67-04-05789" class="usa-link" aria-describedby="b50-ijo-67-04-05789">50</a>,<a href="#b56-ijo-67-04-05789" class="usa-link" aria-describedby="b56-ijo-67-04-05789">56</a>,<a href="#b67-ijo-67-04-05789" class="usa-link" aria-describedby="b67-ijo-67-04-05789">67</a>).</p>
<p>PLGA-based NPs are widely used to deliver chemotherapeutic agents across the BBB. For example, PTX-loaded PLGA NPs coated with poloxamer 188 significantly increased BBB penetration and PTX accumulation in glioblastoma tissues, outperforming free drug administration in a rat GBM model (<a href="#b56-ijo-67-04-05789" class="usa-link" aria-describedby="b56-ijo-67-04-05789">56</a>). Co-delivery systems based on PLGA and chitosan have also been developed to encapsulate carmustine and O6-benzylguanine. This combination synergistically depleted O6-methylguanine-DNA methyltransferase, sensitizing tumors to alkylating agents and improving survival in F98 glioma-bearing rats (<a href="#b116-ijo-67-04-05789" class="usa-link" aria-describedby="b116-ijo-67-04-05789">116</a>). Targeted polymeric micelles further enhance brain accumulation. For instance, 2-deoxy-D-glucose-modified poly(ethylene glycol)-co-poly(trimethylene carbonate) PTX NPs were developed as a potential dual-target drug delivery system that can enhance BBB penetration through glucose transporter (GLUT)-mediated cross-cellular action and improve drug accumulation in gliomas through GLUT-mediated endocytosis. These glucose-decorated NPs increased drug accumulation in the brain and led to improved survival rates in an RG2 mouse glioma model, compared with plain NPs and PTX (<a href="#b50-ijo-67-04-05789" class="usa-link" aria-describedby="b50-ijo-67-04-05789">50</a>). Similarly, transferrin receptor-targeted micelles carrying PTX showed prolonged tumor retention and increased therapeutic efficacy in U87 MG intracranial gliomas (<a href="#b117-ijo-67-04-05789" class="usa-link" aria-describedby="b117-ijo-67-04-05789">117</a>). Other advanced polymeric formulations include DOX-loaded polybutylcyanoacrylate NPs and methoxy-PE G-poly(ε-caprolactone) micelles, which have demonstrated superior tumor accumulation, reduced systemic toxicity and enhanced survival in C6 glioma models (<a href="#b69-ijo-67-04-05789" class="usa-link" aria-describedby="b69-ijo-67-04-05789">69</a>,<a href="#b118-ijo-67-04-05789" class="usa-link" aria-describedby="b118-ijo-67-04-05789">118</a>).</p>
<p>Polymeric nanocarriers also support efficient gene transfer across the BBB. One example is cationic albumin-conjugated PEG NPs loaded with plasmid-encoding tumor necrosis factor-related apoptosis-inducing ligand. These particles have been shown to cross the BBB via AMT and induce selective apoptosis in glioma cells following systemic administration, with strong antitumor effects <em>in vivo</em> (<a href="#b66-ijo-67-04-05789" class="usa-link" aria-describedby="b66-ijo-67-04-05789">66</a>). DNA-loaded NPs formulated with an inclusion of densely PEGylated PEI (that is, brain-penetrating NPs) were recently reported to provide widespread transgene expression in the rat brain while exhibiting good <em>in vivo</em> safety profiles (<a href="#b119-ijo-67-04-05789" class="usa-link" aria-describedby="b119-ijo-67-04-05789">119</a>). Additionally, Negron <em>et al</em> (<a href="#b67-ijo-67-04-05789" class="usa-link" aria-describedby="b67-ijo-67-04-05789">67</a>) developed polymer-based DNA-loaded NPs with small particle diameters (~50 nm) and non-adhesive surface PEG coatings, which efficiently penetrated both brain tumor tissue and healthy brain parenchyma. These brain-penetrating NPs facilitated widespread transgene expression in heathy rodent striatum and aggressive brain tumor tissue through intracranial administration. These systems efficiently delivered DNA and siRNA while minimizing neuroinflammation and cytotoxicity.</p>
<p>In summary, polymeric NPs offer an adaptable platform to deliver a broad spectrum of therapeutic agents, including cytotoxic drugs, plasmid DNA and siRNA, across the BBB. Their ability to incorporate targeting ligands, modulate release kinetics and achieve sustained transgene expression makes polymeric NPs invaluable in both standalone and combination therapy strategies for malignant brain tumors.</p></section><section id="sec12"><h3 class="pmc_sec_title">Inorganic NPs</h3>
<p>Inorganic NPs offer distinct physicochemical advantages, such as precise size control, surface reactivity, magnetic or optical responsiveness and structural rigidity, which makes them highly valuable in brain tumor therapy (<a href="#b120-ijo-67-04-05789" class="usa-link" aria-describedby="b120-ijo-67-04-05789">120</a>). Unlike organic materials, inorganic carriers can integrate diagnostic and therapeutic functions within a single platform (that is, theranostics) (<a href="#b121-ijo-67-04-05789" class="usa-link" aria-describedby="b121-ijo-67-04-05789">121</a>). This section focuses on three prominent classes: AuNPs, graphene-based nanocarriers and IONPs, detailing their respective applications in both drug and gene delivery.</p></section><section id="sec13"><h3 class="pmc_sec_title">AuNPs</h3>
<p>AuNPs have been used to enhance drug stability, targeting and controlled release. For example, self-assembled gold nanospheres (~80 nm) have been designed to remain stable in circulation but disassemble in response to acidic and reductive conditions in the glioma microenvironment. This responsiveness improves intratumoral accumulation while minimizing off-target toxicity through renal clearance of dissociated particles (<a href="#b64-ijo-67-04-05789" class="usa-link" aria-describedby="b64-ijo-67-04-05789">64</a>). In targeted chemotherapy, antibody-conjugated gold-silica nanoshells directed against IL-13Rα2, which is upregulated in glioblastoma, enabled precise tumor cell recognition and thermal ablation. Upon near-infrared irradiation, these nanoshells induced cell death in U373 and U87 glioma models (<a href="#b122-ijo-67-04-05789" class="usa-link" aria-describedby="b122-ijo-67-04-05789">122</a>). Moreover, Feng <em>et al</em> (<a href="#b64-ijo-67-04-05789" class="usa-link" aria-describedby="b64-ijo-67-04-05789">64</a>) described a practical method for assembling AuNPs into ~80 nm nanospheres for use as a drug delivery platform. This platform not only enhanced drug retention in brain tumors but was able to dynamically switch to the single formulation for excretion. These self-assembled AuNPs can target brain tumor cells and respond to tumor microenvironmental parameters, including high vascular permeability and acidic and reductive conditions, suggesting that gold nanoassemblies may be an effective targeting strategy for brain tumor treatment (<a href="#b123-ijo-67-04-05789" class="usa-link" aria-describedby="b123-ijo-67-04-05789">123</a>).</p>
<p>AuNPs are also efficient vehicles for genetic payloads due to their high surface area and ease of nucleic acid conjugation. For instance, β-cyclodextrin-modified dendrimer-entrapped AuNPs have been used to co-deliver siRNAs targeting Bcl-2 and vascular endothelial growth factor. These carriers achieved robust gene silencing in glioma cells with minimal cytotoxicity and good serum stability (<a href="#b124-ijo-67-04-05789" class="usa-link" aria-describedby="b124-ijo-67-04-05789">124</a>). Another notable approach involves spherical nucleic acids, in which oligonucleotides are densely arranged on AuNP cores. When encapsulated in ApoE-modified liposomes, these spherical nucleic acids accumulate in glioma tissues and facilitate efficient miRNA modulation, opening avenues for post-transcriptional gene regulation (<a href="#b53-ijo-67-04-05789" class="usa-link" aria-describedby="b53-ijo-67-04-05789">53</a>).</p></section><section id="sec14"><h3 class="pmc_sec_title">Graphene-based nanocarriers</h3>
<p>GO sheets, with their large surface area and π-π interaction capability, are excellent carriers for chemotherapeutics. Angiopep-2-modified GO loaded with DOX was shown to enhance uptake by LRP1-upregulated glioma cells, achieving greater cytotoxicity than that with free DOX or unmodified GO formulations (<a href="#b57-ijo-67-04-05789" class="usa-link" aria-describedby="b57-ijo-67-04-05789">57</a>). In a dual-modality platform, mesoporous silica-coated GO nanosheets (GSPI) were functionalized with targeting peptide and loaded with DOX (GPSID). The resulting GSPID system combined chemo- and photothermal therapy. Upon near-infrared laser exposure, the GSPID system induced significant glioma cell death through thermal enhancement of drug activity (<a href="#b68-ijo-67-04-05789" class="usa-link" aria-describedby="b68-ijo-67-04-05789">68</a>).</p>
<p>Although limited compared with drug delivery, GO has also been used to deliver nucleic acids. The surface of GO enables electrostatic complexation with negatively-charged RNA or DNA (<a href="#b125-ijo-67-04-05789" class="usa-link" aria-describedby="b125-ijo-67-04-05789">125</a>). Modified GO-PEI hybrids can deliver shRNA into glioma cells with good transfection efficiency, especially when further engineered for nuclear targeting or stimuli-responsive release. For example, co-delivery of irinotecan and shRNA targeting stomatin-like protein 2 (SLP2) using magnetic GO hybrid nanocarriers improved glioma treatment efficacy by downregulating oncogenic pathways and enhancing chemotherapeutic synergy (<a href="#b126-ijo-67-04-05789" class="usa-link" aria-describedby="b126-ijo-67-04-05789">126</a>).</p></section><section id="sec15"><h3 class="pmc_sec_title">IONPs</h3>
<p>IONPs exhibit superparamagnetic properties, allowing external magnetic fields to enhance tumor-specific delivery across the BBB. For example, DOX-loaded trimethoxysilylpropyl-ethylenediamine triacetic acid-stabilized IONPs, when co-administered with a cadherin-binding peptide and magnetically-guided, significantly enhanced toxicity in glioma cells by temporarily loosening TJs at the BBB (<a href="#b127-ijo-67-04-05789" class="usa-link" aria-describedby="b127-ijo-67-04-05789">127</a>). Targeting was further improved using linTT1 peptide-functionalized IONPs, which bind to p32/gC1qR proteins upregulated in the glioma vasculature. These IONPs boosted glioma-specific uptake and promoted co-delivery of other NPs, such as albumin-PTX and silver nanocarriers (<a href="#b128-ijo-67-04-05789" class="usa-link" aria-describedby="b128-ijo-67-04-05789">128</a>). Another innovative application involved salinomycin-loaded IONPs, modified with PEG and PEI to improve circulation and BBB transit. These NPs selectively induced apoptosis in GBM cells via the generation of reactive oxygen species while sparing healthy tissue, making them a promising candidate for magnetically-targeted chemotherapy (<a href="#b129-ijo-67-04-05789" class="usa-link" aria-describedby="b129-ijo-67-04-05789">129</a>).</p>
<p>Although still at a preclinical stage, IONPs have been adapted for magnetofection, which is a technique that uses magnetic force to accelerate and direct nucleic acid delivery (<a href="#b130-ijo-67-04-05789" class="usa-link" aria-describedby="b130-ijo-67-04-05789">130</a>). PEI-coated IONPs complexed with plasmids or siRNA have been shown to transfect glioma cells both <em>in vitro</em> and <em>in vivo</em> under magnetic guidance (<a href="#b131-ijo-67-04-05789" class="usa-link" aria-describedby="b131-ijo-67-04-05789">131</a>). Co-delivery systems integrating siRNA and small molecules (such as cisplatin) are also under exploration, aiming to synergize gene silencing and DNA damage mechanisms.</p></section></section><section id="sec16"><h2 class="pmc_sec_title">4. Delivery strategies based on the protein corona (PC) in brain tumors</h2>
<p>Although NPs as drug carriers hold great promise for brain tumor therapy, numerous challenges remain in clinical translation (<a href="#b132-ijo-67-04-05789" class="usa-link" aria-describedby="b132-ijo-67-04-05789">132</a>). The PC poses a significant biological challenge for the translation of targeted drug delivery systems from the laboratory to clinical use, greatly impacting the targeting accuracy and biodistribution (<a href="#b133-ijo-67-04-05789" class="usa-link" aria-describedby="b133-ijo-67-04-05789">133</a>). NPs entering a biological environment experience surface modification due to dynamic physicochemical interactions with proteins and other biomolecules. The surface becomes coated with plasma proteins, lipids and other molecules, forming a PC (<a href="#b134-ijo-67-04-05789" class="usa-link" aria-describedby="b134-ijo-67-04-05789">134</a>). The PC modifies the size and surface properties of NPs (<a href="#b135-ijo-67-04-05789" class="usa-link" aria-describedby="b135-ijo-67-04-05789">135</a>), which makes it difficult for NPs to arrive at target sites, including brain tumors (<a href="#f2-ijo-67-04-05789" class="usa-link">Fig. 2</a>) (<a href="#b136-ijo-67-04-05789" class="usa-link" aria-describedby="b136-ijo-67-04-05789">136</a>,<a href="#b137-ijo-67-04-05789" class="usa-link" aria-describedby="b137-ijo-67-04-05789">137</a>). Therefore, PC-mediated targeting by maintaining the function of target plasma proteins on the NP surface may offer a new approach for specific drug delivery. The two most important types of proteins in the PC are opsonins and de-opsonins (<a href="#b138-ijo-67-04-05789" class="usa-link" aria-describedby="b138-ijo-67-04-05789">138</a>). Mononuclear macrophages can easily identify and clear NPs with surface opsonins, which greatly reduces drug delivery (<a href="#b139-ijo-67-04-05789" class="usa-link" aria-describedby="b139-ijo-67-04-05789">139</a>). De-opsonins show the opposite effect to that of opsonins as they prevent NP uptake by macrophages and prolong the NP circulation time. Albumin, the most abundant plasma protein, is a typical de-opsonin. Coating NPs with albumin significantly inhibits the adsorption of opsonin, reduces macrophage phagocytosis, decreases NP cytotoxicity and prolongs NP circulation in the blood (<a href="#b140-ijo-67-04-05789" class="usa-link" aria-describedby="b140-ijo-67-04-05789">140</a>).</p>
<figure class="fig xbox font-sm" id="f2-ijo-67-04-05789"><h3 class="obj_head">Figure 2.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370360_ijo-67-04-05789-g01.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/408e/12370360/475928da5fb5/ijo-67-04-05789-g01.jpg" loading="lazy" height="544" width="677" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/f2-ijo-67-04-05789/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>General structure of PC and nanoparticles with PC across the BBB in brain tumors. The chemical structure of PC and the dynamics of its configuration depend on the affinity of proteins to the functional groups located on the surface of NPs and the concentration of protein. High affinity coated proteins form 'hard' corona, while low affinity coated proteins form 'soft' corona. The BBB is selective and restrictive to a variety of molecules. Endothelial cells and the basement membrane, together with strong lateral tight junctions, further impede its permeability. This figure was created in BioRender (paid version; <a href="https://www.biorender.com/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.biorender.com/</a>). BBB, blood-brain barrier; NP, nanoparticle; PC, protein corona.</p></figcaption></figure><p>PC-mediated targeting provides a novel approach to precise drug delivery by accurately controlling the interaction modes of functional plasma proteins on the surface of NPs. Zhang <em>et al</em> (<a href="#b141-ijo-67-04-05789" class="usa-link" aria-describedby="b141-ijo-67-04-05789">141</a>) developed bioinspired liposomes (SP-sLips) by modifying the liposomal surface with a short non-toxic peptide derived from amyloid β-protein (Aβ)1-42. This peptide specifically interacts with the lipid-binding domain of exchangeable apolipoproteins. SP-sLips absorb plasma apolipoproteins A1, E and J, and achieve brain-targeted delivery by exposing the receptor-binding domain of apolipoproteins. DOX-loaded SP-sLips have demonstrated a significant improvement in brain distribution and anti-brain cancer effects compared with DOX-loaded plain liposomes. Another study (<a href="#b142-ijo-67-04-05789" class="usa-link" aria-describedby="b142-ijo-67-04-05789">142</a>) fabricated PEG-polyethylene-polylactice acid nanomicelles (PMs) decorated by Aβ25-35 with an amide bond (Aβ-CN) to load PTX. Aβ-CN peptide was used to bind the C-terminal domain of ApoE when exposed to physiological conditions and specifically bound to the lipid-binding domain of ApoE <em>in vivo</em>, forming an ApoE-enriched PC surrounding Aβ-CN-PMs. This formation demonstrated enhanced anticancer effects and a favorable tissue distribution profile, with rapid accumulation in brain tumor tissues.</p></section><section id="sec17"><h2 class="pmc_sec_title">5. Clinical challenges in translating NP-based therapies for brain tumors</h2>
<p>Despite the notable preclinical progress achieved using nanocarriers for drug and gene delivery in brain tumors, translating these systems into clinical practice remains a formidable task. Numerous NP platforms, ranging from liposomes and dendrimers to inorganic and hybrid systems, have demonstrated efficient BBB penetration, tumor targeting and therapeutic efficacy in animal models. However, only a handful have advanced to clinical trials (<a href="#b14-ijo-67-04-05789" class="usa-link" aria-describedby="b14-ijo-67-04-05789">14</a>,<a href="#b17-ijo-67-04-05789" class="usa-link" aria-describedby="b17-ijo-67-04-05789">17</a>) and none have become standard-of-care for glioma treatment. Several key clinical challenges hinder this transition: i) Safety, immunogenicity and long-term biocompatibility. Nanocarriers often exhibit unpredictable interactions with the immune system. For example, cationic surfaces can activate complement cascades or induce cytokine release, leading to hypersensitivity or off-target effects (<a href="#b18-ijo-67-04-05789" class="usa-link" aria-describedby="b18-ijo-67-04-05789">18</a>). Even biocompatible materials, such as PEG, may elicit anti-PEG antibodies after repeat administration (<a href="#b16-ijo-67-04-05789" class="usa-link" aria-describedby="b16-ijo-67-04-05789">16</a>), undermining therapeutic efficacy. Moreover, long-term accumulation of inorganic NPs (such as gold or iron oxide) in non-target tissues raises concerns about potential chronic toxicity. ii) Physiological complexity of the human BBB and tumor microenvironment. While most nanocarrier studies rely on rodent models, the human BBB is markedly more selective and the glioblastoma vasculature is heterogeneous and dynamically remodeled during disease progression (<a href="#b15-ijo-67-04-05789" class="usa-link" aria-describedby="b15-ijo-67-04-05789">15</a>). As a result, targeting strategies that succeed in preclinical models may underperform or fail in clinical settings. Additionally, the tumor microenvironment, including hypoxia, immune suppression and abnormal interstitial pressure, can impair nanocarrier penetration and distribution within brain tumors (<a href="#b143-ijo-67-04-05789" class="usa-link" aria-describedby="b143-ijo-67-04-05789">143</a>). iii) Reproducibility, scale-up and manufacturing constraints. The structural complexity of nanocarriers presents a major hurdle for consistent large-scale production. Batch-to-batch variability in size, surface charge and drug loading efficiency can affect pharmacokinetics and therapeutic outcomes. Moreover, regulatory agencies require detailed physicochemical characterization, stability profiling and Good Manufacturing Practice compliance, all of which remain difficult to achieve for sophisticated multifunctional systems. iv) Lack of predictive models for human translation. Currently, to the best of our knowledge, there is a lack of robust <em>in vitro</em> or <em>in silico</em> models that accurately predict nanocarrier behavior in the human brain. This limits the ability to assess clinical feasibility early in the developmental pipeline, resulting in high attrition rates during translation.</p>
<p>To bridge the gap between bench and bedside, future efforts must focus not only on optimizing the design and targeting efficiency of nanocarriers, but also on improving their biological stability, minimizing immunogenicity and enhancing reproducibility on a clinical scale. Among the most critical biological factors influencing <em>in vivo</em> behavior is the formation of a PC, a dynamic biomolecular layer that adsorbs onto NPs upon contact with biological fluids.</p></section><section id="sec18"><h2 class="pmc_sec_title">6. Conclusions and new perspectives</h2>
<p>Innovative local chemotherapy using gene therapy-based NPs has been proposed as a treatment for patients with brain tumors. Zhang <em>et al</em> (<a href="#b130-ijo-67-04-05789" class="usa-link" aria-describedby="b130-ijo-67-04-05789">130</a>) modified the porous structure of IONPs by attaching carboxyl groups to enable the codelivery of siRNA targeting glutathione peroxidase 4 (si-GPX4) and cisplatin with high drug loading efficiencies. This nanoformulation exerted notable effects on glioblastoma cells, but the effects on normal human astrocytes were limited. During intracellular degradation, IONPs significantly increased iron (Fe<sup>2+</sup> and Fe<sup>3+</sup>) levels, while cisplatin destroyed nuclear DNA and mitochondrial DNA, resulting in apoptosis. Additionally, the co-released si-GPX4 enhanced the therapeutic efficacy by promoting ferroptosis, suggesting that si-GPX4 may be a safe and effective inducer of ferroptosis and apoptosis for combined brain tumor therapy. Chuang <em>et al</em> (<a href="#b126-ijo-67-04-05789" class="usa-link" aria-describedby="b126-ijo-67-04-05789">126</a>) developed a co-delivery strategy for the chemotherapeutic drug, irinotecan (CPT-11), and SLP2 shRNA using dual targeting NPs by combining magnetic targeting with ligand-mediated active targeting for the treatment of brain tumors. The magnetic GO (mGO) nanocarrier was conjugated with chitosan and urocanic acid (mGOCU) for shRNA complexation and endosomal escape. After PEGylation by interaction of the hydrophobic tails of 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide(polyethylene glycol)-2000] with the mGO surface followed by binding gastrin releasing peptide to PEG (mGOCUG), CPT-11 was loaded via π-π interaction and the SLP2 shRNA was complexed to form mGOCUG/CPT-11/shRNA. Intravenous administration of mGOCUG/CPT-11/shRNA exhibited excellent antitumor efficacy in orthotopic brain tumors, which presents a versatile mGO-based drug and gene delivery system for effective combination therapy in brain tumors.</p>
<p>Notably, efforts to incorporate multiple organic and inorganic nanomaterials as potential therapeutic agents have also been made. A theranostic liposome incorporating superparamagnetic IONPs, quantum dots and cilengitide has been developed for optical imaging and as a therapeutic drug delivery system (<a href="#b144-ijo-67-04-05789" class="usa-link" aria-describedby="b144-ijo-67-04-05789">144</a>). Wu <em>et al</em> (<a href="#b145-ijo-67-04-05789" class="usa-link" aria-describedby="b145-ijo-67-04-05789">145</a>) have also created an aqueous, surfactant-free ferrofluid composed of superparamagnetic IONPs coated with silicate mesolayers and carbon shells. It was found that this NP decreased the viability of brain tumors more than that of the respective primary analogues of the NP. Conjugated polymer NPs have been designed and synthesized by integrating a metal oxide magnetic core (Fe<sub>3</sub>O<sub>4</sub> and NiFe<sub>2</sub>O<sub>4</sub> NPs; 5 nm) into their matrix during the nanoprecipitation process (<a href="#b146-ijo-67-04-05789" class="usa-link" aria-describedby="b146-ijo-67-04-05789">146</a>). This incorporation may be used for simultaneous magnetic resonance and fluorescence imaging in brain tumors.</p>
<p>The effectiveness of NP-based delivery systems indicates the potential to develop more effective and personalized combination therapies for patients with brain tumors. However, despite these advancements, drug carriers with controllable size, integrated targeting function, appropriate structure and the ability to cross biological barriers must be developed and further optimized in the future.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>Not applicable.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>This work was supported by the Medical Science and Technology Project of Zhejiang Province (grant nos. 2023KY465 and 2021KY529).</p></section><section id="sec19"><h2 class="pmc_sec_title">Availability of data and materials</h2>
<p>Not applicable.</p></section><section id="sec20"><h2 class="pmc_sec_title">Authors' contributions</h2>
<p>JXS reviewed the literature and wrote the first draft. ZCL produced the figures. FG and XJ collected part of the data. YYM supervised and revised the manuscript. JXS, ZCL, FG, XJ and YYM were involved in writing the paper. All authors read and approved the final version of the manuscript. Data authentication is not applicable.</p></section><section id="sec21"><h2 class="pmc_sec_title">Ethics approval and consent to participate</h2>
<p>Not applicable.</p></section><section id="sec22"><h2 class="pmc_sec_title">Patient consent for publication</h2>
<p>Not applicable.</p></section><section id="sec23"><h2 class="pmc_sec_title">Competing interests</h2>
<p>The authors declare that they have no competing interests.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="b1-ijo-67-04-05789">
<span class="label">1.</span><cite>Miller KD, Ostrom QT, Kruchko C, Patil N, Tihan T, Cioffi G, Fuchs HE, Waite KA, Jemal A, Siegel RL, Barnholtz-Sloan JS. Brain and other central nervous system tumor statistics, 2021. CA Cancer J Clin. 2021;71:381–406. doi: 10.3322/caac.21693.</cite> [<a href="https://doi.org/10.3322/caac.21693" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34427324/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CA%20Cancer%20J%20Clin&amp;title=Brain%20and%20other%20central%20nervous%20system%20tumor%20statistics,%202021&amp;author=KD%20Miller&amp;author=QT%20Ostrom&amp;author=C%20Kruchko&amp;author=N%20Patil&amp;author=T%20Tihan&amp;volume=71&amp;publication_year=2021&amp;pages=381-406&amp;pmid=34427324&amp;doi=10.3322/caac.21693&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b2-ijo-67-04-05789">
<span class="label">2.</span><cite>Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the united states in 2013-2017. Neuro Oncol. 2020;22(12 Suppl 2):iv1–iv96. doi: 10.1093/neuonc/noaa200.</cite> [<a href="https://doi.org/10.1093/neuonc/noaa200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7596247/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33123732/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuro%20Oncol&amp;title=CBTRUS%20statistical%20report:%20Primary%20brain%20and%20other%20central%20nervous%20system%20tumors%20diagnosed%20in%20the%20united%20states%20in%202013-2017&amp;author=QT%20Ostrom&amp;author=N%20Patil&amp;author=G%20Cioffi&amp;author=K%20Waite&amp;author=C%20Kruchko&amp;volume=22&amp;issue=12%20Suppl%202&amp;publication_year=2020&amp;pages=iv1-iv96&amp;pmid=33123732&amp;doi=10.1093/neuonc/noaa200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b3-ijo-67-04-05789">
<span class="label">3.</span><cite>Sadad T, Rehman A, Munir A, Saba T, Tariq U, Ayesha N, Abbasi R. Brain tumor detection and multi-classification using advanced deep learning techniques. Microsc Res Tech. 2021;84:1296–1308. doi: 10.1002/jemt.23688.</cite> [<a href="https://doi.org/10.1002/jemt.23688" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33400339/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Microsc%20Res%20Tech&amp;title=Brain%20tumor%20detection%20and%20multi-classification%20using%20advanced%20deep%20learning%20techniques&amp;author=T%20Sadad&amp;author=A%20Rehman&amp;author=A%20Munir&amp;author=T%20Saba&amp;author=U%20Tariq&amp;volume=84&amp;publication_year=2021&amp;pages=1296-1308&amp;pmid=33400339&amp;doi=10.1002/jemt.23688&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b4-ijo-67-04-05789">
<span class="label">4.</span><cite>Tan AC, Ashley DM, Lopez GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: State of the art and future directions. CA Cancer J Clin. 2020;70:299–312. doi: 10.3322/caac.21613.</cite> [<a href="https://doi.org/10.3322/caac.21613" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32478924/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CA%20Cancer%20J%20Clin&amp;title=Management%20of%20glioblastoma:%20State%20of%20the%20art%20and%20future%20directions&amp;author=AC%20Tan&amp;author=DM%20Ashley&amp;author=GY%20Lopez&amp;author=M%20Malinzak&amp;author=HS%20Friedman&amp;volume=70&amp;publication_year=2020&amp;pages=299-312&amp;pmid=32478924&amp;doi=10.3322/caac.21613&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b5-ijo-67-04-05789">
<span class="label">5.</span><cite>Arvanitis CD, Ferraro GB, Jain RK. The blood-brain barrier and blood-tumour barrier in brain tumours and metastases. Nat Rev Cancer. 2020;20:26–41. doi: 10.1038/s41568-019-0205-x.</cite> [<a href="https://doi.org/10.1038/s41568-019-0205-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8246629/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31601988/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cancer&amp;title=The%20blood-brain%20barrier%20and%20blood-tumour%20barrier%20in%20brain%20tumours%20and%20metastases&amp;author=CD%20Arvanitis&amp;author=GB%20Ferraro&amp;author=RK%20Jain&amp;volume=20&amp;publication_year=2020&amp;pages=26-41&amp;pmid=31601988&amp;doi=10.1038/s41568-019-0205-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b6-ijo-67-04-05789">
<span class="label">6.</span><cite>Da Ros M, De Gregorio V, Iorio AL, Giunti L, Guidi M, de Martino M, Genitori L, Sardi I. Glioblastoma chemoresistance: The double play by microenvironment and Blood-brain barrier. Int J Mol Sci. 2018;19:2879. doi: 10.3390/ijms19102879.</cite> [<a href="https://doi.org/10.3390/ijms19102879" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6213072/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30248992/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Sci&amp;title=Glioblastoma%20chemoresistance:%20The%20double%20play%20by%20microenvironment%20and%20Blood-brain%20barrier&amp;author=M%20Da%20Ros&amp;author=V%20De%20Gregorio&amp;author=AL%20Iorio&amp;author=L%20Giunti&amp;author=M%20Guidi&amp;volume=19&amp;publication_year=2018&amp;pages=2879&amp;pmid=30248992&amp;doi=10.3390/ijms19102879&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b7-ijo-67-04-05789">
<span class="label">7.</span><cite>Gao H, Yang Z, Zhang S, Cao S, Pang Z, Yang X, Jiang X. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth. J Control Release. 2013;172:921–928. doi: 10.1016/j.jconrel.2013.10.002.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2013.10.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24120853/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Control%20Release&amp;title=Glioma-homing%20peptide%20with%20a%20cell-penetrating%20effect%20for%20targeting%20delivery%20with%20enhanced%20glioma%20localization,%20penetration%20and%20suppression%20of%20glioma%20growth&amp;author=H%20Gao&amp;author=Z%20Yang&amp;author=S%20Zhang&amp;author=S%20Cao&amp;author=Z%20Pang&amp;volume=172&amp;publication_year=2013&amp;pages=921-928&amp;pmid=24120853&amp;doi=10.1016/j.jconrel.2013.10.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b8-ijo-67-04-05789">
<span class="label">8.</span><cite>Liu Y, Lu W. Recent advances in brain tumor-targeted nano-drug delivery systems. Expert Opin Drug Deliv. 2012;9:671–686. doi: 10.1517/17425247.2012.682726.</cite> [<a href="https://doi.org/10.1517/17425247.2012.682726" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22607535/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opin%20Drug%20Deliv&amp;title=Recent%20advances%20in%20brain%20tumor-targeted%20nano-drug%20delivery%20systems&amp;author=Y%20Liu&amp;author=W%20Lu&amp;volume=9&amp;publication_year=2012&amp;pages=671-686&amp;pmid=22607535&amp;doi=10.1517/17425247.2012.682726&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b9-ijo-67-04-05789">
<span class="label">9.</span><cite>Han L, Jiang C. Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies. Acta Pharm Sin B. 2021;11:2306–2325. doi: 10.1016/j.apsb.2020.11.023.</cite> [<a href="https://doi.org/10.1016/j.apsb.2020.11.023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8424230/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34522589/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Pharm%20Sin%20B&amp;title=Evolution%20of%20blood-brain%20barrier%20in%20brain%20diseases%20and%20related%20systemic%20nanoscale%20brain-targeting%20drug%20delivery%20strategies&amp;author=L%20Han&amp;author=C%20Jiang&amp;volume=11&amp;publication_year=2021&amp;pages=2306-2325&amp;pmid=34522589&amp;doi=10.1016/j.apsb.2020.11.023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b10-ijo-67-04-05789">
<span class="label">10.</span><cite>Jena L, McErlean E, McCarthy H. Delivery across the blood-brain barrier: Nanomedicine for glioblastoma multiforme. Drug Deliv Transl Res. 2020;10:304–318. doi: 10.1007/s13346-019-00679-2.</cite> [<a href="https://doi.org/10.1007/s13346-019-00679-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7066289/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31728942/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Deliv%20Transl%20Res&amp;title=Delivery%20across%20the%20blood-brain%20barrier:%20Nanomedicine%20for%20glioblastoma%20multiforme&amp;author=L%20Jena&amp;author=E%20McErlean&amp;author=H%20McCarthy&amp;volume=10&amp;publication_year=2020&amp;pages=304-318&amp;pmid=31728942&amp;doi=10.1007/s13346-019-00679-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b11-ijo-67-04-05789">
<span class="label">11.</span><cite>Hersh AM, Alomari S, Tyler BM. Crossing the blood-brain barrier: Advances in nanoparticle technology for drug delivery in Neuro-oncology. Int J Mol Sci. 2022;23:4153. doi: 10.3390/ijms23084153.</cite> [<a href="https://doi.org/10.3390/ijms23084153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9032478/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35456971/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Sci&amp;title=Crossing%20the%20blood-brain%20barrier:%20Advances%20in%20nanoparticle%20technology%20for%20drug%20delivery%20in%20Neuro-oncology&amp;author=AM%20Hersh&amp;author=S%20Alomari&amp;author=BM%20Tyler&amp;volume=23&amp;publication_year=2022&amp;pages=4153&amp;pmid=35456971&amp;doi=10.3390/ijms23084153&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b12-ijo-67-04-05789">
<span class="label">12.</span><cite>Chen J, Guo Z, Tian H, Chen X. Production and clinical development of nanoparticles for gene delivery. Mol Ther Methods Clin Dev. 2016;3:16023. doi: 10.1038/mtm.2016.23.</cite> [<a href="https://doi.org/10.1038/mtm.2016.23" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4822651/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27088105/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Ther%20Methods%20Clin%20Dev&amp;title=Production%20and%20clinical%20development%20of%20nanoparticles%20for%20gene%20delivery&amp;author=J%20Chen&amp;author=Z%20Guo&amp;author=H%20Tian&amp;author=X%20Chen&amp;volume=3&amp;publication_year=2016&amp;pages=16023&amp;pmid=27088105&amp;doi=10.1038/mtm.2016.23&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b13-ijo-67-04-05789">
<span class="label">13.</span><cite>Huh MS, Lee EJ, Koo H, Yhee JY, Oh KS, Son S, Lee S, Kim SH, Kwon IC, Kim K. Polysaccharide-based nanoparticles for gene delivery. Top Curr Chem (Cham) 2017;375:31. doi: 10.1007/s41061-017-0114-y.</cite> [<a href="https://doi.org/10.1007/s41061-017-0114-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28251564/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Top%20Curr%20Chem%20(Cham)&amp;title=Polysaccharide-based%20nanoparticles%20for%20gene%20delivery&amp;author=MS%20Huh&amp;author=EJ%20Lee&amp;author=H%20Koo&amp;author=JY%20Yhee&amp;author=KS%20Oh&amp;volume=375&amp;publication_year=2017&amp;pages=31&amp;pmid=28251564&amp;doi=10.1007/s41061-017-0114-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b14-ijo-67-04-05789">
<span class="label">14.</span><cite>Arami H, Patel CB, Madsen SJ, Dickinson PJ, Davis RM, Zeng Y, Sturges BK, Woolard KD, Habte FG, Akin D, et al.  Nanomedicine for spontaneous brain tumors: A companion clinical trial. ACS Nano. 2019;13:2858–2869. doi: 10.1021/acsnano.8b04406.</cite> [<a href="https://doi.org/10.1021/acsnano.8b04406" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6584029/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30714717/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Nano&amp;title=Nanomedicine%20for%20spontaneous%20brain%20tumors:%20A%20companion%20clinical%20trial&amp;author=H%20Arami&amp;author=CB%20Patel&amp;author=SJ%20Madsen&amp;author=PJ%20Dickinson&amp;author=RM%20Davis&amp;volume=13&amp;publication_year=2019&amp;pages=2858-2869&amp;pmid=30714717&amp;doi=10.1021/acsnano.8b04406&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b15-ijo-67-04-05789">
<span class="label">15.</span><cite>Hahn A, Bode J, Kruwel T, Solecki G, Heiland S, Bendszus M, Tews B, Winkler F, Breckwoldt MO, Kurz FT. Glioblastoma multiforme restructures the topological connectivity of cerebrovascular networks. Sci Rep. 2019;9:11757. doi: 10.1038/s41598-019-47567-w.</cite> [<a href="https://doi.org/10.1038/s41598-019-47567-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6692362/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31409816/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Glioblastoma%20multiforme%20restructures%20the%20topological%20connectivity%20of%20cerebrovascular%20networks&amp;author=A%20Hahn&amp;author=J%20Bode&amp;author=T%20Kruwel&amp;author=G%20Solecki&amp;author=S%20Heiland&amp;volume=9&amp;publication_year=2019&amp;pages=11757&amp;pmid=31409816&amp;doi=10.1038/s41598-019-47567-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b16-ijo-67-04-05789">
<span class="label">16.</span><cite>Moreno A, Pitoc GA, Ganson NJ, Layzer JM, Hershfield MS, Tarantal AF, Sullenger BA. Anti-PEG Antibodies inhibit the anticoagulant activity of PEgylated aptamers. Cell Chem Biol. 2019;26:634–644.e3. doi: 10.1016/j.chembiol.2019.02.001.</cite> [<a href="https://doi.org/10.1016/j.chembiol.2019.02.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6707742/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30827937/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Chem%20Biol&amp;title=Anti-PEG%20Antibodies%20inhibit%20the%20anticoagulant%20activity%20of%20PEgylated%20aptamers&amp;author=A%20Moreno&amp;author=GA%20Pitoc&amp;author=NJ%20Ganson&amp;author=JM%20Layzer&amp;author=MS%20Hershfield&amp;volume=26&amp;publication_year=2019&amp;pages=634-644.e3&amp;pmid=30827937&amp;doi=10.1016/j.chembiol.2019.02.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b17-ijo-67-04-05789">
<span class="label">17.</span><cite>Verry C, Dufort S, Villa J, Gavard M, Iriart C, Grand S, Charles J, Chovelon B, Cracowski JL, Quesada JL, et al.  Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial) Radiother Oncol. 2021;160:159–165. doi: 10.1016/j.radonc.2021.04.021.</cite> [<a href="https://doi.org/10.1016/j.radonc.2021.04.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33961915/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Radiother%20Oncol&amp;title=Theranostic%20AGuIX%20nanoparticles%20as%20radiosensitizer:%20A%20phase%20I,%20dose-escalation%20study%20in%20patients%20with%20multiple%20brain%20metastases%20(NANO-RAD%20trial)&amp;author=C%20Verry&amp;author=S%20Dufort&amp;author=J%20Villa&amp;author=M%20Gavard&amp;author=C%20Iriart&amp;volume=160&amp;publication_year=2021&amp;pages=159-165&amp;pmid=33961915&amp;doi=10.1016/j.radonc.2021.04.021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b18-ijo-67-04-05789">
<span class="label">18.</span><cite>Zhanataev AK, Anisina EA, Kulakova AV, Shilovskiy IP, Lisitsyn AA, Koloskova OO, Khaitov MR, Durnev AD. Genotoxicity of cationic lipopeptide nanoparticles. Toxicol Lett. 2020;328:1–6. doi: 10.1016/j.toxlet.2020.04.011.</cite> [<a href="https://doi.org/10.1016/j.toxlet.2020.04.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32315709/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Toxicol%20Lett&amp;title=Genotoxicity%20of%20cationic%20lipopeptide%20nanoparticles&amp;author=AK%20Zhanataev&amp;author=EA%20Anisina&amp;author=AV%20Kulakova&amp;author=IP%20Shilovskiy&amp;author=AA%20Lisitsyn&amp;volume=328&amp;publication_year=2020&amp;pages=1-6&amp;pmid=32315709&amp;doi=10.1016/j.toxlet.2020.04.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b19-ijo-67-04-05789">
<span class="label">19.</span><cite>Lalatsa A, Butt AM.  Nanotechnology-based Targeted Drug Delivery Systems for Brain Tumors. Elsevier Inc.; 2018. Physiology of the Blood-brain barrier and mechanisms of transport across the BBB; pp. 49–74.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Nanotechnology-based%20Targeted%20Drug%20Delivery%20Systems%20for%20Brain%20Tumors&amp;author=A%20Lalatsa&amp;author=AM%20Butt&amp;publication_year=2018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b20-ijo-67-04-05789">
<span class="label">20.</span><cite>Crone C, Olesen SP. Electrical resistance of brain microvascular endothelium. Brain Res. 1982;241:49–55. doi: 10.1016/0006-8993(82)91227-6.</cite> [<a href="https://doi.org/10.1016/0006-8993(82)91227-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6980688/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Res&amp;title=Electrical%20resistance%20of%20brain%20microvascular%20endothelium&amp;author=C%20Crone&amp;author=SP%20Olesen&amp;volume=241&amp;publication_year=1982&amp;pages=49-55&amp;pmid=6980688&amp;doi=10.1016/0006-8993(82)91227-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b21-ijo-67-04-05789">
<span class="label">21.</span><cite>Kadry H, Noorani B, Cucullo L. A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS. 2020;17:69. doi: 10.1186/s12987-020-00230-3.</cite> [<a href="https://doi.org/10.1186/s12987-020-00230-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7672931/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33208141/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Fluids%20Barriers%20CNS&amp;title=A%20blood-brain%20barrier%20overview%20on%20structure,%20function,%20impairment,%20and%20biomarkers%20of%20integrity&amp;author=H%20Kadry&amp;author=B%20Noorani&amp;author=L%20Cucullo&amp;volume=17&amp;publication_year=2020&amp;pages=69&amp;pmid=33208141&amp;doi=10.1186/s12987-020-00230-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b22-ijo-67-04-05789">
<span class="label">22.</span><cite>Andreone BJ, Chow BW, Tata A, Lacoste B, Ben-Zvi A, Bullock K, Deik AA, Ginty DD, Clish CB, Gu C. Blood-brain barrier permeability is regulated by lipid transport-dependent suppression of caveolae-mediated transcytosis. Neuron. 2017;94:581–594.e5. doi: 10.1016/j.neuron.2017.03.043.</cite> [<a href="https://doi.org/10.1016/j.neuron.2017.03.043" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5474951/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28416077/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;title=Blood-brain%20barrier%20permeability%20is%20regulated%20by%20lipid%20transport-dependent%20suppression%20of%20caveolae-mediated%20transcytosis&amp;author=BJ%20Andreone&amp;author=BW%20Chow&amp;author=A%20Tata&amp;author=B%20Lacoste&amp;author=A%20Ben-Zvi&amp;volume=94&amp;publication_year=2017&amp;pages=581-594.e5&amp;pmid=28416077&amp;doi=10.1016/j.neuron.2017.03.043&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b23-ijo-67-04-05789">
<span class="label">23.</span><cite>Eng ME, Imperio GE, Bloise E, Matthews SG. ATP-binding cassette (ABC) drug transporters in the developing blood-brain barrier: Role in fetal brain protection. Cell Mol Life Sci. 2022;79:415. doi: 10.1007/s00018-022-04432-w.</cite> [<a href="https://doi.org/10.1007/s00018-022-04432-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11071850/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35821142/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Mol%20Life%20Sci&amp;title=ATP-binding%20cassette%20(ABC)%20drug%20transporters%20in%20the%20developing%20blood-brain%20barrier:%20Role%20in%20fetal%20brain%20protection&amp;author=ME%20Eng&amp;author=GE%20Imperio&amp;author=E%20Bloise&amp;author=SG%20Matthews&amp;volume=79&amp;publication_year=2022&amp;pages=415&amp;pmid=35821142&amp;doi=10.1007/s00018-022-04432-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b24-ijo-67-04-05789">
<span class="label">24.</span><cite>Lochhead JJ, Yang J, Ronaldson PT, Davis TP. Structure, function, and regulation of the blood-brain barrier tight junction in central nervous system disorders. Front Physiol. 2020;11:914. doi: 10.3389/fphys.2020.00914.</cite> [<a href="https://doi.org/10.3389/fphys.2020.00914" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7424030/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32848858/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Physiol&amp;title=Structure,%20function,%20and%20regulation%20of%20the%20blood-brain%20barrier%20tight%20junction%20in%20central%20nervous%20system%20disorders&amp;author=JJ%20Lochhead&amp;author=J%20Yang&amp;author=PT%20Ronaldson&amp;author=TP%20Davis&amp;volume=11&amp;publication_year=2020&amp;pages=914&amp;pmid=32848858&amp;doi=10.3389/fphys.2020.00914&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b25-ijo-67-04-05789">
<span class="label">25.</span><cite>Salama NN, Eddington ND, Fasano A. Tight junction modulation and its relationship to drug delivery. Adv Drug Deliv Rev. 2006;58:15–28. doi: 10.1016/j.addr.2006.01.003.</cite> [<a href="https://doi.org/10.1016/j.addr.2006.01.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16517003/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv%20Drug%20Deliv%20Rev&amp;title=Tight%20junction%20modulation%20and%20its%20relationship%20to%20drug%20delivery&amp;author=NN%20Salama&amp;author=ND%20Eddington&amp;author=A%20Fasano&amp;volume=58&amp;publication_year=2006&amp;pages=15-28&amp;pmid=16517003&amp;doi=10.1016/j.addr.2006.01.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b26-ijo-67-04-05789">
<span class="label">26.</span><cite>Lemmer HJ, Hamman JH. Paracellular drug absorption enhancement through tight junction modulation. Expert Opin Drug Deliv. 2013;10:103–114. doi: 10.1517/17425247.2013.745509.</cite> [<a href="https://doi.org/10.1517/17425247.2013.745509" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23163247/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opin%20Drug%20Deliv&amp;title=Paracellular%20drug%20absorption%20enhancement%20through%20tight%20junction%20modulation&amp;author=HJ%20Lemmer&amp;author=JH%20Hamman&amp;volume=10&amp;publication_year=2013&amp;pages=103-114&amp;pmid=23163247&amp;doi=10.1517/17425247.2013.745509&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b27-ijo-67-04-05789">
<span class="label">27.</span><cite>Lin Y, Gan L, Ren L, Ma C, Dai M, Qian K, Ye Q, Lin X. Acupuncture with specific mode electro-stimulation effectively and transiently opens the BBB through Shh signaling pathway. Neuroreport. 2023;34:873–886. doi: 10.1097/WNR.0000000000001970.</cite> [<a href="https://doi.org/10.1097/WNR.0000000000001970" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37942738/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuroreport&amp;title=Acupuncture%20with%20specific%20mode%20electro-stimulation%20effectively%20and%20transiently%20opens%20the%20BBB%20through%20Shh%20signaling%20pathway&amp;author=Y%20Lin&amp;author=L%20Gan&amp;author=L%20Ren&amp;author=C%20Ma&amp;author=M%20Dai&amp;volume=34&amp;publication_year=2023&amp;pages=873-886&amp;pmid=37942738&amp;doi=10.1097/WNR.0000000000001970&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b28-ijo-67-04-05789">
<span class="label">28.</span><cite>Yang J, Betterton RD, Williams EI, Stanton JA, Reddell ES, Ogbonnaya CE, Dorn E, Davis TP, Lochhead JJ, Ronaldson PT. High-dose acetaminophen alters the integrity of the blood-brain barrier and leads to increased CNS uptake of codeine in rats. Pharmaceutics. 2022;14:949. doi: 10.3390/pharmaceutics14050949.</cite> [<a href="https://doi.org/10.3390/pharmaceutics14050949" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9144323/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35631535/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceutics&amp;title=High-dose%20acetaminophen%20alters%20the%20integrity%20of%20the%20blood-brain%20barrier%20and%20leads%20to%20increased%20CNS%20uptake%20of%20codeine%20in%20rats&amp;author=J%20Yang&amp;author=RD%20Betterton&amp;author=EI%20Williams&amp;author=JA%20Stanton&amp;author=ES%20Reddell&amp;volume=14&amp;publication_year=2022&amp;pages=949&amp;pmid=35631535&amp;doi=10.3390/pharmaceutics14050949&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b29-ijo-67-04-05789">
<span class="label">29.</span><cite>Han S, Mei L, Quach T, Porter C, Trevaskis N. Lipophilic conjugates of drugs: A tool to improve drug pharmacokinetic and therapeutic profiles. Pharm Res. 2021;38:1497–1518. doi: 10.1007/s11095-021-03093-x.</cite> [<a href="https://doi.org/10.1007/s11095-021-03093-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34463935/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharm%20Res&amp;title=Lipophilic%20conjugates%20of%20drugs:%20A%20tool%20to%20improve%20drug%20pharmacokinetic%20and%20therapeutic%20profiles&amp;author=S%20Han&amp;author=L%20Mei&amp;author=T%20Quach&amp;author=C%20Porter&amp;author=N%20Trevaskis&amp;volume=38&amp;publication_year=2021&amp;pages=1497-1518&amp;pmid=34463935&amp;doi=10.1007/s11095-021-03093-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b30-ijo-67-04-05789">
<span class="label">30.</span><cite>Muller J, Martins A, Csabi J, Fenyvesi F, Konczol A, Hunyadi A, Balogh GT. BBB penetration-targeting physicochemical lead selection: Ecdysteroids as chemo-sensitizers against CNS tumors. Eur J Pharm Sci. 2017;96:571–577. doi: 10.1016/j.ejps.2016.10.034.</cite> [<a href="https://doi.org/10.1016/j.ejps.2016.10.034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27810561/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Pharm%20Sci&amp;title=BBB%20penetration-targeting%20physicochemical%20lead%20selection:%20Ecdysteroids%20as%20chemo-sensitizers%20against%20CNS%20tumors&amp;author=J%20Muller&amp;author=A%20Martins&amp;author=J%20Csabi&amp;author=F%20Fenyvesi&amp;author=A%20Konczol&amp;volume=96&amp;publication_year=2017&amp;pages=571-577&amp;pmid=27810561&amp;doi=10.1016/j.ejps.2016.10.034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b31-ijo-67-04-05789">
<span class="label">31.</span><cite>Rankovic Z. CNS drug design: Balancing physicochemical properties for optimal brain exposure. J Med Chem. 2015;58:2584–2608. doi: 10.1021/jm501535r.</cite> [<a href="https://doi.org/10.1021/jm501535r" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25494650/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Chem&amp;title=CNS%20drug%20design:%20Balancing%20physicochemical%20properties%20for%20optimal%20brain%20exposure&amp;author=Z%20Rankovic&amp;volume=58&amp;publication_year=2015&amp;pages=2584-2608&amp;pmid=25494650&amp;doi=10.1021/jm501535r&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b32-ijo-67-04-05789">
<span class="label">32.</span><cite>van Tellingen O, Yetkin-Arik B, de Gooijer MC, Wesseling P, Wurdinger T, de Vries HE. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment. Drug Resist Updat. 2015;19:1–12. doi: 10.1016/j.drup.2015.02.002.</cite> [<a href="https://doi.org/10.1016/j.drup.2015.02.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25791797/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Resist%20Updat&amp;title=Overcoming%20the%20blood-brain%20tumor%20barrier%20for%20effective%20glioblastoma%20treatment&amp;author=O%20van%20Tellingen&amp;author=B%20Yetkin-Arik&amp;author=MC%20de%20Gooijer&amp;author=P%20Wesseling&amp;author=T%20Wurdinger&amp;volume=19&amp;publication_year=2015&amp;pages=1-12&amp;pmid=25791797&amp;doi=10.1016/j.drup.2015.02.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b33-ijo-67-04-05789">
<span class="label">33.</span><cite>Zhang Y, Liu Z, Gao C, Bian H, Ma Y, Jing F, Zhao X. Role of rituximab in treatment of patients with primary central nervous system lymphoma (PCNSL): A systematic review and Meta-analysis. Clin Lymphoma Myeloma Leuk. 2023;23:733–741. doi: 10.1016/j.clml.2023.06.008.</cite> [<a href="https://doi.org/10.1016/j.clml.2023.06.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37453867/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Lymphoma%20Myeloma%20Leuk&amp;title=Role%20of%20rituximab%20in%20treatment%20of%20patients%20with%20primary%20central%20nervous%20system%20lymphoma%20(PCNSL):%20A%20systematic%20review%20and%20Meta-analysis&amp;author=Y%20Zhang&amp;author=Z%20Liu&amp;author=C%20Gao&amp;author=H%20Bian&amp;author=Y%20Ma&amp;volume=23&amp;publication_year=2023&amp;pages=733-741&amp;pmid=37453867&amp;doi=10.1016/j.clml.2023.06.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b34-ijo-67-04-05789">
<span class="label">34.</span><cite>Paul PR, Mishra MK, Bora S, Kukal S, Singh A, Kukreti S, Kukreti R. The Impact of P-Glycoprotein on CNS drug efflux and variability in response. J Biochem Mol Toxicol. 2025;39:e70190. doi: 10.1002/jbt.70190.</cite> [<a href="https://doi.org/10.1002/jbt.70190" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39987512/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Biochem%20Mol%20Toxicol&amp;title=The%20Impact%20of%20P-Glycoprotein%20on%20CNS%20drug%20efflux%20and%20variability%20in%20response&amp;author=PR%20Paul&amp;author=MK%20Mishra&amp;author=S%20Bora&amp;author=S%20Kukal&amp;author=A%20Singh&amp;volume=39&amp;publication_year=2025&amp;pages=e70190&amp;pmid=39987512&amp;doi=10.1002/jbt.70190&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b35-ijo-67-04-05789">
<span class="label">35.</span><cite>Zensi A, Begley D, Pontikis C, Legros C, Mihoreanu L, Wagner S, Buchel C, von Briesen H, Kreuter J. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. J Control Release. 2009;137:78–86. doi: 10.1016/j.jconrel.2009.03.002.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2009.03.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19285109/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Control%20Release&amp;title=Albumin%20nanoparticles%20targeted%20with%20Apo%20E%20enter%20the%20CNS%20by%20transcytosis%20and%20are%20delivered%20to%20neurones&amp;author=A%20Zensi&amp;author=D%20Begley&amp;author=C%20Pontikis&amp;author=C%20Legros&amp;author=L%20Mihoreanu&amp;volume=137&amp;publication_year=2009&amp;pages=78-86&amp;pmid=19285109&amp;doi=10.1016/j.jconrel.2009.03.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b36-ijo-67-04-05789">
<span class="label">36.</span><cite>Demeule M, Regina A, Che C, Poirier J, Nguyen T, Gabathuler R, Castaigne JP, Beliveau R. Identification and design of peptides as a new drug delivery system for the brain. J Pharmacol Exp Ther. 2008;324:1064–1072. doi: 10.1124/jpet.107.131318.</cite> [<a href="https://doi.org/10.1124/jpet.107.131318" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18156463/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pharmacol%20Exp%20Ther&amp;title=Identification%20and%20design%20of%20peptides%20as%20a%20new%20drug%20delivery%20system%20for%20the%20brain&amp;author=M%20Demeule&amp;author=A%20Regina&amp;author=C%20Che&amp;author=J%20Poirier&amp;author=T%20Nguyen&amp;volume=324&amp;publication_year=2008&amp;pages=1064-1072&amp;pmid=18156463&amp;doi=10.1124/jpet.107.131318&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b37-ijo-67-04-05789">
<span class="label">37.</span><cite>Johnsen KB, Burkhart A, Thomsen LB, Andresen TL, Moos T. Targeting the transferrin receptor for brain drug delivery. Prog Neurobiol. 2019;181:101665. doi: 10.1016/j.pneurobio.2019.101665.</cite> [<a href="https://doi.org/10.1016/j.pneurobio.2019.101665" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31376426/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Prog%20Neurobiol&amp;title=Targeting%20the%20transferrin%20receptor%20for%20brain%20drug%20delivery&amp;author=KB%20Johnsen&amp;author=A%20Burkhart&amp;author=LB%20Thomsen&amp;author=TL%20Andresen&amp;author=T%20Moos&amp;volume=181&amp;publication_year=2019&amp;pages=101665&amp;pmid=31376426&amp;doi=10.1016/j.pneurobio.2019.101665&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b38-ijo-67-04-05789">
<span class="label">38.</span><cite>Xin H, Jiang X, Gu J, Sha X, Chen L, Law K, Chen Y, Wang X, Jiang Y, Fang X. Angiopep-conjugated poly(ethylene glycol)-co-poly(epsilon-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Biomaterials. 2011;32:4293–4305. doi: 10.1016/j.biomaterials.2011.02.044.</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2011.02.044" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21427009/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Angiopep-conjugated%20poly(ethylene%20glycol)-co-poly(epsilon-caprolactone)%20nanoparticles%20as%20dual-targeting%20drug%20delivery%20system%20for%20brain%20glioma&amp;author=H%20Xin&amp;author=X%20Jiang&amp;author=J%20Gu&amp;author=X%20Sha&amp;author=L%20Chen&amp;volume=32&amp;publication_year=2011&amp;pages=4293-4305&amp;pmid=21427009&amp;doi=10.1016/j.biomaterials.2011.02.044&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b39-ijo-67-04-05789">
<span class="label">39.</span><cite>Gonatas NK, Stieber A, Hickey WF, Herbert SH, Gonatas JO. Endosomes and Golgi vesicles in adsorptive and fluid phase endocytosis. J Cell Biol. 1984;99:1379–1390. doi: 10.1083/jcb.99.4.1379.</cite> [<a href="https://doi.org/10.1083/jcb.99.4.1379" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2113314/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6548223/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Cell%20Biol&amp;title=Endosomes%20and%20Golgi%20vesicles%20in%20adsorptive%20and%20fluid%20phase%20endocytosis&amp;author=NK%20Gonatas&amp;author=A%20Stieber&amp;author=WF%20Hickey&amp;author=SH%20Herbert&amp;author=JO%20Gonatas&amp;volume=99&amp;publication_year=1984&amp;pages=1379-1390&amp;pmid=6548223&amp;doi=10.1083/jcb.99.4.1379&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b40-ijo-67-04-05789">
<span class="label">40.</span><cite>Szecsko A, Meszaros M, Simoes B, Cavaco M, Chaparro C, Porkolab G, Castanho M, Deli MA, Neves V, Veszelka S. PepH3-modified nanocarriers for delivery of therapeutics across the blood-brain barrier. Fluids Barriers CNS. 2025;22:31. doi: 10.1186/s12987-025-00641-0.</cite> [<a href="https://doi.org/10.1186/s12987-025-00641-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11959756/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40170024/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Fluids%20Barriers%20CNS&amp;title=PepH3-modified%20nanocarriers%20for%20delivery%20of%20therapeutics%20across%20the%20blood-brain%20barrier&amp;author=A%20Szecsko&amp;author=M%20Meszaros&amp;author=B%20Simoes&amp;author=M%20Cavaco&amp;author=C%20Chaparro&amp;volume=22&amp;publication_year=2025&amp;pages=31&amp;pmid=40170024&amp;doi=10.1186/s12987-025-00641-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b41-ijo-67-04-05789">
<span class="label">41.</span><cite>Li Y, Zheng X, Gong M, Zhang J. Delivery of a peptide-drug conjugate targeting the blood brain barrier improved the efficacy of paclitaxel against glioma. Oncotarget. 2016;7:79401–79407. doi: 10.18632/oncotarget.12708.</cite> [<a href="https://doi.org/10.18632/oncotarget.12708" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5346723/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27765902/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Delivery%20of%20a%20peptide-drug%20conjugate%20targeting%20the%20blood%20brain%20barrier%20improved%20the%20efficacy%20of%20paclitaxel%20against%20glioma&amp;author=Y%20Li&amp;author=X%20Zheng&amp;author=M%20Gong&amp;author=J%20Zhang&amp;volume=7&amp;publication_year=2016&amp;pages=79401-79407&amp;pmid=27765902&amp;doi=10.18632/oncotarget.12708&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b42-ijo-67-04-05789">
<span class="label">42.</span><cite>Wang ZH, Wang ZY, Sun CS, Wang CY, Jiang TY, Wang SL. Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain. Biomaterials. 2010;31:908–915. doi: 10.1016/j.biomaterials.2009.09.104.</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2009.09.104" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19853292/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Trimethylated%20chitosan-conjugated%20PLGA%20nanoparticles%20for%20the%20delivery%20of%20drugs%20to%20the%20brain&amp;author=ZH%20Wang&amp;author=ZY%20Wang&amp;author=CS%20Sun&amp;author=CY%20Wang&amp;author=TY%20Jiang&amp;volume=31&amp;publication_year=2010&amp;pages=908-915&amp;pmid=19853292&amp;doi=10.1016/j.biomaterials.2009.09.104&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b43-ijo-67-04-05789">
<span class="label">43.</span><cite>Dowaidar M. Cell-penetrating peptides with nanoparticles hybrid delivery vectors and their uptake pathways. Mitochondrion. 2024;78:101906. doi: 10.1016/j.mito.2024.101906.</cite> [<a href="https://doi.org/10.1016/j.mito.2024.101906" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38797356/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mitochondrion&amp;title=Cell-penetrating%20peptides%20with%20nanoparticles%20hybrid%20delivery%20vectors%20and%20their%20uptake%20pathways&amp;author=M%20Dowaidar&amp;volume=78&amp;publication_year=2024&amp;pages=101906&amp;pmid=38797356&amp;doi=10.1016/j.mito.2024.101906&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b44-ijo-67-04-05789">
<span class="label">44.</span><cite>Liu Y, Huang R, Han L, Ke W, Shao K, Ye L, Lou J, Jiang C. Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles. Biomaterials. 2009;30:4195–4202. doi: 10.1016/j.biomaterials.2009.02.051.</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2009.02.051" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19467700/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Brain-targeting%20gene%20delivery%20and%20cellular%20internalization%20mechanisms%20for%20modified%20rabies%20virus%20glycoprotein%20RVG29%20nanoparticles&amp;author=Y%20Liu&amp;author=R%20Huang&amp;author=L%20Han&amp;author=W%20Ke&amp;author=K%20Shao&amp;volume=30&amp;publication_year=2009&amp;pages=4195-4202&amp;pmid=19467700&amp;doi=10.1016/j.biomaterials.2009.02.051&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b45-ijo-67-04-05789">
<span class="label">45.</span><cite>Wu MC, Wang EY, Lai TW. TAT peptide at treatment-level concentrations crossed brain endothelial cell monolayer independent of receptor-mediated endocytosis or peptide-inflicted barrier disruption. PLoS One. 2023;18:e0292681. doi: 10.1371/journal.pone.0292681.</cite> [<a href="https://doi.org/10.1371/journal.pone.0292681" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10566733/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37819924/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=TAT%20peptide%20at%20treatment-level%20concentrations%20crossed%20brain%20endothelial%20cell%20monolayer%20independent%20of%20receptor-mediated%20endocytosis%20or%20peptide-inflicted%20barrier%20disruption&amp;author=MC%20Wu&amp;author=EY%20Wang&amp;author=TW%20Lai&amp;volume=18&amp;publication_year=2023&amp;pages=e0292681&amp;pmid=37819924&amp;doi=10.1371/journal.pone.0292681&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b46-ijo-67-04-05789">
<span class="label">46.</span><cite>Hu C, Tao L, Cao X, Chen L. The solute carrier transporters and the brain: Physiological and pharmacological implications. Asian J Pharm Sci. 2020;15:131–144. doi: 10.1016/j.jphs.2019.12.008.</cite> [<a href="https://doi.org/10.1016/j.jphs.2019.12.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7193445/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32373195/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Asian%20J%20Pharm%20Sci&amp;title=The%20solute%20carrier%20transporters%20and%20the%20brain:%20Physiological%20and%20pharmacological%20implications&amp;author=C%20Hu&amp;author=L%20Tao&amp;author=X%20Cao&amp;author=L%20Chen&amp;volume=15&amp;publication_year=2020&amp;pages=131-144&amp;pmid=32373195&amp;doi=10.1016/j.jphs.2019.12.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b47-ijo-67-04-05789">
<span class="label">47.</span><cite>Al-Ahmad AJ. Comparative study of expression and activity of glucose transporters between stem cell-derived brain microvascular endothelial cells and hCMEC/D3 cells. Am J Physiol Cell Physiol. 2017;313:C421–C429. doi: 10.1152/ajpcell.00116.2017.</cite> [<a href="https://doi.org/10.1152/ajpcell.00116.2017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5668574/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28993322/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Physiol%20Cell%20Physiol&amp;title=Comparative%20study%20of%20expression%20and%20activity%20of%20glucose%20transporters%20between%20stem%20cell-derived%20brain%20microvascular%20endothelial%20cells%20and%20hCMEC/D3%20cells&amp;author=AJ%20Al-Ahmad&amp;volume=313&amp;publication_year=2017&amp;pages=C421-C429&amp;pmid=28993322&amp;doi=10.1152/ajpcell.00116.2017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b48-ijo-67-04-05789">
<span class="label">48.</span><cite>Singh N, Ecker GF. Insights into the structure, function, and ligand discovery of the large neutral amino acid transporter 1, LAT1. Int J Mol Sci. 2018;19:1278. doi: 10.3390/ijms19051278.</cite> [<a href="https://doi.org/10.3390/ijms19051278" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5983779/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29695141/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Sci&amp;title=Insights%20into%20the%20structure,%20function,%20and%20ligand%20discovery%20of%20the%20large%20neutral%20amino%20acid%20transporter%201,%20LAT1&amp;author=N%20Singh&amp;author=GF%20Ecker&amp;volume=19&amp;publication_year=2018&amp;pages=1278&amp;pmid=29695141&amp;doi=10.3390/ijms19051278&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b49-ijo-67-04-05789">
<span class="label">49.</span><cite>Vijay N, Morris ME. Role of monocarboxylate transporters in drug delivery to the brain. Curr Pharm Des. 2014;20:1487–1498. doi: 10.2174/13816128113199990462.</cite> [<a href="https://doi.org/10.2174/13816128113199990462" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4084603/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23789956/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Pharm%20Des&amp;title=Role%20of%20monocarboxylate%20transporters%20in%20drug%20delivery%20to%20the%20brain&amp;author=N%20Vijay&amp;author=ME%20Morris&amp;volume=20&amp;publication_year=2014&amp;pages=1487-1498&amp;pmid=23789956&amp;doi=10.2174/13816128113199990462&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b50-ijo-67-04-05789">
<span class="label">50.</span><cite>Jiang X, Xin H, Ren Q, Gu J, Zhu L, Du F, Feng C, Xie Y, Sha X, Fang X. Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment. Biomaterials. 2014;35:518–529. doi: 10.1016/j.biomaterials.2013.09.094.</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2013.09.094" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24125772/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Nanoparticles%20of%202-deoxy-D-glucose%20functionalized%20poly(ethylene%20glycol)-co-poly(trimethylene%20carbonate)%20for%20dual-targeted%20drug%20delivery%20in%20glioma%20treatment&amp;author=X%20Jiang&amp;author=H%20Xin&amp;author=Q%20Ren&amp;author=J%20Gu&amp;author=L%20Zhu&amp;volume=35&amp;publication_year=2014&amp;pages=518-529&amp;pmid=24125772&amp;doi=10.1016/j.biomaterials.2013.09.094&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b51-ijo-67-04-05789">
<span class="label">51.</span><cite>Campani V, Zappavigna S, Scotti L, Abate M, Porru M, Leonetti C, Caraglia M, De Rosa G. Hybrid lipid self-assembling nanoparticles for brain delivery of microRNA. Int J Pharm. 2020;588:119693. doi: 10.1016/j.ijpharm.2020.119693.</cite> [<a href="https://doi.org/10.1016/j.ijpharm.2020.119693" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32755686/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Pharm&amp;title=Hybrid%20lipid%20self-assembling%20nanoparticles%20for%20brain%20delivery%20of%20microRNA&amp;author=V%20Campani&amp;author=S%20Zappavigna&amp;author=L%20Scotti&amp;author=M%20Abate&amp;author=M%20Porru&amp;volume=588&amp;publication_year=2020&amp;pages=119693&amp;pmid=32755686&amp;doi=10.1016/j.ijpharm.2020.119693&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b52-ijo-67-04-05789">
<span class="label">52.</span><cite>Estella-Hermoso de Mendoza A, Preat V, Mollinedo F, Blanco-Prieto MJ. In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma. J Control Release. 2011;156:421–426. doi: 10.1016/j.jconrel.2011.07.030.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2011.07.030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21821074/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Control%20Release&amp;title=In%20vitro%20and%20in%20vivo%20efficacy%20of%20edelfosine-loaded%20lipid%20nanoparticles%20against%20glioma&amp;author=A%20Estella-Hermoso%20de%20Mendoza&amp;author=V%20Preat&amp;author=F%20Mollinedo&amp;author=MJ%20Blanco-Prieto&amp;volume=156&amp;publication_year=2011&amp;pages=421-426&amp;pmid=21821074&amp;doi=10.1016/j.jconrel.2011.07.030&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b53-ijo-67-04-05789">
<span class="label">53.</span><cite>Grafals-Ruiz N, Rios-Vicil CI, Lozada-Delgado EL, Quinones-Diaz BI, Noriega-Rivera RA, Martinez-Zayas G, Santana-Rivera Y, Santiago-Sanchez GS, Valiyeva F, Vivas-Mejia PE. Brain targeted gold liposomes improve RNAi delivery for glioblastoma. Int J Nanomedicine. 2020;15:2809–2828. doi: 10.2147/IJN.S241055.</cite> [<a href="https://doi.org/10.2147/IJN.S241055" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7185647/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32368056/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Nanomedicine&amp;title=Brain%20targeted%20gold%20liposomes%20improve%20RNAi%20delivery%20for%20glioblastoma&amp;author=N%20Grafals-Ruiz&amp;author=CI%20Rios-Vicil&amp;author=EL%20Lozada-Delgado&amp;author=BI%20Quinones-Diaz&amp;author=RA%20Noriega-Rivera&amp;volume=15&amp;publication_year=2020&amp;pages=2809-2828&amp;pmid=32368056&amp;doi=10.2147/IJN.S241055&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b54-ijo-67-04-05789">
<span class="label">54.</span><cite>Pandian SRK, Pavadai P, Vellaisamy S, Ravishankar V, Palanisamy P, Sundar LM, Chandramohan V, Sankaranarayanan M, Panneerselvam T, Kunjiappan S. Formulation and evaluation of Rutin-loaded solid lipid nanoparticles for the treatment of brain tumor. Naunyn Schmiedebergs Arch Pharmacol. 2021;394:735–749. doi: 10.1007/s00210-020-02015-9.</cite> [<a href="https://doi.org/10.1007/s00210-020-02015-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33156389/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Naunyn%20Schmiedebergs%20Arch%20Pharmacol&amp;title=Formulation%20and%20evaluation%20of%20Rutin-loaded%20solid%20lipid%20nanoparticles%20for%20the%20treatment%20of%20brain%20tumor&amp;author=SRK%20Pandian&amp;author=P%20Pavadai&amp;author=S%20Vellaisamy&amp;author=V%20Ravishankar&amp;author=P%20Palanisamy&amp;volume=394&amp;publication_year=2021&amp;pages=735-749&amp;pmid=33156389&amp;doi=10.1007/s00210-020-02015-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b55-ijo-67-04-05789">
<span class="label">55.</span><cite>Norouzi M, Yathindranath V, Thliveris JA, Kopec BM, Siahaan TJ, Miller DW. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: A combinational approach for enhanced delivery of nanoparticles. Sci Rep. 2020;10:11292. doi: 10.1038/s41598-020-68017-y.</cite> [<a href="https://doi.org/10.1038/s41598-020-68017-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7347880/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32647151/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Doxorubicin-loaded%20iron%20oxide%20nanoparticles%20for%20glioblastoma%20therapy:%20A%20combinational%20approach%20for%20enhanced%20delivery%20of%20nanoparticles&amp;author=M%20Norouzi&amp;author=V%20Yathindranath&amp;author=JA%20Thliveris&amp;author=BM%20Kopec&amp;author=TJ%20Siahaan&amp;volume=10&amp;publication_year=2020&amp;pages=11292&amp;pmid=32647151&amp;doi=10.1038/s41598-020-68017-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b56-ijo-67-04-05789">
<span class="label">56.</span><cite>Wohlfart S, Khalansky AS, Gelperina S, Maksimenko O, Bernreuther C, Glatzel M, Kreuter J. Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers. PLoS One. 2011;6:e19121. doi: 10.1371/journal.pone.0019121.</cite> [<a href="https://doi.org/10.1371/journal.pone.0019121" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3089596/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21573151/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Efficient%20chemotherapy%20of%20rat%20glioblastoma%20using%20doxorubicin-loaded%20PLGA%20nanoparticles%20with%20different%20stabilizers&amp;author=S%20Wohlfart&amp;author=AS%20Khalansky&amp;author=S%20Gelperina&amp;author=O%20Maksimenko&amp;author=C%20Bernreuther&amp;volume=6&amp;publication_year=2011&amp;pages=e19121&amp;pmid=21573151&amp;doi=10.1371/journal.pone.0019121&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b57-ijo-67-04-05789">
<span class="label">57.</span><cite>Zhao Y, Yin H, Zhang X. Modification of graphene oxide by angiopep-2 enhances anti-glioma efficiency of the nanoscaled delivery system for doxorubicin. Aging (Albany NY) 2020;12:10506–10516. doi: 10.18632/aging.103275.</cite> [<a href="https://doi.org/10.18632/aging.103275" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7346081/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32474457/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Aging%20(Albany%20NY)&amp;title=Modification%20of%20graphene%20oxide%20by%20angiopep-2%20enhances%20anti-glioma%20efficiency%20of%20the%20nanoscaled%20delivery%20system%20for%20doxorubicin&amp;author=Y%20Zhao&amp;author=H%20Yin&amp;author=X%20Zhang&amp;volume=12&amp;publication_year=2020&amp;pages=10506-10516&amp;pmid=32474457&amp;doi=10.18632/aging.103275&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b58-ijo-67-04-05789">
<span class="label">58.</span><cite>Cen J, Dai X, Zhao H, Li X, Hu X, Wu J, Duan S. Doxorubicin-loaded liposome with the function of 'Killing two birds with one stone' against Glioma. ACS Appl Mater Interfaces. 2023;15:46697–46709. doi: 10.1021/acsami.3c10364.</cite> [<a href="https://doi.org/10.1021/acsami.3c10364" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37782688/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Appl%20Mater%20Interfaces&amp;title=Doxorubicin-loaded%20liposome%20with%20the%20function%20of%20'Killing%20two%20birds%20with%20one%20stone'%20against%20Glioma&amp;author=J%20Cen&amp;author=X%20Dai&amp;author=H%20Zhao&amp;author=X%20Li&amp;author=X%20Hu&amp;volume=15&amp;publication_year=2023&amp;pages=46697-46709&amp;pmid=37782688&amp;doi=10.1021/acsami.3c10364&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b59-ijo-67-04-05789">
<span class="label">59.</span><cite>He H, Li Y, Jia XR, Du J, Ying X, Lu WL, Lou JN, Wei Y. PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors. Biomaterials. 2011;32:478–487. doi: 10.1016/j.biomaterials.2010.09.002.</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2010.09.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20934215/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=PEGylated%20Poly(amidoamine)%20dendrimer-based%20dual-targeting%20carrier%20for%20treating%20brain%20tumors&amp;author=H%20He&amp;author=Y%20Li&amp;author=XR%20Jia&amp;author=J%20Du&amp;author=X%20Ying&amp;volume=32&amp;publication_year=2011&amp;pages=478-487&amp;pmid=20934215&amp;doi=10.1016/j.biomaterials.2010.09.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b60-ijo-67-04-05789">
<span class="label">60.</span><cite>Khoury ES, Sharma A, Ramireddy RR, Thomas AG, Alt J, Fowler A, Rais R, Tsukamoto T, Blue ME, Slusher B, et al.  Dendrimer-conjugated glutaminase inhibitor selectively targets microglial glutaminase in a mouse model of Rett syndrome. Theranostics. 2020;10:5736–5748. doi: 10.7150/thno.41714.</cite> [<a href="https://doi.org/10.7150/thno.41714" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7254984/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32483415/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Theranostics&amp;title=Dendrimer-conjugated%20glutaminase%20inhibitor%20selectively%20targets%20microglial%20glutaminase%20in%20a%20mouse%20model%20of%20Rett%20syndrome&amp;author=ES%20Khoury&amp;author=A%20Sharma&amp;author=RR%20Ramireddy&amp;author=AG%20Thomas&amp;author=J%20Alt&amp;volume=10&amp;publication_year=2020&amp;pages=5736-5748&amp;pmid=32483415&amp;doi=10.7150/thno.41714&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b61-ijo-67-04-05789">
<span class="label">61.</span><cite>Liu C, Zhao Z, Gao H, Rostami I, You Q, Jia X, Wang C, Zhu L, Yang Y. Enhanced blood-brain-barrier penetrability and tumor-targeting efficiency by peptide-functionalized poly(amidoamine) dendrimer for the therapy of gliomas. Nanotheranostics. 2019;3:311–330. doi: 10.7150/ntno.38954.</cite> [<a href="https://doi.org/10.7150/ntno.38954" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6821994/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31687320/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanotheranostics&amp;title=Enhanced%20blood-brain-barrier%20penetrability%20and%20tumor-targeting%20efficiency%20by%20peptide-functionalized%20poly(amidoamine)%20dendrimer%20for%20the%20therapy%20of%20gliomas&amp;author=C%20Liu&amp;author=Z%20Zhao&amp;author=H%20Gao&amp;author=I%20Rostami&amp;author=Q%20You&amp;volume=3&amp;publication_year=2019&amp;pages=311-330&amp;pmid=31687320&amp;doi=10.7150/ntno.38954&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b62-ijo-67-04-05789">
<span class="label">62.</span><cite>Saw PE, Zhang A, Nie Y, Zhang L, Xu Y, Xu X. Tumor-associated fibronectin targeted liposomal nanoplatform for cyclophilin a siRNA delivery and targeted malignant glioblastoma therapy. Front Pharmacol. 2018;9:1194. doi: 10.3389/fphar.2018.01194.</cite> [<a href="https://doi.org/10.3389/fphar.2018.01194" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6199375/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30386245/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Pharmacol&amp;title=Tumor-associated%20fibronectin%20targeted%20liposomal%20nanoplatform%20for%20cyclophilin%20a%20siRNA%20delivery%20and%20targeted%20malignant%20glioblastoma%20therapy&amp;author=PE%20Saw&amp;author=A%20Zhang&amp;author=Y%20Nie&amp;author=L%20Zhang&amp;author=Y%20Xu&amp;volume=9&amp;publication_year=2018&amp;pages=1194&amp;pmid=30386245&amp;doi=10.3389/fphar.2018.01194&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b63-ijo-67-04-05789">
<span class="label">63.</span><cite>Zong T, Mei L, Gao H, Shi K, Chen J, Wang Y, Zhang Q, Yang Y, He Q. Enhanced glioma targeting and penetration by dual-targeting liposome co-modified with T7 and TAT. J Pharm Sci. 2014;103:3891–3901. doi: 10.1002/jps.24186.</cite> [<a href="https://doi.org/10.1002/jps.24186" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25339554/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pharm%20Sci&amp;title=Enhanced%20glioma%20targeting%20and%20penetration%20by%20dual-targeting%20liposome%20co-modified%20with%20T7%20and%20TAT&amp;author=T%20Zong&amp;author=L%20Mei&amp;author=H%20Gao&amp;author=K%20Shi&amp;author=J%20Chen&amp;volume=103&amp;publication_year=2014&amp;pages=3891-3901&amp;pmid=25339554&amp;doi=10.1002/jps.24186&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b64-ijo-67-04-05789">
<span class="label">64.</span><cite>Feng Q, Shen Y, Fu Y, Muroski ME, Zhang P, Wang Q, Xu C, Lesniak MS, Li G, Cheng Y. Self-assembly of gold nanoparticles shows microenvironment-mediated dynamic switching and enhanced brain tumor targeting. Theranostics. 2017;7:1875–1889. doi: 10.7150/thno.18985.</cite> [<a href="https://doi.org/10.7150/thno.18985" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5479275/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28638474/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Theranostics&amp;title=Self-assembly%20of%20gold%20nanoparticles%20shows%20microenvironment-mediated%20dynamic%20switching%20and%20enhanced%20brain%20tumor%20targeting&amp;author=Q%20Feng&amp;author=Y%20Shen&amp;author=Y%20Fu&amp;author=ME%20Muroski&amp;author=P%20Zhang&amp;volume=7&amp;publication_year=2017&amp;pages=1875-1889&amp;pmid=28638474&amp;doi=10.7150/thno.18985&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b65-ijo-67-04-05789">
<span class="label">65.</span><cite>Liaw K, Sharma R, Sharma A, Salazar S, Appiani La Rosa S, Kannan RM. Systemic dendrimer delivery of triptolide to tumor-associated macrophages improves Anti-tumor efficacy and reduces systemic toxicity in glioblastoma. J Control Release. 2021;329:434–444. doi: 10.1016/j.jconrel.2020.12.003.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2020.12.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7904646/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33290796/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Control%20Release&amp;title=Systemic%20dendrimer%20delivery%20of%20triptolide%20to%20tumor-associated%20macrophages%20improves%20Anti-tumor%20efficacy%20and%20reduces%20systemic%20toxicity%20in%20glioblastoma&amp;author=K%20Liaw&amp;author=R%20Sharma&amp;author=A%20Sharma&amp;author=S%20Salazar&amp;author=S%20Appiani%20La%20Rosa&amp;volume=329&amp;publication_year=2021&amp;pages=434-444&amp;pmid=33290796&amp;doi=10.1016/j.jconrel.2020.12.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b66-ijo-67-04-05789">
<span class="label">66.</span><cite>Lu W, Sun Q, Wan J, She Z, Jiang XG. Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration. Cancer Res. 2006;66:11878–11887. doi: 10.1158/0008-5472.CAN-06-2354.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-06-2354" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17178885/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&amp;title=Cationic%20albumin-conjugated%20pegylated%20nanoparticles%20allow%20gene%20delivery%20into%20brain%20tumors%20via%20intravenous%20administration&amp;author=W%20Lu&amp;author=Q%20Sun&amp;author=J%20Wan&amp;author=Z%20She&amp;author=XG%20Jiang&amp;volume=66&amp;publication_year=2006&amp;pages=11878-11887&amp;pmid=17178885&amp;doi=10.1158/0008-5472.CAN-06-2354&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b67-ijo-67-04-05789">
<span class="label">67.</span><cite>Negron K, Khalasawi N, Lu B, Ho CY, Lee J, Shenoy S, Mao HQ, Wang TH, Hanes J, Suk JS. Widespread gene transfer to malignant gliomas with In vitro-to-In vivo correlation. J Control Release. 2019;303:1–11. doi: 10.1016/j.jconrel.2019.04.010.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2019.04.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6579670/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30978431/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Control%20Release&amp;title=Widespread%20gene%20transfer%20to%20malignant%20gliomas%20with%20In%20vitro-to-In%20vivo%20correlation&amp;author=K%20Negron&amp;author=N%20Khalasawi&amp;author=B%20Lu&amp;author=CY%20Ho&amp;author=J%20Lee&amp;volume=303&amp;publication_year=2019&amp;pages=1-11&amp;pmid=30978431&amp;doi=10.1016/j.jconrel.2019.04.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b68-ijo-67-04-05789">
<span class="label">68.</span><cite>Wang Y, Wang K, Zhao J, Liu X, Bu J, Yan X, Huang R. Multifunctional mesoporous Silica-coated graphene nanosheet used for chemo-photothermal synergistic targeted therapy of glioma. J Am Chem Soc. 2013;135:4799–4804. doi: 10.1021/ja312221g.</cite> [<a href="https://doi.org/10.1021/ja312221g" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23495667/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Chem%20Soc&amp;title=Multifunctional%20mesoporous%20Silica-coated%20graphene%20nanosheet%20used%20for%20chemo-photothermal%20synergistic%20targeted%20therapy%20of%20glioma&amp;author=Y%20Wang&amp;author=K%20Wang&amp;author=J%20Zhao&amp;author=X%20Liu&amp;author=J%20Bu&amp;volume=135&amp;publication_year=2013&amp;pages=4799-4804&amp;pmid=23495667&amp;doi=10.1021/ja312221g&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b69-ijo-67-04-05789">
<span class="label">69.</span><cite>Zhang Y, Yu J, Zhang L, Cai J, Cai D, Lv C. Enhanced anti-tumor effects of doxorubicin on glioma by entrapping in polybutylcyanoacrylate nanoparticles. Tumour Biol. 2016;37:2703–2708. doi: 10.1007/s13277-015-4106-7.</cite> [<a href="https://doi.org/10.1007/s13277-015-4106-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26404136/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Tumour%20Biol&amp;title=Enhanced%20anti-tumor%20effects%20of%20doxorubicin%20on%20glioma%20by%20entrapping%20in%20polybutylcyanoacrylate%20nanoparticles&amp;author=Y%20Zhang&amp;author=J%20Yu&amp;author=L%20Zhang&amp;author=J%20Cai&amp;author=D%20Cai&amp;volume=37&amp;publication_year=2016&amp;pages=2703-2708&amp;pmid=26404136&amp;doi=10.1007/s13277-015-4106-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b70-ijo-67-04-05789">
<span class="label">70.</span><cite>Dal Magro R, Ornaghi F, Cambianica I, Beretta S, Re F, Musicanti C, Rigolio R, Donzelli E, Canta A, Ballarini E, et al.  ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier. J Control Release. 2017;249:103–110. doi: 10.1016/j.jconrel.2017.01.039.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2017.01.039" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28153761/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Control%20Release&amp;title=ApoE-modified%20solid%20lipid%20nanoparticles:%20A%20feasible%20strategy%20to%20cross%20the%20blood-brain%20barrier&amp;author=R%20Dal%20Magro&amp;author=F%20Ornaghi&amp;author=I%20Cambianica&amp;author=S%20Beretta&amp;author=F%20Re&amp;volume=249&amp;publication_year=2017&amp;pages=103-110&amp;pmid=28153761&amp;doi=10.1016/j.jconrel.2017.01.039&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b71-ijo-67-04-05789">
<span class="label">71.</span><cite>Demeule M, Currie JC, Bertrand Y, Che C, Nguyen T, Regina A, Gabathuler R, Castaigne JP, Beliveau R. Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2. J Neurochem. 2008;106:1534–1544. doi: 10.1111/j.1471-4159.2008.05492.x.</cite> [<a href="https://doi.org/10.1111/j.1471-4159.2008.05492.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18489712/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neurochem&amp;title=Involvement%20of%20the%20low-density%20lipoprotein%20receptor-related%20protein%20in%20the%20transcytosis%20of%20the%20brain%20delivery%20vector%20angiopep-2&amp;author=M%20Demeule&amp;author=JC%20Currie&amp;author=Y%20Bertrand&amp;author=C%20Che&amp;author=T%20Nguyen&amp;volume=106&amp;publication_year=2008&amp;pages=1534-1544&amp;pmid=18489712&amp;doi=10.1111/j.1471-4159.2008.05492.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b72-ijo-67-04-05789">
<span class="label">72.</span><cite>Hultqvist G, Syvanen S, Fang XT, Lannfelt L, Sehlin D. Bivalent brain shuttle increases antibody uptake by monovalent binding to the transferrin receptor. Theranostics. 2017;7:308–318. doi: 10.7150/thno.17155.</cite> [<a href="https://doi.org/10.7150/thno.17155" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5197066/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28042336/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Theranostics&amp;title=Bivalent%20brain%20shuttle%20increases%20antibody%20uptake%20by%20monovalent%20binding%20to%20the%20transferrin%20receptor&amp;author=G%20Hultqvist&amp;author=S%20Syvanen&amp;author=XT%20Fang&amp;author=L%20Lannfelt&amp;author=D%20Sehlin&amp;volume=7&amp;publication_year=2017&amp;pages=308-318&amp;pmid=28042336&amp;doi=10.7150/thno.17155&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b73-ijo-67-04-05789">
<span class="label">73.</span><cite>Molino Y, David M, Varini K, Jabes F, Gaudin N, Fortoul A, Bakloul K, Masse M, Bernard A, Drobecq L, et al.  Use of LDL receptor-targeting peptide vectors for in vitro and in vivo cargo transport across the blood-brain barrier. FASEB J. 2017;31:1807–1827. doi: 10.1096/fj.201600827R.</cite> [<a href="https://doi.org/10.1096/fj.201600827R" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28108572/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FASEB%20J&amp;title=Use%20of%20LDL%20receptor-targeting%20peptide%20vectors%20for%20in%20vitro%20and%20in%20vivo%20cargo%20transport%20across%20the%20blood-brain%20barrier&amp;author=Y%20Molino&amp;author=M%20David&amp;author=K%20Varini&amp;author=F%20Jabes&amp;author=N%20Gaudin&amp;volume=31&amp;publication_year=2017&amp;pages=1807-1827&amp;pmid=28108572&amp;doi=10.1096/fj.201600827R&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b74-ijo-67-04-05789">
<span class="label">74.</span><cite>Pardridge WM, Kang YS, Buciak JL, Yang J. Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate. Pharm Res. 1995;12:807–816. doi: 10.1023/A:1016244500596.</cite> [<a href="https://doi.org/10.1023/A:1016244500596" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7667183/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharm%20Res&amp;title=Human%20insulin%20receptor%20monoclonal%20antibody%20undergoes%20high%20affinity%20binding%20to%20human%20brain%20capillaries%20in%20vitro%20and%20rapid%20transcytosis%20through%20the%20blood-brain%20barrier%20in%20vivo%20in%20the%20primate&amp;author=WM%20Pardridge&amp;author=YS%20Kang&amp;author=JL%20Buciak&amp;author=J%20Yang&amp;volume=12&amp;publication_year=1995&amp;pages=807-816&amp;pmid=7667183&amp;doi=10.1023/A:1016244500596&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b75-ijo-67-04-05789">
<span class="label">75.</span><cite>Ribecco-Lutkiewicz M, Sodja C, Haukenfrers J, Haqqani AS, Ly D, Zachar P, Baumann E, Ball M, Huang J, Rukhlova M, et al.  A novel human induced pluripotent stem cell blood-brain barrier model: Applicability to study antibody-triggered receptor-mediated transcytosis. Sci Rep. 2018;8:1873. doi: 10.1038/s41598-018-19522-8.</cite> [<a href="https://doi.org/10.1038/s41598-018-19522-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5789839/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29382846/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=A%20novel%20human%20induced%20pluripotent%20stem%20cell%20blood-brain%20barrier%20model:%20Applicability%20to%20study%20antibody-triggered%20receptor-mediated%20transcytosis&amp;author=M%20Ribecco-Lutkiewicz&amp;author=C%20Sodja&amp;author=J%20Haukenfrers&amp;author=AS%20Haqqani&amp;author=D%20Ly&amp;volume=8&amp;publication_year=2018&amp;pages=1873&amp;pmid=29382846&amp;doi=10.1038/s41598-018-19522-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b76-ijo-67-04-05789">
<span class="label">76.</span><cite>Wu LP, Ahmadvand D, Su J, Hall A, Tan X, Farhangrazi ZS, Moghimi SM. Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled from a phage display peptide. Nat Commun. 2019;10:4635. doi: 10.1038/s41467-019-12554-2.</cite> [<a href="https://doi.org/10.1038/s41467-019-12554-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6789111/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31604928/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=Crossing%20the%20blood-brain-barrier%20with%20nanoligand%20drug%20carriers%20self-assembled%20from%20a%20phage%20display%20peptide&amp;author=LP%20Wu&amp;author=D%20Ahmadvand&amp;author=J%20Su&amp;author=A%20Hall&amp;author=X%20Tan&amp;volume=10&amp;publication_year=2019&amp;pages=4635&amp;pmid=31604928&amp;doi=10.1038/s41467-019-12554-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b77-ijo-67-04-05789">
<span class="label">77.</span><cite>Zhan C, Li B, Hu L, Wei X, Feng L, Fu W, Lu W. Micelle-based Brain-targeted drug delivery enabled by a nicotine acetylcholine receptor ligand. Angew Chem Int Ed Engl. 2011;50:5482–5485. doi: 10.1002/anie.201100875.</cite> [<a href="https://doi.org/10.1002/anie.201100875" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21542074/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Angew%20Chem%20Int%20Ed%20Engl&amp;title=Micelle-based%20Brain-targeted%20drug%20delivery%20enabled%20by%20a%20nicotine%20acetylcholine%20receptor%20ligand&amp;author=C%20Zhan&amp;author=B%20Li&amp;author=L%20Hu&amp;author=X%20Wei&amp;author=L%20Feng&amp;volume=50&amp;publication_year=2011&amp;pages=5482-5485&amp;pmid=21542074&amp;doi=10.1002/anie.201100875&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b78-ijo-67-04-05789">
<span class="label">78.</span><cite>Bera S, Kar RK, Mondal S, Pahan K, Bhunia A. Structural elucidation of the Cell-penetrating penetratin peptide in model membranes at the atomic level: Probing hydrophobic interactions in the Blood-brain barrier. Biochemistry. 2016;55:4982–4996. doi: 10.1021/acs.biochem.6b00518.</cite> [<a href="https://doi.org/10.1021/acs.biochem.6b00518" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5014585/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27532224/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=Structural%20elucidation%20of%20the%20Cell-penetrating%20penetratin%20peptide%20in%20model%20membranes%20at%20the%20atomic%20level:%20Probing%20hydrophobic%20interactions%20in%20the%20Blood-brain%20barrier&amp;author=S%20Bera&amp;author=RK%20Kar&amp;author=S%20Mondal&amp;author=K%20Pahan&amp;author=A%20Bhunia&amp;volume=55&amp;publication_year=2016&amp;pages=4982-4996&amp;pmid=27532224&amp;doi=10.1021/acs.biochem.6b00518&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b79-ijo-67-04-05789">
<span class="label">79.</span><cite>Bertrand Y, Currie JC, Poirier J, Demeule M, Abulrob A, Fatehi D, Stanimirovic D, Sartelet H, Castaigne JP, Beliveau R. Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1. Br J Cancer. 2011;105:1697–1707. doi: 10.1038/bjc.2011.427.</cite> [<a href="https://doi.org/10.1038/bjc.2011.427" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3242593/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22027709/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Cancer&amp;title=Influence%20of%20glioma%20tumour%20microenvironment%20on%20the%20transport%20of%20ANG1005%20via%20low-density%20lipoprotein%20receptor-related%20protein%201&amp;author=Y%20Bertrand&amp;author=JC%20Currie&amp;author=J%20Poirier&amp;author=M%20Demeule&amp;author=A%20Abulrob&amp;volume=105&amp;publication_year=2011&amp;pages=1697-1707&amp;pmid=22027709&amp;doi=10.1038/bjc.2011.427&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b80-ijo-67-04-05789">
<span class="label">80.</span><cite>Du D, Chang N, Sun S, Li M, Yu H, Liu M, Liu X, Wang G, Li H, Liu X, et al.  The role of glucose transporters in the distribution of p-aminophenyl-α-d-mannopyranoside modified liposomes within mice brain. J Control Release. 2014;182:99–110. doi: 10.1016/j.jconrel.2014.03.006.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2014.03.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24631863/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Control%20Release&amp;title=The%20role%20of%20glucose%20transporters%20in%20the%20distribution%20of%20p-aminophenyl-%CE%B1-d-mannopyranoside%20modified%20liposomes%20within%20mice%20brain&amp;author=D%20Du&amp;author=N%20Chang&amp;author=S%20Sun&amp;author=M%20Li&amp;author=H%20Yu&amp;volume=182&amp;publication_year=2014&amp;pages=99-110&amp;pmid=24631863&amp;doi=10.1016/j.jconrel.2014.03.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b81-ijo-67-04-05789">
<span class="label">81.</span><cite>Joshi S, Cooke JRN, Ellis JA, Emala CW, Bruce JN. Targeting brain tumors by intra-arterial delivery of cell-penetrating peptides: A novel approach for primary and metastatic brain malignancy. J Neurooncol. 2017;135:497–506. doi: 10.1007/s11060-017-2615-5.</cite> [<a href="https://doi.org/10.1007/s11060-017-2615-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28875440/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neurooncol&amp;title=Targeting%20brain%20tumors%20by%20intra-arterial%20delivery%20of%20cell-penetrating%20peptides:%20A%20novel%20approach%20for%20primary%20and%20metastatic%20brain%20malignancy&amp;author=S%20Joshi&amp;author=JRN%20Cooke&amp;author=JA%20Ellis&amp;author=CW%20Emala&amp;author=JN%20Bruce&amp;volume=135&amp;publication_year=2017&amp;pages=497-506&amp;pmid=28875440&amp;doi=10.1007/s11060-017-2615-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b82-ijo-67-04-05789">
<span class="label">82.</span><cite>Liu Y, Li J, Shao K, Huang R, Ye L, Lou J, Jiang C. A leptin derived 30-amino-acid peptide modified pegylated poly-L-lysine dendrigraft for brain targeted gene delivery. Biomaterials. 2010;31:5246–5257. doi: 10.1016/j.biomaterials.2010.03.011.</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2010.03.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20382424/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=A%20leptin%20derived%2030-amino-acid%20peptide%20modified%20pegylated%20poly-L-lysine%20dendrigraft%20for%20brain%20targeted%20gene%20delivery&amp;author=Y%20Liu&amp;author=J%20Li&amp;author=K%20Shao&amp;author=R%20Huang&amp;author=L%20Ye&amp;volume=31&amp;publication_year=2010&amp;pages=5246-5257&amp;pmid=20382424&amp;doi=10.1016/j.biomaterials.2010.03.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b83-ijo-67-04-05789">
<span class="label">83.</span><cite>Molina-Arcas M, Casado FJ, Pastor-Anglada M. Nucleoside transporter proteins. Curr Vasc Pharmacol. 2009;7:426–434. doi: 10.2174/157016109789043892.</cite> [<a href="https://doi.org/10.2174/157016109789043892" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19485885/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Vasc%20Pharmacol&amp;title=Nucleoside%20transporter%20proteins&amp;author=M%20Molina-Arcas&amp;author=FJ%20Casado&amp;author=M%20Pastor-Anglada&amp;volume=7&amp;publication_year=2009&amp;pages=426-434&amp;pmid=19485885&amp;doi=10.2174/157016109789043892&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b84-ijo-67-04-05789">
<span class="label">84.</span><cite>Romano A, Koczwara JB, Gallelli CA, Vergara D, Micioni Di Bonaventura MV, Gaetani S, Giudett AM. Fats for thoughts: An update on brain fatty acid metabolism. Int J Biochem Cell Biol. 2017;84:40–45. doi: 10.1016/j.biocel.2016.12.015.</cite> [<a href="https://doi.org/10.1016/j.biocel.2016.12.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28065757/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Biochem%20Cell%20Biol&amp;title=Fats%20for%20thoughts:%20An%20update%20on%20brain%20fatty%20acid%20metabolism&amp;author=A%20Romano&amp;author=JB%20Koczwara&amp;author=CA%20Gallelli&amp;author=D%20Vergara&amp;author=MV%20Micioni%20Di%20Bonaventura&amp;volume=84&amp;publication_year=2017&amp;pages=40-45&amp;pmid=28065757&amp;doi=10.1016/j.biocel.2016.12.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b85-ijo-67-04-05789">
<span class="label">85.</span><cite>Strickland M, Stoll EA. Metabolic reprogramming in glioma. Front Cell Dev Biol. 2017;5:43. doi: 10.3389/fcell.2017.00043.</cite> [<a href="https://doi.org/10.3389/fcell.2017.00043" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5405080/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28491867/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Cell%20Dev%20Biol&amp;title=Metabolic%20reprogramming%20in%20glioma&amp;author=M%20Strickland&amp;author=EA%20Stoll&amp;volume=5&amp;publication_year=2017&amp;pages=43&amp;pmid=28491867&amp;doi=10.3389/fcell.2017.00043&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b86-ijo-67-04-05789">
<span class="label">86.</span><cite>Yang Y, Yang Y, Xie X, Cai X, Zhang H, Gong W, Wang Z, Mei X. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy. Biomaterials. 2014;35:4368–4381. doi: 10.1016/j.biomaterials.2014.01.076.</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2014.01.076" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24565519/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=PEGylated%20liposomes%20with%20NGR%20ligand%20and%20heat-activable%20cell-penetrating%20peptide-doxorubicin%20conjugate%20for%20tumor-specific%20therapy&amp;author=Y%20Yang&amp;author=Y%20Yang&amp;author=X%20Xie&amp;author=X%20Cai&amp;author=H%20Zhang&amp;volume=35&amp;publication_year=2014&amp;pages=4368-4381&amp;pmid=24565519&amp;doi=10.1016/j.biomaterials.2014.01.076&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b87-ijo-67-04-05789">
<span class="label">87.</span><cite>Minty A, Chalon P, Derocq JM, Dumont X, Guillemot JC, Kaghad M, Labit C, Leplatois P, Liauzun P, Miloux B, et al.  Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature. 1993;362:248–250. doi: 10.1038/362248a0.</cite> [<a href="https://doi.org/10.1038/362248a0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8096327/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Interleukin-13%20is%20a%20new%20human%20lymphokine%20regulating%20inflammatory%20and%20immune%20responses&amp;author=A%20Minty&amp;author=P%20Chalon&amp;author=JM%20Derocq&amp;author=X%20Dumont&amp;author=JC%20Guillemot&amp;volume=362&amp;publication_year=1993&amp;pages=248-250&amp;pmid=8096327&amp;doi=10.1038/362248a0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b88-ijo-67-04-05789">
<span class="label">88.</span><cite>Debinski W, Gibo DM. Molecular expression analysis of restrictive receptor for interleukin 13, a brain tumor-associated cancer/testis antigen. Mol Med. 2000;6:440–449. doi: 10.1007/BF03401786.</cite> [<a href="https://doi.org/10.1007/BF03401786" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1949955/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10952023/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Med&amp;title=Molecular%20expression%20analysis%20of%20restrictive%20receptor%20for%20interleukin%2013,%20a%20brain%20tumor-associated%20cancer/testis%20antigen&amp;author=W%20Debinski&amp;author=DM%20Gibo&amp;volume=6&amp;publication_year=2000&amp;pages=440-449&amp;pmid=10952023&amp;doi=10.1007/BF03401786&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b89-ijo-67-04-05789">
<span class="label">89.</span><cite>Kawakami M, Kawakami K, Takahashi S, Abe M, Puri RK. Analysis of interleukin-13 receptor alpha2 expression in human pediatric brain tumors. Cancer. 2004;101:1036–1042. doi: 10.1002/cncr.20470.</cite> [<a href="https://doi.org/10.1002/cncr.20470" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15329913/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Analysis%20of%20interleukin-13%20receptor%20alpha2%20expression%20in%20human%20pediatric%20brain%20tumors&amp;author=M%20Kawakami&amp;author=K%20Kawakami&amp;author=S%20Takahashi&amp;author=M%20Abe&amp;author=RK%20Puri&amp;volume=101&amp;publication_year=2004&amp;pages=1036-1042&amp;pmid=15329913&amp;doi=10.1002/cncr.20470&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b90-ijo-67-04-05789">
<span class="label">90.</span><cite>Madhankumar AB, Slagle-Webb B, Mintz A, Sheehan JM, Connor JR. Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme. Mol Cancer Ther. 2006;5:3162–3169. doi: 10.1158/1535-7163.MCT-06-0480.</cite> [<a href="https://doi.org/10.1158/1535-7163.MCT-06-0480" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17172420/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cancer%20Ther&amp;title=Interleukin-13%20receptor-targeted%20nanovesicles%20are%20a%20potential%20therapy%20for%20glioblastoma%20multiforme&amp;author=AB%20Madhankumar&amp;author=B%20Slagle-Webb&amp;author=A%20Mintz&amp;author=JM%20Sheehan&amp;author=JR%20Connor&amp;volume=5&amp;publication_year=2006&amp;pages=3162-3169&amp;pmid=17172420&amp;doi=10.1158/1535-7163.MCT-06-0480&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b91-ijo-67-04-05789">
<span class="label">91.</span><cite>Wei L, Guo XY, Yang T, Yu MZ, Chen DW, Wang JC. Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles. Int J Pharm. 2016;510:394–405. doi: 10.1016/j.ijpharm.2016.06.127.</cite> [<a href="https://doi.org/10.1016/j.ijpharm.2016.06.127" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27374198/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Pharm&amp;title=Brain%20tumor-targeted%20therapy%20by%20systemic%20delivery%20of%20siRNA%20with%20Transferrin%20receptor-mediated%20core-shell%20nanoparticles&amp;author=L%20Wei&amp;author=XY%20Guo&amp;author=T%20Yang&amp;author=MZ%20Yu&amp;author=DW%20Chen&amp;volume=510&amp;publication_year=2016&amp;pages=394-405&amp;pmid=27374198&amp;doi=10.1016/j.ijpharm.2016.06.127&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b92-ijo-67-04-05789">
<span class="label">92.</span><cite>Gong Z, Chi C, Huang X, Chu H, Wang J, Du F, Jiang L, Chen J. Cyclophilin a is overexpressed in hepatocellular carcinoma and is associated with the cell cycle. Anticancer Res. 2017;37:4443–4447. doi: 10.21873/anticanres.11839.</cite> [<a href="https://doi.org/10.21873/anticanres.11839" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28739738/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Anticancer%20Res&amp;title=Cyclophilin%20a%20is%20overexpressed%20in%20hepatocellular%20carcinoma%20and%20is%20associated%20with%20the%20cell%20cycle&amp;author=Z%20Gong&amp;author=C%20Chi&amp;author=X%20Huang&amp;author=H%20Chu&amp;author=J%20Wang&amp;volume=37&amp;publication_year=2017&amp;pages=4443-4447&amp;pmid=28739738&amp;doi=10.21873/anticanres.11839&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b93-ijo-67-04-05789">
<span class="label">93.</span><cite>Jain R, Atak A, Yeola A, Srivastava S. Proteomic level changes associated with S3I201 treated U87 glioma cells. J Proteomics. 2017;150:341–350. doi: 10.1016/j.jprot.2016.08.011.</cite> [<a href="https://doi.org/10.1016/j.jprot.2016.08.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27565396/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Proteomics&amp;title=Proteomic%20level%20changes%20associated%20with%20S3I201%20treated%20U87%20glioma%20cells&amp;author=R%20Jain&amp;author=A%20Atak&amp;author=A%20Yeola&amp;author=S%20Srivastava&amp;volume=150&amp;publication_year=2017&amp;pages=341-350&amp;pmid=27565396&amp;doi=10.1016/j.jprot.2016.08.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b94-ijo-67-04-05789">
<span class="label">94.</span><cite>Yang H, Chen J, Yang J, Qiao S, Zhao S, Yu L. Cyclophilin A is upregulated in small cell lung cancer and activates ERK1/2 signal. Biochem Biophys Res Commun. 2007;361:763–767. doi: 10.1016/j.bbrc.2007.07.085.</cite> [<a href="https://doi.org/10.1016/j.bbrc.2007.07.085" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17678621/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem%20Biophys%20Res%20Commun&amp;title=Cyclophilin%20A%20is%20upregulated%20in%20small%20cell%20lung%20cancer%20and%20activates%20ERK1/2%20signal&amp;author=H%20Yang&amp;author=J%20Chen&amp;author=J%20Yang&amp;author=S%20Qiao&amp;author=S%20Zhao&amp;volume=361&amp;publication_year=2007&amp;pages=763-767&amp;pmid=17678621&amp;doi=10.1016/j.bbrc.2007.07.085&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b95-ijo-67-04-05789">
<span class="label">95.</span><cite>Campani V, De Rosa G, Misso G, Zarone MR, Grimaldi A. Lipid nanoparticles to deliver miRNA in cancer. Curr Pharm Biotechnol. 2016;17:741–749. doi: 10.2174/138920101708160517234941.</cite> [<a href="https://doi.org/10.2174/138920101708160517234941" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27215371/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Pharm%20Biotechnol&amp;title=Lipid%20nanoparticles%20to%20deliver%20miRNA%20in%20cancer&amp;author=V%20Campani&amp;author=G%20De%20Rosa&amp;author=G%20Misso&amp;author=MR%20Zarone&amp;author=A%20Grimaldi&amp;volume=17&amp;publication_year=2016&amp;pages=741-749&amp;pmid=27215371&amp;doi=10.2174/138920101708160517234941&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b96-ijo-67-04-05789">
<span class="label">96.</span><cite>Singh A, Trivedi P, Jain NK. Advances in siRNA delivery in cancer therapy. Artif Cells Nanomed Biotechnol. 2018;46:274–283. doi: 10.1080/21691401.2017.1307210.</cite> [<a href="https://doi.org/10.1080/21691401.2017.1307210" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28423924/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Artif%20Cells%20Nanomed%20Biotechnol&amp;title=Advances%20in%20siRNA%20delivery%20in%20cancer%20therapy&amp;author=A%20Singh&amp;author=P%20Trivedi&amp;author=NK%20Jain&amp;volume=46&amp;publication_year=2018&amp;pages=274-283&amp;pmid=28423924&amp;doi=10.1080/21691401.2017.1307210&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b97-ijo-67-04-05789">
<span class="label">97.</span><cite>Pink DL, Loruthai O, Ziolek RM, Wasutrasawat P, Terry AE, Lawrence MJ, Lorenz CD. On the structure of solid lipid nanoparticles. Small. 2019;15:e1903156. doi: 10.1002/smll.201903156.</cite> [<a href="https://doi.org/10.1002/smll.201903156" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31532892/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Small&amp;title=On%20the%20structure%20of%20solid%20lipid%20nanoparticles&amp;author=DL%20Pink&amp;author=O%20Loruthai&amp;author=RM%20Ziolek&amp;author=P%20Wasutrasawat&amp;author=AE%20Terry&amp;volume=15&amp;publication_year=2019&amp;pages=e1903156&amp;pmid=31532892&amp;doi=10.1002/smll.201903156&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b98-ijo-67-04-05789">
<span class="label">98.</span><cite>Negahdari R, Bohlouli S, Sharifi S, Maleki Dizaj S, Rahbar Saadat Y, Khezri K, Jafari S, Ahmadian E, Gorbani Jahandizi N, Raeesi S. Therapeutic benefits of rutin and its nanoformulations. Phytother Res. 2021;35:1719–1738. doi: 10.1002/ptr.6904.</cite> [<a href="https://doi.org/10.1002/ptr.6904" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33058407/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Phytother%20Res&amp;title=Therapeutic%20benefits%20of%20rutin%20and%20its%20nanoformulations&amp;author=R%20Negahdari&amp;author=S%20Bohlouli&amp;author=S%20Sharifi&amp;author=S%20Maleki%20Dizaj&amp;author=Y%20Rahbar%20Saadat&amp;volume=35&amp;publication_year=2021&amp;pages=1719-1738&amp;pmid=33058407&amp;doi=10.1002/ptr.6904&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b99-ijo-67-04-05789">
<span class="label">99.</span><cite>Ishak RAH, Mostafa NM, Kamel AO. Stealth lipid polymer hybrid nanoparticles loaded with rutin for effective brain delivery-comparative study with the gold standard (Tween 80): Optimization, characterization and biodistribution. Drug Deliv. 2017;24:1874–1890. doi: 10.1080/10717544.2017.1410263.</cite> [<a href="https://doi.org/10.1080/10717544.2017.1410263" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8241138/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29191047/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Deliv&amp;title=Stealth%20lipid%20polymer%20hybrid%20nanoparticles%20loaded%20with%20rutin%20for%20effective%20brain%20delivery-comparative%20study%20with%20the%20gold%20standard%20(Tween%2080):%20Optimization,%20characterization%20and%20biodistribution&amp;author=RAH%20Ishak&amp;author=NM%20Mostafa&amp;author=AO%20Kamel&amp;volume=24&amp;publication_year=2017&amp;pages=1874-1890&amp;pmid=29191047&amp;doi=10.1080/10717544.2017.1410263&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b100-ijo-67-04-05789">
<span class="label">100.</span><cite>Neves AR, Queiroz JF, Lima SAC, Reis S. Apo E-Functionalization of solid lipid nanoparticles enhances brain drug delivery: Uptake mechanism and transport pathways. Bioconjug Chem. 2017;28:995–1004. doi: 10.1021/acs.bioconjchem.6b00705.</cite> [<a href="https://doi.org/10.1021/acs.bioconjchem.6b00705" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28355061/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioconjug%20Chem&amp;title=Apo%20E-Functionalization%20of%20solid%20lipid%20nanoparticles%20enhances%20brain%20drug%20delivery:%20Uptake%20mechanism%20and%20transport%20pathways&amp;author=AR%20Neves&amp;author=JF%20Queiroz&amp;author=SAC%20Lima&amp;author=S%20Reis&amp;volume=28&amp;publication_year=2017&amp;pages=995-1004&amp;pmid=28355061&amp;doi=10.1021/acs.bioconjchem.6b00705&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b101-ijo-67-04-05789">
<span class="label">101.</span><cite>Banerjee I, De K, Mukherjee D, Dey G, Chattopadhyay S, Mukherjee M, Mandal M, Bandyopadhyay AK, Gupta A, Ganguly S, Misra M. Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapy. Acta Biomater. 2016;38:69–81. doi: 10.1016/j.actbio.2016.04.026.</cite> [<a href="https://doi.org/10.1016/j.actbio.2016.04.026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27109765/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Biomater&amp;title=Paclitaxel-loaded%20solid%20lipid%20nanoparticles%20modified%20with%20Tyr-3-octreotide%20for%20enhanced%20anti-angiogenic%20and%20anti-glioma%20therapy&amp;author=I%20Banerjee&amp;author=K%20De&amp;author=D%20Mukherjee&amp;author=G%20Dey&amp;author=S%20Chattopadhyay&amp;volume=38&amp;publication_year=2016&amp;pages=69-81&amp;pmid=27109765&amp;doi=10.1016/j.actbio.2016.04.026&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b102-ijo-67-04-05789">
<span class="label">102.</span><cite>Mukherjee A, Waters AK, Kalyan P, Achrol AS, Kesari S, Yenugonda VM. Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: State of the art, emerging technologies, and perspectives. Int J Nanomedicine. 2019;14:1937–1952. doi: 10.2147/IJN.S198353.</cite> [<a href="https://doi.org/10.2147/IJN.S198353" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6430183/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30936695/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Nanomedicine&amp;title=Lipid-polymer%20hybrid%20nanoparticles%20as%20a%20next-generation%20drug%20delivery%20platform:%20State%20of%20the%20art,%20emerging%20technologies,%20and%20perspectives&amp;author=A%20Mukherjee&amp;author=AK%20Waters&amp;author=P%20Kalyan&amp;author=AS%20Achrol&amp;author=S%20Kesari&amp;volume=14&amp;publication_year=2019&amp;pages=1937-1952&amp;pmid=30936695&amp;doi=10.2147/IJN.S198353&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b103-ijo-67-04-05789">
<span class="label">103.</span><cite>Salzano G, Zappavigna S, Luce A, D'Onofrio N, Balestrieri ML, Grimaldi A, Lusa S, Ingrosso D, Artuso S, Porru M, et al.  Transferrin-targeted nanoparticles containing zoledronic acid as a potential tool to inhibit glioblastoma growth. J Biomed Nanotechnol. 2016;12:811–830. doi: 10.1166/jbn.2016.2214.</cite> [<a href="https://doi.org/10.1166/jbn.2016.2214" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27301207/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Biomed%20Nanotechnol&amp;title=Transferrin-targeted%20nanoparticles%20containing%20zoledronic%20acid%20as%20a%20potential%20tool%20to%20inhibit%20glioblastoma%20growth&amp;author=G%20Salzano&amp;author=S%20Zappavigna&amp;author=A%20Luce&amp;author=N%20D'Onofrio&amp;author=ML%20Balestrieri&amp;volume=12&amp;publication_year=2016&amp;pages=811-830&amp;pmid=27301207&amp;doi=10.1166/jbn.2016.2214&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b104-ijo-67-04-05789">
<span class="label">104.</span><cite>Aili T, Zong JB, Zhou YF, Liu YX, Yang XL, Hu B, Wu JH. Recent advances of self-assembled nanoparticles in the diagnosis and treatment of atherosclerosis. Theranostics. 2024;14:7505–7533. doi: 10.7150/thno.100388.</cite> [<a href="https://doi.org/10.7150/thno.100388" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11626940/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39659570/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Theranostics&amp;title=Recent%20advances%20of%20self-assembled%20nanoparticles%20in%20the%20diagnosis%20and%20treatment%20of%20atherosclerosis&amp;author=T%20Aili&amp;author=JB%20Zong&amp;author=YF%20Zhou&amp;author=YX%20Liu&amp;author=XL%20Yang&amp;volume=14&amp;publication_year=2024&amp;pages=7505-7533&amp;pmid=39659570&amp;doi=10.7150/thno.100388&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b105-ijo-67-04-05789">
<span class="label">105.</span><cite>Chen C, Shen M, Liao H, Guo Q, Fu H, Yu J, Duan Y. A paclitaxel and microRNA-124 coloaded stepped cleavable nanosystem against triple negative breast cancer. J Nanobiotechnology. 2021;19:55. doi: 10.1186/s12951-021-00800-z.</cite> [<a href="https://doi.org/10.1186/s12951-021-00800-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7905927/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33632232/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Nanobiotechnology&amp;title=A%20paclitaxel%20and%20microRNA-124%20coloaded%20stepped%20cleavable%20nanosystem%20against%20triple%20negative%20breast%20cancer&amp;author=C%20Chen&amp;author=M%20Shen&amp;author=H%20Liao&amp;author=Q%20Guo&amp;author=H%20Fu&amp;volume=19&amp;publication_year=2021&amp;pages=55&amp;pmid=33632232&amp;doi=10.1186/s12951-021-00800-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b106-ijo-67-04-05789">
<span class="label">106.</span><cite>Srinageshwar B, Peruzzaro S, Andrews M, Johnson K, Hietpas A, Clark B, McGuire C, Petersen E, Kippe J, Stewart A, et al.  PAMAM dendrimers cross the Blood-brain barrier when administered through the carotid artery in C57BL/6J mice. Int J Mol Sci. 2017;18:628. doi: 10.3390/ijms18030628.</cite> [<a href="https://doi.org/10.3390/ijms18030628" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5372641/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28335421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Sci&amp;title=PAMAM%20dendrimers%20cross%20the%20Blood-brain%20barrier%20when%20administered%20through%20the%20carotid%20artery%20in%20C57BL/6J%20mice&amp;author=B%20Srinageshwar&amp;author=S%20Peruzzaro&amp;author=M%20Andrews&amp;author=K%20Johnson&amp;author=A%20Hietpas&amp;volume=18&amp;publication_year=2017&amp;pages=628&amp;pmid=28335421&amp;doi=10.3390/ijms18030628&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b107-ijo-67-04-05789">
<span class="label">107.</span><cite>Li J, Liang H, Liu J, Wang Z. Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy. Int J Pharm. 2018;546:215–225. doi: 10.1016/j.ijpharm.2018.05.045.</cite> [<a href="https://doi.org/10.1016/j.ijpharm.2018.05.045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29787895/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Pharm&amp;title=Poly%20(amidoamine)%20(PAMAM)%20dendrimer%20mediated%20delivery%20of%20drug%20and%20pDNA/siRNA%20for%20cancer%20therapy&amp;author=J%20Li&amp;author=H%20Liang&amp;author=J%20Liu&amp;author=Z%20Wang&amp;volume=546&amp;publication_year=2018&amp;pages=215-225&amp;pmid=29787895&amp;doi=10.1016/j.ijpharm.2018.05.045&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b108-ijo-67-04-05789">
<span class="label">108.</span><cite>Fana M, Gallien J, Srinageshwar B, Dunbar GL, Rossignol J. PAMAM dendrimer nanomolecules utilized as drug delivery systems for potential treatment of glioblastoma: A systematic review. Int J Nanomedicine. 2020;15:2789–2808. doi: 10.2147/IJN.S243155.</cite> [<a href="https://doi.org/10.2147/IJN.S243155" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7185330/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32368055/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Nanomedicine&amp;title=PAMAM%20dendrimer%20nanomolecules%20utilized%20as%20drug%20delivery%20systems%20for%20potential%20treatment%20of%20glioblastoma:%20A%20systematic%20review&amp;author=M%20Fana&amp;author=J%20Gallien&amp;author=B%20Srinageshwar&amp;author=GL%20Dunbar&amp;author=J%20Rossignol&amp;volume=15&amp;publication_year=2020&amp;pages=2789-2808&amp;pmid=32368055&amp;doi=10.2147/IJN.S243155&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b109-ijo-67-04-05789">
<span class="label">109.</span><cite>Saraswathy M, Knight GT, Pilla S, Ashton RS, Gong S. Multifunctional drug nanocarriers formed by cRGD-conjugated betaCD-PAMAM-PEG for targeted cancer therapy. Colloids Surf B Biointerfaces. 2015;126:590–597. doi: 10.1016/j.colsurfb.2014.12.042.</cite> [<a href="https://doi.org/10.1016/j.colsurfb.2014.12.042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4336634/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25591850/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Colloids%20Surf%20B%20Biointerfaces&amp;title=Multifunctional%20drug%20nanocarriers%20formed%20by%20cRGD-conjugated%20betaCD-PAMAM-PEG%20for%20targeted%20cancer%20therapy&amp;author=M%20Saraswathy&amp;author=GT%20Knight&amp;author=S%20Pilla&amp;author=RS%20Ashton&amp;author=S%20Gong&amp;volume=126&amp;publication_year=2015&amp;pages=590-597&amp;pmid=25591850&amp;doi=10.1016/j.colsurfb.2014.12.042&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b110-ijo-67-04-05789">
<span class="label">110.</span><cite>Tambe V, Thakkar S, Raval N, Sharma D, Kalia K, Tekade RK. Surface engineered dendrimers in siRNA delivery and gene silencing. Curr Pharm Des. 2017;23:2952–2975. doi: 10.2174/1381612823666170314104619.</cite> [<a href="https://doi.org/10.2174/1381612823666170314104619" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28292248/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Pharm%20Des&amp;title=Surface%20engineered%20dendrimers%20in%20siRNA%20delivery%20and%20gene%20silencing&amp;author=V%20Tambe&amp;author=S%20Thakkar&amp;author=N%20Raval&amp;author=D%20Sharma&amp;author=K%20Kalia&amp;volume=23&amp;publication_year=2017&amp;pages=2952-2975&amp;pmid=28292248&amp;doi=10.2174/1381612823666170314104619&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b111-ijo-67-04-05789">
<span class="label">111.</span><cite>Liaw K, Zhang F, Mangraviti A, Kannan S, Tyler B, Kannan RM. Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration. Bioeng Transl Med. 2020;5:e10160. doi: 10.1002/btm2.10160.</cite> [<a href="https://doi.org/10.1002/btm2.10160" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7237147/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32440565/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioeng%20Transl%20Med&amp;title=Dendrimer%20size%20effects%20on%20the%20selective%20brain%20tumor%20targeting%20in%20orthotopic%20tumor%20models%20upon%20systemic%20administration&amp;author=K%20Liaw&amp;author=F%20Zhang&amp;author=A%20Mangraviti&amp;author=S%20Kannan&amp;author=B%20Tyler&amp;volume=5&amp;publication_year=2020&amp;pages=e10160&amp;pmid=32440565&amp;doi=10.1002/btm2.10160&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b112-ijo-67-04-05789">
<span class="label">112.</span><cite>Sharma A, Liaw K, Sharma R, Zhang Z, Kannan S, Kannan RM. Targeting mitochondrial dysfunction and oxidative stress in activated microglia using Dendrimer-based therapeutics. Theranostics. 2018;8:5529–5547. doi: 10.7150/thno.29039.</cite> [<a href="https://doi.org/10.7150/thno.29039" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6276292/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30555562/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Theranostics&amp;title=Targeting%20mitochondrial%20dysfunction%20and%20oxidative%20stress%20in%20activated%20microglia%20using%20Dendrimer-based%20therapeutics&amp;author=A%20Sharma&amp;author=K%20Liaw&amp;author=R%20Sharma&amp;author=Z%20Zhang&amp;author=S%20Kannan&amp;volume=8&amp;publication_year=2018&amp;pages=5529-5547&amp;pmid=30555562&amp;doi=10.7150/thno.29039&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b113-ijo-67-04-05789">
<span class="label">113.</span><cite>Sharma R, Kim SY, Sharma A, Zhang Z, Kambhampati SP, Kannan S, Kannan RM. Activated microglia targeting Dendrimer-minocycline conjugate as therapeutics for neuroinflammation. Bioconjug Chem. 2017;28:2874–2886. doi: 10.1021/acs.bioconjchem.7b00569.</cite> [<a href="https://doi.org/10.1021/acs.bioconjchem.7b00569" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6023550/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29028353/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioconjug%20Chem&amp;title=Activated%20microglia%20targeting%20Dendrimer-minocycline%20conjugate%20as%20therapeutics%20for%20neuroinflammation&amp;author=R%20Sharma&amp;author=SY%20Kim&amp;author=A%20Sharma&amp;author=Z%20Zhang&amp;author=SP%20Kambhampati&amp;volume=28&amp;publication_year=2017&amp;pages=2874-2886&amp;pmid=29028353&amp;doi=10.1021/acs.bioconjchem.7b00569&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b114-ijo-67-04-05789">
<span class="label">114.</span><cite>Hu Q, Yao J, Wang X, Wang Y, Fu X, Ma J, Lin H, Xu J, Shen L, Yu X. Combinational chemoimmunotherapy for breast cancer by codelivery of doxorubicin and PD-L1 siRNA using a PAMAM-incorporated liposomal nanoplatform. ACS Appl Mater Interfaces. 2022;14:8782–8792. doi: 10.1021/acsami.1c21775.</cite> [<a href="https://doi.org/10.1021/acsami.1c21775" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35138103/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Appl%20Mater%20Interfaces&amp;title=Combinational%20chemoimmunotherapy%20for%20breast%20cancer%20by%20codelivery%20of%20doxorubicin%20and%20PD-L1%20siRNA%20using%20a%20PAMAM-incorporated%20liposomal%20nanoplatform&amp;author=Q%20Hu&amp;author=J%20Yao&amp;author=X%20Wang&amp;author=Y%20Wang&amp;author=X%20Fu&amp;volume=14&amp;publication_year=2022&amp;pages=8782-8792&amp;pmid=35138103&amp;doi=10.1021/acsami.1c21775&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b115-ijo-67-04-05789">
<span class="label">115.</span><cite>Caraway CA, Gaitsch H, Wicks EE, Kalluri A, Kunadi N, Tyler BM. Polymeric nanoparticles in brain cancer therapy: A review of current approaches. Polymers (Basel) 2022;14:2963. doi: 10.3390/polym14142963.</cite> [<a href="https://doi.org/10.3390/polym14142963" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9322801/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35890738/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Polymers%20(Basel)&amp;title=Polymeric%20nanoparticles%20in%20brain%20cancer%20therapy:%20A%20review%20of%20current%20approaches&amp;author=CA%20Caraway&amp;author=H%20Gaitsch&amp;author=EE%20Wicks&amp;author=A%20Kalluri&amp;author=N%20Kunadi&amp;volume=14&amp;publication_year=2022&amp;pages=2963&amp;pmid=35890738&amp;doi=10.3390/polym14142963&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b116-ijo-67-04-05789">
<span class="label">116.</span><cite>Qian L, Zheng J, Wang K, Tang Y, Zhang X, Zhang H, Huang F, Pei Y, Jiang Y. Cationic core-shell nanoparticles with carmustine contained within O6-benzylguanine shell for glioma therapy. Biomaterials. 2013;34:8968–8978. doi: 10.1016/j.biomaterials.2013.07.097.</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2013.07.097" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23953782/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Cationic%20core-shell%20nanoparticles%20with%20carmustine%20contained%20within%20O6-benzylguanine%20shell%20for%20glioma%20therapy&amp;author=L%20Qian&amp;author=J%20Zheng&amp;author=K%20Wang&amp;author=Y%20Tang&amp;author=X%20Zhang&amp;volume=34&amp;publication_year=2013&amp;pages=8968-8978&amp;pmid=23953782&amp;doi=10.1016/j.biomaterials.2013.07.097&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b117-ijo-67-04-05789">
<span class="label">117.</span><cite>Zhang P, Hu L, Yin Q, Feng L, Li Y. Transferrin-modified c[RGDfK]-paclitaxel loaded hybrid micelle for sequential blood-brain barrier penetration and glioma targeting therapy. Mol Pharm. 2012;9:1590–1598. doi: 10.1021/mp200600t.</cite> [<a href="https://doi.org/10.1021/mp200600t" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22497485/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Pharm&amp;title=Transferrin-modified%20c%5BRGDfK%5D-paclitaxel%20loaded%20hybrid%20micelle%20for%20sequential%20blood-brain%20barrier%20penetration%20and%20glioma%20targeting%20therapy&amp;author=P%20Zhang&amp;author=L%20Hu&amp;author=Q%20Yin&amp;author=L%20Feng&amp;author=Y%20Li&amp;volume=9&amp;publication_year=2012&amp;pages=1590-1598&amp;pmid=22497485&amp;doi=10.1021/mp200600t&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b118-ijo-67-04-05789">
<span class="label">118.</span><cite>Xin H, Chen L, Gu J, Ren X, Wei Z, Luo J, Chen Y, Jiang X, Sha X, Fang X. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(varepsilon-caprolactone) nanoparticles: In vitro and in vivo evaluation. Int J Pharm. 2010;402:238–247. doi: 10.1016/j.ijpharm.2010.10.005.</cite> [<a href="https://doi.org/10.1016/j.ijpharm.2010.10.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20934500/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Pharm&amp;title=Enhanced%20anti-glioblastoma%20efficacy%20by%20PTX-loaded%20PEGylated%20poly(varepsilon-caprolactone)%20nanoparticles:%20In%20vitro%20and%20in%20vivo%20evaluation&amp;author=H%20Xin&amp;author=L%20Chen&amp;author=J%20Gu&amp;author=X%20Ren&amp;author=Z%20Wei&amp;volume=402&amp;publication_year=2010&amp;pages=238-247&amp;pmid=20934500&amp;doi=10.1016/j.ijpharm.2010.10.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b119-ijo-67-04-05789">
<span class="label">119.</span><cite>Izquierdo M. Short interfering RNAs as a tool for cancer gene therapy. Cancer Gene Ther. 2005;12:217–227. doi: 10.1038/sj.cgt.7700791.</cite> [<a href="https://doi.org/10.1038/sj.cgt.7700791" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15550938/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Gene%20Ther&amp;title=Short%20interfering%20RNAs%20as%20a%20tool%20for%20cancer%20gene%20therapy&amp;author=M%20Izquierdo&amp;volume=12&amp;publication_year=2005&amp;pages=217-227&amp;pmid=15550938&amp;doi=10.1038/sj.cgt.7700791&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b120-ijo-67-04-05789">
<span class="label">120.</span><cite>Razavi ZS, Razavi FS, Alizadeh SS. Inorganic nanoparticles and blood-brain barrier modulation: Advancing targeted neurological therapies. Eur J Med Chem. 2025;287:117357. doi: 10.1016/j.ejmech.2025.117357.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2025.117357" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39947054/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Med%20Chem&amp;title=Inorganic%20nanoparticles%20and%20blood-brain%20barrier%20modulation:%20Advancing%20targeted%20neurological%20therapies&amp;author=ZS%20Razavi&amp;author=FS%20Razavi&amp;author=SS%20Alizadeh&amp;volume=287&amp;publication_year=2025&amp;pages=117357&amp;pmid=39947054&amp;doi=10.1016/j.ejmech.2025.117357&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b121-ijo-67-04-05789">
<span class="label">121.</span><cite>Liu Y, Bhattarai P, Dai Z, Chen X. Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. Chem Soc Rev. 2019;48:2053–2108. doi: 10.1039/C8CS00618K.</cite> [<a href="https://doi.org/10.1039/C8CS00618K" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6437026/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30259015/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem%20Soc%20Rev&amp;title=Photothermal%20therapy%20and%20photoacoustic%20imaging%20via%20nanotheranostics%20in%20fighting%20cancer&amp;author=Y%20Liu&amp;author=P%20Bhattarai&amp;author=Z%20Dai&amp;author=X%20Chen&amp;volume=48&amp;publication_year=2019&amp;pages=2053-2108&amp;pmid=30259015&amp;doi=10.1039/C8CS00618K&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b122-ijo-67-04-05789">
<span class="label">122.</span><cite>Bernardi RJ, Lowery AR, Thompson PA, Blaney SM, West JL. Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: An in vitro evaluation using human cell lines. J Neurooncol. 2008;86:165–172. doi: 10.1007/s11060-007-9467-3.</cite> [<a href="https://doi.org/10.1007/s11060-007-9467-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17805488/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neurooncol&amp;title=Immunonanoshells%20for%20targeted%20photothermal%20ablation%20in%20medulloblastoma%20and%20glioma:%20An%20in%20vitro%20evaluation%20using%20human%20cell%20lines&amp;author=RJ%20Bernardi&amp;author=AR%20Lowery&amp;author=PA%20Thompson&amp;author=SM%20Blaney&amp;author=JL%20West&amp;volume=86&amp;publication_year=2008&amp;pages=165-172&amp;pmid=17805488&amp;doi=10.1007/s11060-007-9467-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b123-ijo-67-04-05789">
<span class="label">123.</span><cite>Ruan S, Xie R, Qin L, Yu M, Xiao W, Hu C, Yu W, Qian Z, Ouyang L, He Q, Gao H. Aggregable Nanoparticles-enabled chemotherapy and autophagy inhibition combined with Anti-PD-L1 antibody for improved glioma treatment. Nano Lett. 2019;19:8318–8332. doi: 10.1021/acs.nanolett.9b03968.</cite> [<a href="https://doi.org/10.1021/acs.nanolett.9b03968" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31610656/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nano%20Lett&amp;title=Aggregable%20Nanoparticles-enabled%20chemotherapy%20and%20autophagy%20inhibition%20combined%20with%20Anti-PD-L1%20antibody%20for%20improved%20glioma%20treatment&amp;author=S%20Ruan&amp;author=R%20Xie&amp;author=L%20Qin&amp;author=M%20Yu&amp;author=W%20Xiao&amp;volume=19&amp;publication_year=2019&amp;pages=8318-8332&amp;pmid=31610656&amp;doi=10.1021/acs.nanolett.9b03968&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b124-ijo-67-04-05789">
<span class="label">124.</span><cite>Qiu J, Kong L, Cao X, Li A, Wei P, Wang L, Mignani S, Caminade AM, Majoral JP, Shi X. Enhanced delivery of therapeutic siRNA into glioblastoma cells using Dendrimer-entrapped gold nanoparticles conjugated with β-cyclodextrin. Nanomaterials (Basel) 2018;8:131. doi: 10.3390/nano8030131.</cite> [<a href="https://doi.org/10.3390/nano8030131" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5869622/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29495429/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanomaterials%20(Basel)&amp;title=Enhanced%20delivery%20of%20therapeutic%20siRNA%20into%20glioblastoma%20cells%20using%20Dendrimer-entrapped%20gold%20nanoparticles%20conjugated%20with%20%CE%B2-cyclodextrin&amp;author=J%20Qiu&amp;author=L%20Kong&amp;author=X%20Cao&amp;author=A%20Li&amp;author=P%20Wei&amp;volume=8&amp;publication_year=2018&amp;pages=131&amp;pmid=29495429&amp;doi=10.3390/nano8030131&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b125-ijo-67-04-05789">
<span class="label">125.</span><cite>Maleki P, Dinari A, Jahangiri B, Raheb J. In vitro assessments of nanoplexes of polyethylenimine-coated graphene oxide-plasmid through various cancer cell lines and primary mesenchymal stem cells. PLoS One. 2023;18:e0295822. doi: 10.1371/journal.pone.0295822.</cite> [<a href="https://doi.org/10.1371/journal.pone.0295822" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10720998/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38096179/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=In%20vitro%20assessments%20of%20nanoplexes%20of%20polyethylenimine-coated%20graphene%20oxide-plasmid%20through%20various%20cancer%20cell%20lines%20and%20primary%20mesenchymal%20stem%20cells&amp;author=P%20Maleki&amp;author=A%20Dinari&amp;author=B%20Jahangiri&amp;author=J%20Raheb&amp;volume=18&amp;publication_year=2023&amp;pages=e0295822&amp;pmid=38096179&amp;doi=10.1371/journal.pone.0295822&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b126-ijo-67-04-05789">
<span class="label">126.</span><cite>Chuang CC, Lan YH, Lu YJ, Weng YL, Chen JP. Targeted delivery of irinotecan and SLP2 shRNA with GRP-conjugated magnetic graphene oxide for glioblastoma treatment. Biomater Sci. 2022;10:3201–3222. doi: 10.1039/D2BM00420H.</cite> [<a href="https://doi.org/10.1039/D2BM00420H" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35579261/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomater%20Sci&amp;title=Targeted%20delivery%20of%20irinotecan%20and%20SLP2%20shRNA%20with%20GRP-conjugated%20magnetic%20graphene%20oxide%20for%20glioblastoma%20treatment&amp;author=CC%20Chuang&amp;author=YH%20Lan&amp;author=YJ%20Lu&amp;author=YL%20Weng&amp;author=JP%20Chen&amp;volume=10&amp;publication_year=2022&amp;pages=3201-3222&amp;pmid=35579261&amp;doi=10.1039/D2BM00420H&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b127-ijo-67-04-05789">
<span class="label">127.</span><cite>Norouzi M, Yathindranath V, Thliveris JA, Miller DW. Salinomycin-loaded iron oxide nanoparticles for glioblastoma therapy. Nanomaterials (Basel) 2020;10:477. doi: 10.3390/nano10030477.</cite> [<a href="https://doi.org/10.3390/nano10030477" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7153627/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32155938/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanomaterials%20(Basel)&amp;title=Salinomycin-loaded%20iron%20oxide%20nanoparticles%20for%20glioblastoma%20therapy&amp;author=M%20Norouzi&amp;author=V%20Yathindranath&amp;author=JA%20Thliveris&amp;author=DW%20Miller&amp;volume=10&amp;publication_year=2020&amp;pages=477&amp;pmid=32155938&amp;doi=10.3390/nano10030477&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b128-ijo-67-04-05789">
<span class="label">128.</span><cite>Saalik P, Lingasamy P, Toome K, Mastandrea I, Rousso-Noori L, Tobi A, Simon-Gracia L, Hunt H, Paiste P, Kotamraju VR, et al.  Peptide-guided nanoparticles for glioblastoma targeting. J Control Release. 2019;308:109–118. doi: 10.1016/j.jconrel.2019.06.018.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2019.06.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31255690/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Control%20Release&amp;title=Peptide-guided%20nanoparticles%20for%20glioblastoma%20targeting&amp;author=P%20Saalik&amp;author=P%20Lingasamy&amp;author=K%20Toome&amp;author=I%20Mastandrea&amp;author=L%20Rousso-Noori&amp;volume=308&amp;publication_year=2019&amp;pages=109-118&amp;pmid=31255690&amp;doi=10.1016/j.jconrel.2019.06.018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b129-ijo-67-04-05789">
<span class="label">129.</span><cite>Manago A, Leanza L, Carraretto L, Sassi N, Grancara S, Quintana-Cabrera R, Trimarco V, Toninello A, Scorrano L, Trentin L, et al.  Early effects of the antineoplastic agent salinomycin on mitochondrial function. Cell Death Dis. 2015;6:e1930. doi: 10.1038/cddis.2015.263.</cite> [<a href="https://doi.org/10.1038/cddis.2015.263" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4632293/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26492365/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Dis&amp;title=Early%20effects%20of%20the%20antineoplastic%20agent%20salinomycin%20on%20mitochondrial%20function&amp;author=A%20Manago&amp;author=L%20Leanza&amp;author=L%20Carraretto&amp;author=N%20Sassi&amp;author=S%20Grancara&amp;volume=6&amp;publication_year=2015&amp;pages=e1930&amp;pmid=26492365&amp;doi=10.1038/cddis.2015.263&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b130-ijo-67-04-05789">
<span class="label">130.</span><cite>Zhang Y, Fu X, Jia J, Wikerholmen T, Xi K, Kong Y, Wang J, Chen H, Ma Y, Li Z, et al.  Glioblastoma therapy using codelivery of cisplatin and glutathione peroxidase targeting siRNA from iron oxide nanoparticles. ACS Appl Mater Interfaces. 2020;12:43408–43421. doi: 10.1021/acsami.0c12042.</cite> [<a href="https://doi.org/10.1021/acsami.0c12042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32885649/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Appl%20Mater%20Interfaces&amp;title=Glioblastoma%20therapy%20using%20codelivery%20of%20cisplatin%20and%20glutathione%20peroxidase%20targeting%20siRNA%20from%20iron%20oxide%20nanoparticles&amp;author=Y%20Zhang&amp;author=X%20Fu&amp;author=J%20Jia&amp;author=T%20Wikerholmen&amp;author=K%20Xi&amp;volume=12&amp;publication_year=2020&amp;pages=43408-43421&amp;pmid=32885649&amp;doi=10.1021/acsami.0c12042&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b131-ijo-67-04-05789">
<span class="label">131.</span><cite>Wang X, Ruifang L, Zhu Y, Wang Z, Zhang H, Cui L, Duan S, Guo Y. Active targeting co-delivery of therapeutic Sur siRNA and an antineoplastic drug via epidermal growth factor receptor-mediated magnetic nanoparticles for synergistic programmed cell death in glioblastoma stem cells. Materials Chemistry Front. 2019;4:574–588. doi: 10.1039/C9QM00666D.</cite> [<a href="https://doi.org/10.1039/C9QM00666D" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Materials%20Chemistry%20Front&amp;title=Active%20targeting%20co-delivery%20of%20therapeutic%20Sur%20siRNA%20and%20an%20antineoplastic%20drug%20via%20epidermal%20growth%20factor%20receptor-mediated%20magnetic%20nanoparticles%20for%20synergistic%20programmed%20cell%20death%20in%20glioblastoma%20stem%20cells&amp;author=X%20Wang&amp;author=L%20Ruifang&amp;author=Y%20Zhu&amp;author=Z%20Wang&amp;author=H%20Zhang&amp;volume=4&amp;publication_year=2019&amp;pages=574-588&amp;doi=10.1039/C9QM00666D&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b132-ijo-67-04-05789">
<span class="label">132.</span><cite>Nichols JW, Bae YH. EPR: Evidence and fallacy. J Control Release. 2014;190:451–464. doi: 10.1016/j.jconrel.2014.03.057.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2014.03.057" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24794900/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Control%20Release&amp;title=EPR:%20Evidence%20and%20fallacy&amp;author=JW%20Nichols&amp;author=YH%20Bae&amp;volume=190&amp;publication_year=2014&amp;pages=451-464&amp;pmid=24794900&amp;doi=10.1016/j.jconrel.2014.03.057&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b133-ijo-67-04-05789">
<span class="label">133.</span><cite>Liu J, Yu M, Ning X, Zhou C, Yang S, Zheng J. PEGylation and zwitterionization: Pros and cons in the renal clearance and tumor targeting of near-IR-emitting gold nanoparticles. Angew Chem Int Ed Engl. 2013;52:12572–12576. doi: 10.1002/anie.201304465.</cite> [<a href="https://doi.org/10.1002/anie.201304465" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4127427/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24123783/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Angew%20Chem%20Int%20Ed%20Engl&amp;title=PEGylation%20and%20zwitterionization:%20Pros%20and%20cons%20in%20the%20renal%20clearance%20and%20tumor%20targeting%20of%20near-IR-emitting%20gold%20nanoparticles&amp;author=J%20Liu&amp;author=M%20Yu&amp;author=X%20Ning&amp;author=C%20Zhou&amp;author=S%20Yang&amp;volume=52&amp;publication_year=2013&amp;pages=12572-12576&amp;pmid=24123783&amp;doi=10.1002/anie.201304465&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b134-ijo-67-04-05789">
<span class="label">134.</span><cite>Corbo C, Molinaro R, Parodi A, Toledano Furman NE, Salvatore F, Tasciotti E. The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery. Nanomedicine (Lond) 2016;11:81–100. doi: 10.2217/nnm.15.188.</cite> [<a href="https://doi.org/10.2217/nnm.15.188" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4910943/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26653875/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanomedicine%20(Lond)&amp;title=The%20impact%20of%20nanoparticle%20protein%20corona%20on%20cytotoxicity,%20immunotoxicity%20and%20target%20drug%20delivery&amp;author=C%20Corbo&amp;author=R%20Molinaro&amp;author=A%20Parodi&amp;author=NE%20Toledano%20Furman&amp;author=F%20Salvatore&amp;volume=11&amp;publication_year=2016&amp;pages=81-100&amp;pmid=26653875&amp;doi=10.2217/nnm.15.188&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b135-ijo-67-04-05789">
<span class="label">135.</span><cite>Zhang TX, Zhu GY, Lu BY, Zhang CL, Peng Q. Concentration-dependent protein adsorption at the nano-bio interfaces of polymeric nanoparticles and serum proteins. Nanomedicine (Lond) 2017;12:2757–2769. doi: 10.2217/nnm-2017-0238.</cite> [<a href="https://doi.org/10.2217/nnm-2017-0238" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29017387/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanomedicine%20(Lond)&amp;title=Concentration-dependent%20protein%20adsorption%20at%20the%20nano-bio%20interfaces%20of%20polymeric%20nanoparticles%20and%20serum%20proteins&amp;author=TX%20Zhang&amp;author=GY%20Zhu&amp;author=BY%20Lu&amp;author=CL%20Zhang&amp;author=Q%20Peng&amp;volume=12&amp;publication_year=2017&amp;pages=2757-2769&amp;pmid=29017387&amp;doi=10.2217/nnm-2017-0238&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b136-ijo-67-04-05789">
<span class="label">136.</span><cite>Liu J, Dong J, Zhang T, Peng Q. Graphene-based nanomaterials and their potentials in advanced drug delivery and cancer therapy. J Control Release. 2018;286:64–73. doi: 10.1016/j.jconrel.2018.07.034.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2018.07.034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30031155/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Control%20Release&amp;title=Graphene-based%20nanomaterials%20and%20their%20potentials%20in%20advanced%20drug%20delivery%20and%20cancer%20therapy&amp;author=J%20Liu&amp;author=J%20Dong&amp;author=T%20Zhang&amp;author=Q%20Peng&amp;volume=286&amp;publication_year=2018&amp;pages=64-73&amp;pmid=30031155&amp;doi=10.1016/j.jconrel.2018.07.034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b137-ijo-67-04-05789">
<span class="label">137.</span><cite>Xiao W, Wang Y, Zhang H, Liu Y, Xie R, He X, Zhou Y, Liang L, Gao H. The protein corona hampers the transcytosis of Transferrin-modified nanoparticles through blood-brain barrier and attenuates their targeting ability to brain tumor. Biomaterials. 2021;274:120888. doi: 10.1016/j.biomaterials.2021.120888.</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2021.120888" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34029915/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=The%20protein%20corona%20hampers%20the%20transcytosis%20of%20Transferrin-modified%20nanoparticles%20through%20blood-brain%20barrier%20and%20attenuates%20their%20targeting%20ability%20to%20brain%20tumor&amp;author=W%20Xiao&amp;author=Y%20Wang&amp;author=H%20Zhang&amp;author=Y%20Liu&amp;author=R%20Xie&amp;volume=274&amp;publication_year=2021&amp;pages=120888&amp;pmid=34029915&amp;doi=10.1016/j.biomaterials.2021.120888&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b138-ijo-67-04-05789">
<span class="label">138.</span><cite>Schottler S, Landfester K, Mailander V. Controlling the stealth effect of nanocarriers through understanding the protein corona. Angew Chem Int Ed Engl. 2016;55:8806–8815. doi: 10.1002/anie.201602233.</cite> [<a href="https://doi.org/10.1002/anie.201602233" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27303916/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Angew%20Chem%20Int%20Ed%20Engl&amp;title=Controlling%20the%20stealth%20effect%20of%20nanocarriers%20through%20understanding%20the%20protein%20corona&amp;author=S%20Schottler&amp;author=K%20Landfester&amp;author=V%20Mailander&amp;volume=55&amp;publication_year=2016&amp;pages=8806-8815&amp;pmid=27303916&amp;doi=10.1002/anie.201602233&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b139-ijo-67-04-05789">
<span class="label">139.</span><cite>Gao H, He Q. The interaction of nanoparticles with plasma proteins and the consequent influence on nanoparticles behavior. Expert Opin Drug Deliv. 2014;11:409–420. doi: 10.1517/17425247.2014.877442.</cite> [<a href="https://doi.org/10.1517/17425247.2014.877442" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24397260/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opin%20Drug%20Deliv&amp;title=The%20interaction%20of%20nanoparticles%20with%20plasma%20proteins%20and%20the%20consequent%20influence%20on%20nanoparticles%20behavior&amp;author=H%20Gao&amp;author=Q%20He&amp;volume=11&amp;publication_year=2014&amp;pages=409-420&amp;pmid=24397260&amp;doi=10.1517/17425247.2014.877442&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b140-ijo-67-04-05789">
<span class="label">140.</span><cite>Peng Q, Wei XQ, Yang Q, Zhang S, Zhang T, Shao XR, Cai XX, Zhang ZR, Lin YF. Enhanced biostability of nanoparticle-based drug delivery systems by albumin corona. Nanomedicine (Lond) 2015;10:205–214. doi: 10.2217/nnm.14.86.</cite> [<a href="https://doi.org/10.2217/nnm.14.86" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25600966/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanomedicine%20(Lond)&amp;title=Enhanced%20biostability%20of%20nanoparticle-based%20drug%20delivery%20systems%20by%20albumin%20corona&amp;author=Q%20Peng&amp;author=XQ%20Wei&amp;author=Q%20Yang&amp;author=S%20Zhang&amp;author=T%20Zhang&amp;volume=10&amp;publication_year=2015&amp;pages=205-214&amp;pmid=25600966&amp;doi=10.2217/nnm.14.86&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b141-ijo-67-04-05789">
<span class="label">141.</span><cite>Zhang Z, Guan J, Jiang Z, Yang Y, Liu J, Hua W, Mao Y, Li C, Lu W, Qian J, Zhan C. Brain-targeted drug delivery by manipulating protein corona functions. Nat Commun. 2019;10:3561. doi: 10.1038/s41467-019-11593-z.</cite> [<a href="https://doi.org/10.1038/s41467-019-11593-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6687821/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31395892/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=Brain-targeted%20drug%20delivery%20by%20manipulating%20protein%20corona%20functions&amp;author=Z%20Zhang&amp;author=J%20Guan&amp;author=Z%20Jiang&amp;author=Y%20Yang&amp;author=J%20Liu&amp;volume=10&amp;publication_year=2019&amp;pages=3561&amp;pmid=31395892&amp;doi=10.1038/s41467-019-11593-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b142-ijo-67-04-05789">
<span class="label">142.</span><cite>Zhang ZA, Xin X, Liu C, Liu YH, Duan HX, Qi LL, Zhang YY, Zhao HM, Chen LQ, Jin MJ, et al.  Novel brain-targeted nanomicelles for anti-glioma therapy mediated by the ApoE-enriched protein corona in vivo. J Nanobiotechnology. 2021;19:453. doi: 10.1186/s12951-021-01097-8.</cite> [<a href="https://doi.org/10.1186/s12951-021-01097-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8715648/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34963449/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Nanobiotechnology&amp;title=Novel%20brain-targeted%20nanomicelles%20for%20anti-glioma%20therapy%20mediated%20by%20the%20ApoE-enriched%20protein%20corona%20in%20vivo&amp;author=ZA%20Zhang&amp;author=X%20Xin&amp;author=C%20Liu&amp;author=YH%20Liu&amp;author=HX%20Duan&amp;volume=19&amp;publication_year=2021&amp;pages=453&amp;pmid=34963449&amp;doi=10.1186/s12951-021-01097-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b143-ijo-67-04-05789">
<span class="label">143.</span><cite>Cheng Z, Li M, Dey R, Chen Y. Nanomaterials for cancer therapy: Current progress and perspectives. J Hematol Oncol. 2021;14:85. doi: 10.1186/s13045-021-01096-0.</cite> [<a href="https://doi.org/10.1186/s13045-021-01096-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8165984/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34059100/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Hematol%20Oncol&amp;title=Nanomaterials%20for%20cancer%20therapy:%20Current%20progress%20and%20perspectives&amp;author=Z%20Cheng&amp;author=M%20Li&amp;author=R%20Dey&amp;author=Y%20Chen&amp;volume=14&amp;publication_year=2021&amp;pages=85&amp;pmid=34059100&amp;doi=10.1186/s13045-021-01096-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b144-ijo-67-04-05789">
<span class="label">144.</span><cite>Xu HL, Yang JJ, ZhuGe DL, Lin MT, Zhu QY, Jin BH, Tong MQ, Shen BX, Xiao J, Zhao YZ. Glioma-targeted delivery of a theranostic liposome integrated with quantum dots, superparamagnetic iron oxide, and cilengitide for Dual-imaging guiding cancer surgery. Adv Healthc Mater. 2018;7:e1701130. doi: 10.1002/adhm.201701130.</cite> [<a href="https://doi.org/10.1002/adhm.201701130" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29350498/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv%20Healthc%20Mater&amp;title=Glioma-targeted%20delivery%20of%20a%20theranostic%20liposome%20integrated%20with%20quantum%20dots,%20superparamagnetic%20iron%20oxide,%20and%20cilengitide%20for%20Dual-imaging%20guiding%20cancer%20surgery&amp;author=HL%20Xu&amp;author=JJ%20Yang&amp;author=DL%20ZhuGe&amp;author=MT%20Lin&amp;author=QY%20Zhu&amp;volume=7&amp;publication_year=2018&amp;pages=e1701130&amp;pmid=29350498&amp;doi=10.1002/adhm.201701130&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b145-ijo-67-04-05789">
<span class="label">145.</span><cite>Wu VM, Huynh E, Tang S, Uskokovic V. Brain and bone cancer targeting by a ferrofluid composed of superparamagnetic iron-oxide/silica/carbon nanoparticles (earthicles) Acta Biomater. 2019;88:422–447. doi: 10.1016/j.actbio.2019.01.064.</cite> [<a href="https://doi.org/10.1016/j.actbio.2019.01.064" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30711662/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Biomater&amp;title=Brain%20and%20bone%20cancer%20targeting%20by%20a%20ferrofluid%20composed%20of%20superparamagnetic%20iron-oxide/silica/carbon%20nanoparticles%20(earthicles)&amp;author=VM%20Wu&amp;author=E%20Huynh&amp;author=S%20Tang&amp;author=V%20Uskokovic&amp;volume=88&amp;publication_year=2019&amp;pages=422-447&amp;pmid=30711662&amp;doi=10.1016/j.actbio.2019.01.064&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b146-ijo-67-04-05789">
<span class="label">146.</span><cite>Arias-Ramos N, Ibarra LE, Serrano-Torres M, Yague B, Caverzan MD, Chesta CA, Palacios RE, Lopez-Larrubia P. Iron oxide incorporated conjugated polymer nanoparticles for simultaneous use in magnetic resonance and fluorescent imaging of brain tumors. Pharmaceutics. 2021;13:1258. doi: 10.3390/pharmaceutics13081258.</cite> [<a href="https://doi.org/10.3390/pharmaceutics13081258" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8400017/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34452219/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceutics&amp;title=Iron%20oxide%20incorporated%20conjugated%20polymer%20nanoparticles%20for%20simultaneous%20use%20in%20magnetic%20resonance%20and%20fluorescent%20imaging%20of%20brain%20tumors&amp;author=N%20Arias-Ramos&amp;author=LE%20Ibarra&amp;author=M%20Serrano-Torres&amp;author=B%20Yague&amp;author=MD%20Caverzan&amp;volume=13&amp;publication_year=2021&amp;pages=1258&amp;pmid=34452219&amp;doi=10.3390/pharmaceutics13081258&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Not applicable.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from International Journal of Oncology are provided here courtesy of <strong>Spandidos Publications</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3892/ijo.2025.5789"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/ijo-67-04-05789.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.6 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12370360/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12370360/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12370360%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370360/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12370360/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12370360/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40849813/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12370360/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40849813/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12370360/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12370360/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="MNg6tVsD0c0YmeWXjlKI5CrjI14ByCtUlxUUfYV1WcyTNRVa8JOQv813z78GTZ8F">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
